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PRELIMINARIES I 
 
ABSTRACT 
A Novel Peptide Hydrogel for an Antimicrobial Bandage Contact Lens by Andrew Gerard Gallagher 
 
Introduction: 
Corneal bandage lenses could have an important role to play in the treatment 
of corneal infection and disease. The application of bandage contact lenses 
for corneal ulcers are of interest as current treatment involves the topical 
administration of antibiotics, of which only 1 - 7% is absorbed to the site of 
infection. This inefficiency allows a lot of scope to improve the delivery of drugs 
to the surface of the eye. This study aimed to investigate the natural 
antimicrobial activity of a novel hydrogel as well as observing differences in 
activity when compounds such as additional poly-ε-lysine (pεK), penicillin G 
and amphotericin B were covalently or ionically coupled to the hydrogel. The 
ability to detect microbial keratitis pathogens was also investigated with the 
association of bacteria-identifying peptides to the hydrogel. 
 
Methods: 
Peptide hydrogels were synthesised from pεK cross-linked with octanedioic 
acid to densities of 0.067 - 0.1 g cm-3 and 45 - 80% cross-linking. The 
hydrogels were evaluated with a range of mechanical and physical tests. The 
hydrogels were also modified to bind additional pεK or the ionic association of 
penicillin G, amphotericin B or fluorescently labelled antimicrobial peptides. 
Hydrogel samples were incubated with E. coli, S. aureus or C. albicans and 
metabolic activity assays, plate counts and immunofluorescence techniques 
used to determine antimicrobial activity and the ability to identify microbes. 
Cytotoxicity of the hydrogels towards a human corneal epithelial cell line was 
monitored via a CCK-8 assay, scratch assay and antibody staining. 
 
Results: 
High water content (> 70%) hydrogels with comparable mechanical and 
physical properties to commercial contact lens materials were developed. A 
significant difference in antimicrobial activity was obtained by altering the 
surface properties of the hydrogel with either additional pεK or penicillin G 
compared to the LB agar control. Similar results for E. coli were observed. 
Hydrogels loaded with amphotericin B retained an antifungal activity against 
C. albicans under both normal conditions and in the presence of horse serum. 
The hydrogel demonstrated a drug release profile which was maintained 
above therapeutic levels for 72 h whilst amphotericin B stability was 
maintained for at least 48 h. The sorption of fluorescently labelled antimicrobial 
peptides to the hydrogel resulted in the successful labelling of both S. aureus 
and E. coli with no cytotoxicity towards HCE-T cells.  
 
Conclusion: 
Cross-linked pεK hydrogels with mechanical and physical properties 
comparable to commercial lens materials were developed. These alone were 
not antimicrobial towards E. coli, S. aureus or C. albicans, however, 
associating known antimicrobials with the free amine groups on the cross-
linked hydrogel caused a significant antimicrobial effect. Furthermore, the 
association of fluorescently labelled antimicrobial peptides enabled the 
hydrogel to label bacteria. These modified hydrogels could have a role as 
bandage contact lenses in the diagnosis and treatment of corneal ulcers. 
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1. INTRODUCTION 
 
1.1 The Cornea 
 
The cornea is a transparent, avascular tissue composed of five layers and 
situated in the anterior segment of the eye (Figure 1.1). It is responsible for 
the refraction of light necessary for vision. The smooth surface of the anterior 
cornea is the refractive surface of the eye and coupled with corneal 
transparency allows light to pass through to the lens and onto the retina for 
photoreceptor activation (Gheorghe et al., 2016). The cornea is the part of 
the eye most exposed to injury from external risk factors but is surrounded by 
a trilayer coating called the tear film that acts as a protective mechanism. The 
cornea, in turn, provides a protective barrier against disease and trauma to 
the rest of the eye tissue. 
 
 
 
 
 Figure 1.1: An illustration of the eye highlighting the position of the cornea at the anterior 
region. 
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1.1.1 Structure and function of the cornea: 
The five layers of the cornea (Figure 1.2) the epithelium, Bowman’s layer, the 
stroma, Descemet’s membrane and the endothelium form the 550 μm thick 
corneal tissue (Shah et al., 1999). As well as providing a barrier to injury and 
infection to the posterior of the eye the cornea also provides approximately 
three quarters of the eyes total refractive power. This is mainly attributed to 
the cornea having a refractive index of 1.38 and a 7.8 mm radius of curvature 
(Eghrari, A.O., Riazuddin, S.A. and Gottsch, 2015; Kim et al., 2004). 
 
The corneal epithelium is a non-keratinised stratified squamous epithelium, 
approximately 50 µm thick and consists of 5 - 7 layers of epithelial cells. The 
main function of the corneal epithelium is to act as a physical barrier to 
intrusions from the external environment whilst preventing a loss of fluid from 
the underlying stroma and maintaining ocular transparency (Szliter-Berger 
and Hazlett, 2010). The posterior layer of the corneal epithelium consists of 
basal epithelial cells that anchor the epithelium to bowman’s layer by way of 
a basement membrane complex, a complex mesh of type VI and VII collagen 
(Forrester et al., 2008). Hemidesmosomes form tight adhesions between the 
basal epithelial cells and the basement membrane and play an important role 
in both cell renewal and the formation of a protective barrier (Stepp, 2010). 
Gap junctions and desmosomes organise the cell-cell barrier function 
between basal epithelial cells and the suprabasal wing-like cells that align 
themselves above the columnar basal cells (Hamrah and Sahin, 2013). The 
outermost cell type in the corneal epithelium is the superficial cells that 
contain microvilli that interact with and stabilise the surrounding tear film. 
Tight junctions are formed between superficial cells via zonula occludens to 
provide the most effective barrier at the anterior surface where the epithelium 
interacts with the tear film. The continuous renewal of the epithelium to 
maintain transparency begins with the proliferation of basal epithelial cells 
that migrate towards the anterior of the epithelium and ultimately result in the 
shedding of superficial cells from the surface (Lu, Reinach and Kao, 2001). In 
response to injury limbal epithelial stem cells located at the limbus begin 
rapid division resulting in their differentiation to early transient amplifying cells 
which in turn differentiate into transient amplifying cells before replacing 
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basal epithelial cells (Hamrah and Sahin, 2013). This continuous renewal of 
corneal epithelial cells allows for maintenance of the integrity of the 
epithelium allowing it to continually function as an effective barrier and 
maintain transparency.  
 
 
 
 
 
 
Bowman’s layer is an acellular region that separates the epithelial basement 
membrane from the anterior corneal stroma. It is between 8 - 14 µm thick 
and formed by fine, densely packed collagen (types I, III, V and VI) (Forrester 
et al., 2008; Lagali, Germundsson and Fagerholm, 2009). Collagen IV fibrils 
are also present and act as an anchoring mechanism to the epithelium above 
(Wilson and Hong, 2000). The collagen fibrils associated with Bowman’s 
layer are randomly ordered compared to the aligned fibrils that make up the 
lamellae of the corneal stroma (Lagali, Germundsson and Fagerholm, 2009). 
Figure 1.2: The five layers of the cornea with their primary cell types. Diagram is not to 
scale. 
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The precise function of Bowman’s layer is unknown; however, nerve axons 
pass through Bowman’s layer to provide innervation to the epithelium. It has 
been suggested that Bowman’s layer facilitates wound healing of the cornea 
by acting as a physical barrier to the underlying stroma, allowing for 
accelerated restoration of transparency whilst protecting the nerve plexus 
underlying the epithelium. The physical, acellular barrier can also prevent the 
passing of viruses through the epithelium to the posterior of the cornea 
(Gandhi and Jain, 2015; Lagali, Germundsson and Fagerholm, 2009).  
 
The stroma is a centrally located, avascular layer of the cornea and is 
approximately 500 µm thick (Chen, Mienaltowski and Birk, 2015). The stroma 
consists of 200 - 250 layers of 2 µm thick lamellae which are mostly 
composed of collagen (types I, V and VI) and proteoglycans that interact with 
collagen fibrils to form an ordered, closely packed network that ensures the 
transparency of the corneal tissue (Forrester et al., 2008; Meek and Boote, 
2004). Type I collagen is the most abundant type of collagen contained within 
the fibrils followed by type V collagen which along with proteoglycans help to 
regulate the gaps between fibrils which is vital to maintaining transparency 
(Forrester et al., 2008). Type VI collagen forms 100 nm thick filaments that 
may also play a role in regulating fibril arrangement (Meek and Boote, 2004). 
Keratocytes, differentiated mesenchymal fibroblasts with a dendritic 
morphology, are the primary cell type within the stroma and are responsible 
for the deposition of the collagenous matrix as well as other extracellular 
matrix macromolecules and proteins such as laminin and fibronectin (Gandhi 
and Jain, 2015). The stratification of keratocytes reduces the surface area of 
the cell exposed to light thereby minimising light scattering and maintaining 
transparency. Keratocytes are interconnected within the stroma by filopodia 
with gap-junctions mediating cell-cell contact (Chen, Mienaltowski and Birk, 
2015). The anterior and the posterior of the stroma differ in their composition. 
The posterior is more ordered, hydrated and has a lower refractive index than 
the anterior with changes in keratocyte number and morphology evident 
(Bron, 2001; Meek et al., 2003). Part of the anterior stroma lamellae 
interweaves into Bowman’s layer resulting in increased mechanical stability 
of the anterior cornea (Meek and Boote, 2004). 
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Descemet’s membrane separates the stroma from the posterior endothelium 
layer of the cornea. At birth, the membrane is 3 µm thick and gradually 
increases to 10 µm in adults due to deposition of extracellular matrix 
macromolecules from the underlying corneal endothelial cells (Pavelka and 
Roth, 2010). Similarly to Bowman’s layer and other basement membranes of 
the body, Descemet’s membrane contains collagen IV. Types V and VI 
collagen are found at the anterior of Descemet’s membrane and most likely 
part of an adherence mechanism linking it with the stroma (Forrester et al., 
2008). Type VIII collagen is present in high concentrations in Descemet’s 
membrane but is rarely seen in other parts of the body. It forms lattice type 
networks and is most prevalent in the anterior segment of the membrane 
(Pavelka and Roth, 2010). Descemet’s membrane is a basement membrane 
for the underlying endothelial cells and assists in maintaining corneal 
dehydration (Eghrari, A.O., Riazuddin, S.A. and Gottsch, 2015).   
 
The posterior segment of the cornea is the endothelium and is composed of 
a monolayer of endothelial cells. The cells are approximately 6 µm thick and 
rest on Descemet’s membrane upon which they excrete extracellular matrix 
proteins and molecules (Forrester et al., 2008). The main function of the 
endothelium is to provide a barrier and regulate deturgescence to maintain 
transparency. This is achieved by way of tight and adherens junctions and an 
ionic pump function associated with bicarbonate dependant Mg2+ -ATPase 
and Na+/K+ -ATPase (Joyce, 2012; Eghrari, A.O., Riazuddin, S.A. and 
Gottsch, 2015; Ali and Murphy, 2016). Corneal endothelial cells are non-
regenerative in vivo reducing from 6,000 cells mm-2 at birth to 2300 cells mm-
2 at 85 years of age with an average rate of loss of 0.6% per year (Bourne, 
2003; Joyce, 2012). During a lifetime, endothelial cell surface area increases 
to maintain the endothelial barrier and maintain function as loss of cells to 
disease and trauma are not replaced (Bourne and McLaren, 2004). Trauma 
to this area of the cornea can result in serious complications most notably if 
the ion pump capacity is compromised as this may result in a loss of visual 
acuity and lead to more serious conditions such as bullous keratopathy 
(Parekh et al., 2013). 
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1.1.2 The tear film: 
The tear film is a physical barrier that protects the outermost mucosal tissue 
of the eye from microorganisms and organic matter whilst retaining a stable 
fluid that complements the rest of the cornea ensuring transparency is 
maintained (McCulley and Shine, 2001; Craig, Tomlinson and McCann, 
2010). The tear film is composed of three layers (Figure 1.3) and is 
approximately 4 - 8 µm thick. The posterior layer consists of mucins secreted 
from the underlying corneal and conjunctival epithelium followed by an 
aqueous layer that is coated with the tear film lipid layer (TFLL). More 
specifically, goblet cells of the conjunctiva play a pivotal role in mucin 
secretion (Johnson and Murphy, 2004; Cwiklik, 2016).  
 
The underlying mucous layer of the tear film is approximately 3 - 5 µm thick 
and is secreted by epithelial cells to provide a hydrophilic surface to stabilise 
and aid spreading of the aqueous portion of the tear film during the blink 
cycle (Cwiklik, 2016; Craig, Tomlinson and McCann, 2010). Mucins have a 
protein rich backbone coupled with an O-linked carbohydrate side chain that 
accounts for 70% of their mass. To date, 21 mucin genes have been 
identified in humans and these can be classed as membrane spanning or 
secretory mucins with the former sub categorised into large gel forming and 
non-gel forming (Johnson and Murphy, 2004; Hodges and Dartt, 2013). 
Membrane spanning mucins (MUC1, -3A, -3B, -4, -12, -13, -15, -16, -17, -20 
and -21) have a short C-terminal cytoplasmic tail and a hydrophobic domain 
that allows the mucin to span the conjunctival and corneal epithelial cell 
membranes and help form the ocular surface glycocalyx. This is followed by 
a threonine/serine rich extracellular region that provide sites for O-
glycosylation (Dartt, 2004; Hodges and Dartt, 2013). Some of these 
extracellular regions can be up to 500 nm long protruding into the aqueous 
portion of the tear film (Govindarajan and Gipson, 2010). The main function 
of membrane spanning mucins is to provide a protective barrier to the ocular 
surface with hydrophilic O-glycans binding water to provide a rigid, gel like 
structure. This mechanism can prevent microbial and viral entry to the 
epithelium as O-glycans are known to prevent viruses from binding to cells 
and mucins can express decoy ligands for bacterial attachment via complex 
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carbohydrates (Guzman-Aranguez and Argüeso, 2010; Hodges and Dartt, 
2013). Membrane bound mucins also provide lubrication and anti-adhesive 
properties to the epithelial cells of the cornea and conjunctiva during blinking 
(Gipson, 2004). 
 
Secretory mucins can be either small soluble mucins (MUC7 and -8) or larger 
gel forming mucins (MUC2, -5AC, -5B, -6 and -19). They are generally stored 
in secretory granules until an appropriate stimulus triggers their release 
(Hodges and Dartt, 2013; Uchino and Tsubota, 2010). MUC5AC is produced 
by goblet cells in the conjunctiva and is important in lubrication and hydration 
of the ocular surface, whereas, MUC7 is produced by the acinar cells of the 
lacrimal gland and the conjunctiva and is thought to play a role in preventing 
pathogens from binding to the ocular surface (Johnson and Murphy, 2004; 
Paulsen and Berry, 2006). 
 
The mid layer of the tear film is an aqueous layer of approximately 4 µm thick 
and it originates from the lacrimal and the accessory glands of Wolfring and 
Krause. Mucin concentration gradually decreases from the posterior to the 
anterior of this layer. The aqueous layer contains an abundance of proteins, 
peptides, electrolytes and other small molecules (Uchino and Tsubota, 2010; 
Cwiklik, 2016). Lipocalin and lysozyme are two of the most abundant proteins 
in the aqueous phase and have specific roles in the spreading of tears and 
antimicrobial activity respectively (McDermott, 2013). Fleming and Allison 
were the first to report the bactericidal activity of lysozyme in 1922 (Fleiszig, 
Kwong and Evans, 2003). Sodium, calcium, potassium and phosphate ions 
help to control osmolality of tears whilst maintaining a constant pH (Johnson 
and Murphy, 2004). Other molecules in the aqueous portion of the tear film 
include lactoferrin which works in synergy with lysozyme by binding to 
bacterial lipoteichoic acids to allow lysozyme access to peptidoglycan and 
IgA which may have an immunological role (Forrester et al., 2008). The 
aqueous phase is secreted continuously by the lacrimal glands at a rate of 
1.2 mm3 min-1 with extra tear production induced by psychophysical or 
mechanical stimuli (Forrester et al., 2008; Dartt and Willcox, 2013; Cwiklik, 
2016). 
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The TFLL is the anterior portion of the tear film and is between 50 - 100 nm 
thick (Hodges and Dartt, 2013; Craig, Tomlinson and McCann, 2010). The 
posterior tear film is composed of polar lipids (e.g. phospholipids) separating 
the aqueous phase and the external environment followed by layers of non-
polar lipids (wax esters, sterol esters and triglycerides) on the outermost 
surface of the TFLL. The lipids are thought to be secreted by meibomian 
glands; however, this has been challenged recently. Proteins are also 
thought to form part of the TFLL but again this is still unknown (Millar and 
Schuett, 2015; Cwiklik, 2016). The main function of the TFLL is to prevent 
evaporation from the aqueous layer of the tear film and prevent any spill over 
of tears whilst providing a clear optical medium. The TFLL also plays a role in 
preventing sebaceous lipids from the skin migrating onto the ocular surface 
(Forrester et al., 2008; Johnson and Murphy, 2004). 
  
 
Figure 1.3: The layers of the tear film with some associated components and its 
interaction with the corneal epithelium. Diagram is not to scale. 
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1.2 Ulcerative Keratitis 
 
There are many conditions that affect the surface of the eye and they range 
from dry eye disease to corneal ulcers. Corneal diseases, in general, are a 
leading cause of blindness worldwide but incidences vary depending on 
location. Approximately 75,000 Americans contract corneal ulcers annually 
but the condition is much more prevalent and still under reported in 
developing countries where up to 1,500,000 people contract the condition 
annually (Whitcher, Srinivasan and Upadhyay, 2002; Amescua, Miller and 
Alfonso, 2012). In the western world microbial infection or herpes simplex 
virus present complications from which opaqueness of the cornea can occur 
and ultimately lead to vision loss (Williams and Wong, 2009). Many of the 
incidences of corneal ulceration in the developing world result in blindness 
mainly due to the expensive cost of antimicrobials, proximity to treatment 
centres and drug resistance (Whitcher, Srinivasan and Upadhyay, 2001). The 
most prevalent causes of corneal ulcers include contact lens wear, ocular 
trauma, ocular surface disease (keratitis) and systemic diseases such as 
rheumatoid arthritis and HIV (Lee and Manche, 2016). Of the infectious 
cases, there is a global divide with fungal keratitis most prevalent in the 
developing world primarily due to manual labourers working in optimal 
environments for fungal pathogens. In the developed world bacterial keratitis 
is the most common cause of corneal ulcers and is most often contracted by 
improper use of contact lenses and their associated lens care solutions 
(Upadhyay, Srinivasan and Whitcher, 2007).  
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1.2.1 Bacterial keratitis: 
Bacterial keratitis (Figure 1.4a) is one of the most threatening ocular 
infections to visual integrity primarily due to complications that may arise and 
the rate of pathogenesis (Schaefer et al., 2001). Treatment is normally 
commenced following culture retrieval from the site of infection and it usually 
takes the form of administration of a single or a combination of antimicrobials 
in drop form to provide a range of activity against both Gram-positive and 
Gram-negative organisms. Once the isolate from the cultures is identified 
then a more tailored treatment is applied (Kaye et al., 2010). One of the 
major challenges for an ophthalmologist is distinguishing bacterial keratitis 
from other ulcer causative conditions and then further identifying the correct 
species of microbial pathogen to administer the correct first-line antibiotic 
(O’Brien, 2003). Any delays in treatment especially with bacterial keratitis can 
result in severe complications due to the rate of pathogenicity with corneal 
perforations occurring in less than 24 h from Pseudomonas aeruginosa and 
Staphylococcus aureus infections (Schaefer et al., 2001). Some of the major 
risk factors include ocular trauma, post-ocular surgery and systemic disease 
such as diabetes mellitus. Bacterial keratitis associated with contact lens 
wear is now the most prevalent risk factor in the developed world. Individuals 
who wear contact lenses are 10 - 20 times more susceptible to bacterial 
keratitis mainly due to extended wear of lenses or contamination due to 
increased bioburden as a result of unhygienic practices (Bourcier et al., 2003; 
Stapleton and Carnt, 2012). Other predisposing factors implicated in the 
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onset of contact lens associated bacterial keratitis include smoking and 
mechanical epithelial trauma from the contact lens itself due to increased 
rigidity of some silicone hydrogel contact lenses. Smoking may increase 
toxins and result in changes to mucous membranes whilst contact lens 
materials have already been implicated in other mechanical complications to 
the cornea such as subepithelial arcuate lesions (Szczotka-Flynn et al., 
2010). It should be noted that microbial invasion of a healthy cornea by 
ocular pathogens is extremely rare as the host response is sufficient to 
maintain ocular surface integrity. A compromised epithelium is required to 
allow pathogens to invade the cornea and in turn cause microbial keratitis 
(Schaefer et al., 2001; Keay et al., 2006). 
 
 
 
 
 
 
 
 
Figure 1.5: Bacterial cell and outer membrane composition followed by some common 
bacterial shapes. 
 INTRODUCTION 12 
 
Both Gram-negative and Gram-positive bacteria are implicated in bacterial 
keratitis (Figure 1.5). Some of the most common isolates are Staphylococcus  
spp., Streptococcus spp., P. aeruginosa and Escherichia coli however 
numbers tend to vary depending on, for example, the geographical region or 
risk factor involved (Green, Apel and Stapleton, 2008; Lichtinger et al., 2012; 
Hong et al., 2013). Streptococcus pneumoniae is most associated with 
permanent damage of the ocular surface and P. aeruginosa infections 
progress rapidly (Karsten, Watson and Foster, 2012).   
 
P. aeruginosa in particular is associated with contact lens wear and is the 
most prevalent isolate of bacterial keratitis in tropical climates such as 
Brisbane (71%), Singapore (79%) and Miami (78%) whereas Gram-positive 
cocci are more commonly reported in non-contact lens associated keratitis 
(Green, Apel and Stapleton, 2008; Saraswathi and Beuerman, 2015). 
Invasive isolates of P. aeruginosa rely on adhesion to the epithelium via 
flagella, pili, membrane proteins and lipopolysaccharide (LPS) and an 
endocytosis-like approach to internalising itself within the corneal epithelial 
cells (Fleiszig, 2006). Once inside epithelial cells the organism is protected 
from extracellular host defences such as antibodies and complement and in 
turn gain access to the cytoplasm where it can replicate at rates of 10-fold 
per hour (Fleiszig and Evans, 2002; Fleiszig, 2006). However, there are 
isolates of P. aeruginosa known to cause cytotoxicity extracellularly via an 
ExoU dependant mechanism. ExoU is a toxin that is injected into epithelial 
cells via ‘needles’ protruding from the microbe (Fleiszig, Kwong and Evans, 
2003). LPS is an important virulence factor in P. aeruginosa infection as well 
as allowing the pathogen to adhere to the corneal epithelium and surfaces 
such as contact lenses it also imparts resistance to the antimicrobial protein 
complement and allows the bacteria to accumulate in the tear film (Fleiszig 
and Evans, 2002). 
 
In most cases of non-contact lens related bacterial keratitis the pathogen 
usually has a route through a damaged epithelium into the stroma. The 
epithelium can be compromised by factors such as disease and trauma. 
Once in the stroma the pathogen can damage the structured order that 
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allows for maintenance of transparency as well as prompting a host immune 
response that can result in tissue degradation (Fleiszig, 2006). Other 
bacterial pathogens such as Neisseria gonorrhoeae, Neisseria meningitides, 
Shigella and Listeria can penetrate the corneal epithelium via a complex 
array of enzymes and virulence factors to enter the stroma. S. aureus 
adheres to host tissue via collagen and fibronectin unlike P. aeruginosa that 
adheres to tissue without fibronectin present (O’Brien, 2003). The collagen 
binding adhesin is an important virulence factor in S. aureus keratitis and 
allows it to penetrate the wounded epithelium of the cornea (Rhem et al., 
2000).       
 
In cases of contact lens associated bacterial keratitis biofilm forming bacteria 
are usually associated. Biofilms present a greater challenge when it comes to 
eradicating the pathogen as microbes within biofilms can be between 10- to 
1000-fold more resistant to antibiotics than their planktonic forms (Zegans, 
Shanks and O’Toole, 2005). Biofilm formation on contact lenses and contact 
lens cases has been well established (McLaughlin-Borlace et al., 1998) and 
they provide a microbial environment for organisms to survive repeated 
cleaning regimes until an opportunity presents itself (e.g. ocular injury) to 
commence infiltration of compromised tissue (Zegans et al., 2002). 
Organisms such as P. aeruginosa have an array of genes that allow it to 
adapt to changes within their environment (Bispo, Haas and Gilmore, 2015). 
 
1.2.2 Fungal keratitis: 
Fungal infections of the cornea (fungal keratitis) are challenging to treat. The 
first sign of fungal keratitis (Figure 1.4b) is a granular infiltration of the corneal 
epithelium and the stroma, however, this is also the case for bacterial 
keratitis (Dóczi et al., 2004). Initial diagnosis may take several days before 
results of corneal scrapes or biopsies become available. However, a 
presumptive diagnosis may be made by examining corneal scrapings directly 
under a microscope followed by an appropriate staining procedure (Gram or 
Giemsa method, periodic acid Schiff or Gomori methenamine silver) and 
administration of a first-line antibiotic until the specific organism is identified 
(Thomas, 2003). Despite intensive antifungal therapy (typically hourly eye 
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drops including through the night, combined with oral medication) it is not 
uncommon for emergency corneal grafts to be necessitated. The associated 
severe inflammation and scarring often leads to some permanent loss of 
vision (Whitcher, Srinivasan and Upadhyay, 2001). If the infection is not 
controlled, it may spread throughout the eye resulting in endophthalmitis. 
Even when the infection is controlled, a recurrence rate of 5 - 14% is typical 
but this can be as high as 31%. These recurrence rates are greater than 
recurrence rates for bacterial keratitis and result in the need for keratoplasty 
more often (Lalitha et al., 2006; Shi et al., 2010). Furthermore, fungi are the 
leading cause of ocular infections in tropical and subtropical regions, which 
cover most developing countries where access to healthcare may be limited 
(Ou and Acharya, 2007). 
 
There are two types of fungi that cause keratitis; filamentous fungi such as 
Fusarium and Aspergillus spp., and yeast-like fungi such as Candida 
albicans (Figure 1.6). Filamentous fungal keratitis tends to occur as a result 
of trauma involving vegetative matter and is more prevalent in tropical 
climates (Thomas and Kaliamurthy, 2013). Candida infections are more 
common in those with pre-existing ocular surface disease such as insufficient 
tear production or poor eyelid closure, topical steroid use, post-surgery or 
with other systemic risk factors (such as diabetes or immunosuppression) 
and is more prevalent in temperate climates (Sun, Jones and Wilhelmus, 
2007). Historically fungal keratitis accounts for ≤ 5% of the total microbial 
keratitis cases, however, this appears to be increasing with estimates of up to 
52% in the early part of the 21st century (Sengupta et al., 2012). From 2005 - 
2007 more than 300 cases of Fusarium keratitis were identified from patients 
who used contact lenses and ReNu with Moistureloc lens cleaning solution 
(Bausch and Lomb, Rochester, NY). Many of the patients required some 
form of keratoplasty resulting in the lens cleaning solution being withdrawn 
from the market (Gower et al., 2010; Mukherjee et al., 2012). A review of 
keratitis cases at Bascom Palmer Eye Institute in Florida, USA from 2001 - 
2007 found that fungal pathogens were identified in 20.8% of keratitis cases. 
Fusarium (54.1%) and Candida (28%) were two of the most common fungal 
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isolates. Of the total fungi recovered 10.7% were implicated in contact lens 
related keratitis (Alfonso et al., 2006). 
 
 
 
 
 
 
The pathogenesis of fungal keratitis is lesser understood on a molecular level 
than bacterial keratitis and the efficacy of anti-mycotic therapy is low. These 
reasons may contribute to lower clinical success rates for fungal keratitis. 
The key mechanisms involved in fungal pathogenesis include adherence, 
invasiveness, toxigenicity and morphogenesis (Ananthi et al., 2008). 
Virulence factors such as toxins and proteases enable hyphal invasion of the 
corneal tissue (Leal et al., 2010). Aspergillus and Fusarium are ubiquitous in 
the environment with up to 200 conidia inhaled by individuals per day. In the 
presence of a disrupted corneal epithelium Aspergillus fumigatus conidia or 
conidiaphores can easily inoculate the wound. Aspergillus conidia are smaller 
than Fusarium conidia and can therefore penetrate deeper into tissue (Leal et 
al., 2010; Pearlman et al., 2010). Candida infects the cornea initially in the 
yeast stage prior to germination and the formation of pseudohyphae which 
then penetrate the stroma. Phospholipases and in particular phospholipase B 
play a pivotal role in facilitating Candida invasion via tissue destruction. It has 
been suggested that genes regulating hyphal formation as opposed to 
adherence determine C. albicans virulence (Pearlman et al., 2010). 
Morphogenesis such as the presence of hypha in hyphae, intrahyphal 
Figure 1.6: Filamentous and yeast-like fungi are causative organisms in fungal keratitis. 
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hyphae and a thickened cell wall provide protective mechanisms to the host 
immune response and antifungal drugs. Mycotoxins such as fumonisin B1, 
moniliformin and fusaric acid from Fusarium spp. are also thought to play a 
role in pathogenesis (Naiker and Odhav, 2004). 
 
1.2.3 The role of biofilms in microbial keratitis: 
The first mention of biofilms came in the 17th century when Anthony van 
Leeuwenhoek took scrapings from his teeth and observed them under an 
early microscope. He identified small living microbes in the plaque samples 
and described how the plaque may have helped the microbes to survive the 
vinegar washes he used to clean his mouth (Bispo, Haas and Gilmore, 
2015). A more modern description of biofilms is that they consist of multiple 
layers of sessile microbial cells attached to a surface and surrounded by a 
complex extracellular matrix. The sessile cells are morphologically and 
phenotypically distinct from their planktonic equivalents (Acker, Dijck and 
Coenye, 2014). The overlying matrix with thicknesses up to 50 µm provides a 
barrier that protects the microbial community from external factors such as 
antibiotics, chemical detergents and increases resistance to a host immune 
response. In some cases a 1000-fold increase in antibiotic resistance has 
been observed from biofilm communities (Høiby et al., 2010; Saraswathi and 
Beuerman, 2015). 
Bacterial biofilm formation is initiated when bacteria attach to a surface. 
Adherence may be aided by the presence of a protein layer that promotes 
increased hydrophobic or electrostatic interactions. Irreversible binding 
followed by the emergence of microcolonies promote the production of 
biofilm extracellular matrix (Høiby et al., 2010). Small water channels are 
formed between the microcolonies that provide a flow of nutrients, waste 
products and communication molecules such as quoromones (Pratt and 
Kolter, 1998; Davies, 2003). A study of bacterial biofilm formation on contact 
lenses revealed that P. aeruginosa could adhere to and form biofilms on 
etafilcon A, balafilcon A and poly-(2-hydroxyethyl methacrylate) (pHEMA) 
lens materials with most attachment observed on balafilcon A lenses (Willcox 
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et al., 2001). Other studies identified a 3 - 9 times greater risk of microbial 
keratitis following extended wear of lotrafilcon A lenses (Willcox, 2013).  
Fungal biofilms begin in much the same way as bacterial biofilms. Biofilm 
formation begins when yeast cells attach to a surface followed by deposition 
of an extracellular matrix primarily composed of β-glucan. Other components 
of the matrix include carbohydrates, proteins, hexosamines and phosphorus. 
Filamentous cells produce a hyphal network within the matrix that helps 
increase resistance to many antifungal drugs (Sardi et al., 2013; Zhang et al., 
2017). The presence of bacteria can help regulate fungal biofilm formation 
and vice-versa. S. aureus has shown decreased susceptibility to vancomycin 
when present in a co-culture of C. albicans (Desai, Mitchell and Andes, 
2014). An in vitro model of fungal biofilm formation on contact lenses 
demonstrated the ease at which both Fusarium spp. and C. albicans could 
form biofilms on lens materials such as etafilcon A, lotrafilcon A and 
balafilcon A (Imamura et al., 2008). In cases of microbial keratitis the 
formation of a biofilm is considered an important developmental characteristic 
(Zhang et al., 2017).  
 
1.2.4 Host response to microbial keratitis: 
The first defensive mechanism microbial pathogens encounter at the ocular 
surface is the tear film and the many proteins and molecules associated with 
it (Figure 1.7). These factors combine with the blinking mechanism and the 
continued renewal of the tear film to successfully limit the numbers of 
microbial pathogens in close proximity to the ocular surface by removing 
them towards the nasolacrimal duct (Gipson and Argüeso, 2003). Lysozyme 
was one of the first characterised antimicrobial components of the tear film, 
whilst the iron binding lactoferrin, mucins, antibodies, complement proteins, 
short cationic β-defensin peptides and secretory phospholipase A2 have also 
been identified as important antimicrobial factors (Fleiszig and Evans, 2002; 
Fleiszig, Kwong and Evans, 2003). Lipocalin binds to fungal siderophores 
and lactoferrin is a divalent cation scavenger which in turn inhibit iron uptake 
by fungi (Shoham, 2015).  Many microbes can be inhibited by the host 
antimicrobials but others have evolved virulence factors that can directly 
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inhibit them. Some Gram-negative bacteria are resistant to secretory 
phospholipase A2 but have been shown to be susceptible to β-defensins 
(Fleiszig, Kwong and Evans, 2003). β-defensins are produced when the 
presence of bacterial LPS is detected (Fleiszig and Evans, 2002). Mucins 
play a role in preventing microbes from adhering to the surface of the 
epithelium by binding to them via decoy ligands or via a barrier mechanism 
(Hodges and Dartt, 2013). The virulence mechanisms of invasive and 
cytotoxic P. aeruginosa isolates are inhibited by mucins.  
 
The epithelium has mechanisms of protection that identify and inhibit 
microbes that penetrate the tear film. Tight junctions between cells via zonula 
occludens in an uncompromised cornea provide a closed barrier to microbial 
penetration through the epithelium. The sloughing mechanism by superficial 
cells of the anterior cornea can remove bacteria that have managed to 
invade these outermost cells. It is thought that the shedding of cells on the 
outermost surfaces of the body is a mechanism of removing pathogens that 
have invaded them (Fleiszig, 2006). However, ocular trauma, surgery, 
disease and other factors that may compromise the epithelium bypass this 
barrier function and open up the deeper stromal tissue to microbial infection 
(Fleiszig and Evans, 2002). 
 
The corneal epithelium also responds to microbial invasion by recruiting 
neutrophils and other cells involved in the immune response. Corneal 
epithelial cells express receptors to LPS such as TLR4 and CD14 that 
upregulates cytokines. This in turn promotes an inflammatory response 
(cytokines and antimicrobial peptides (AMPs)) and the recruitment of 
lymphocytes and macrophages followed by neutrophil infiltration (Fleiszig 
and Evans, 2002; O’Brien, 2003). TLRs can recognise specific pathogens 
such as S. aureus (TLR2) and P. aeruginosa (TLR4). TLRs along with 
leukocytes and keratocytes recognise fungi such as F. solani and A. 
fumigatus (Yuan and Wilhelmus, 2010). It is thought that this enhanced 
immune response plays a pathogenic role in keratitis as an upregulation in 
matrix metalloproteinase (MMPs) and other inflammatory factors released 
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from neutrophils and macrophages can lead to stromal necrosis and corneal 
edema (Hazlett, 2010; Shoham, 2015).  
 
In particular it is thought that increased levels of MMP-9 and neutrophil 
infiltration leads to invasion of the stroma by fungi as it changes from yeast to 
hyphae (Mitchell and Wilhelmus, 2005). Epithelial and stromal cells also 
release cytokine IL-1α after their cell membranes are compromised. IL-1α 
and tumour necrosis factor (TNF-α) combine to promote keratocyte synthesis 
of IL-6 and β-defensins. The neuropeptides substance P and calcitonin are 
released when pain is detected by corneal nerves and then bind to corneal 
epithelial cells to promote IL-8 synthesis which in turn promotes neutrophil 
infiltration (Akpek and Gottsch, 2003).  Bowman’s layer is thought to provide 
a barrier to the stromal layer of the cornea. The pores of the membrane are 
much smaller than 2 µm and therefore should prevent bacteria from 
penetrating it (Fleiszig, 2006). 
 
 
 
Figure 1.7: Factors involved in host response to microbial invasion of the cornea. 
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1.2.5 Current treatments for microbial keratitis: 
In all cases of microbial keratitis, the first action is to identify the pathogen 
involved in infection. As stated previously (section 1.2.1) this involves 
retrieval of the pathogen from the cornea via a corneal scrape usually after 
the application of local anaesthetic to help relieve discomfort. The scrapes 
are sent for culture and susceptibility testing but can take several days to 
weeks to determine the pathogen involved resulting in diagnosis at the later 
stages of the condition (Akram et al., 2015; Leck, 2015). Direct microscopic 
observation of the scrape followed by specific staining procedures can yield 
more accurate determinations of the pathogen involved and identify the 
correct class of antibiotic to administer. However, this approach is not as 
accurate and may lead to inefficient treatment regimens that can result in 
unresponsive keratitis. Antibiotics are usually administered topically via drops 
or ointments due to the avascular nature of the cornea and a blood-aqueous 
barrier rendering systemically delivered antibiotics mostly ineffective 
(Garhwal et al., 2012). In vitro susceptibility testing of microorganisms 
obtained from corneal scrapes are also not representative of the 
concentrations required to eradicate organisms using antibiotic drops. The 
breakpoints used in vitro are generally for systemic concentrations as 
opposed to those required for ocular topical administration. Several other 
methods have been deployed to speed up diagnosis times including antibody 
based detection systems, polymerase chain reaction (PCR) and AMPs 
(Wang et al., 2014). Antibody based detection systems are powerful tools, 
however, they have limited stability under harsh environmental conditions, 
lack of batch to batch consistency and can be expensive to produce. PCR is 
another powerful tool but requires an extraction step and with a lack of 
portability may hinder its use in the field (Kulagina et al., 2005; Mannoor et 
al., 2010). AMPs with their natural affinity towards microbes have been 
modified structurally to identify specific organisms or classes of organisms 
via fluorescent based detection systems. AMPs are more stable than normal 
proteins with some maintaining antimicrobial activity after autoclaving or in 
the presence of chemical denaturants (Mannoor et al., 2010). Cationic AMPs 
such as magainin I and fragments of ubiquicidin are currently being 
investigated as they have a broad binding spectrum to microbes, are highly 
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stable and can be produced at a comparably low cost via well-established 
peptide synthesis procedures (Kulagina et al., 2005; Akram et al., 2015). The 
stability of AMPs coupled with a fluorescent detection system should allow for 
a greater deal of portability for use in the field.       
 
1.2.5.1 Bacterial keratitis: 
After initially ruling out fungi as the causative organism in microbial keratitis, 
bacteria are the main suspect. This is especially true in temperate climates 
where they are the most prevalent organism implicated in microbial keratitis. 
Empirical broad-spectrum antibiotic treatment usually in the form of eye 
drops or an ointment is then administered until the culture and susceptibility 
data of the pathogen becomes available. The choice of antibiotic (Figure 1.8) 
is usually determined by the geographic location and associated antibiotic 
susceptibility data to known pathogens (Orlans, Hornby and Bowler, 2011; 
Shalchi et al., 2011).  
 
 
 
 
 
Figure 1.8: Mechanism of action of common antibiotics against bacteria. 
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The current first-line therapy treatment for bacterial keratitis has been shaped 
by decades of global antibiotic resistance patterns. Resistance started to 
become a problem in the 1960s when S. aureus resistance to penicillin 
became common and resulted in the introduction of cephalosporins followed 
by gentamycin in the 1970s mainly due to the rise of contact lens related 
keratitis caused by P. aeruginosa (Sueke et al., 2010). Until the early 1990s 
the choice of first-line therapy was a fortified antibiotic formulation of 
gentamycin (1.5%) and cefuroxime (5%) that covered a broad-spectrum of 
Gram-positive and Gram-negative organisms. The main issue with this 
treatment was toxicity to the corneal epithelium and the limited stability of the 
fortified antibiotics at room temperature (Tuft and Matheson, 2000). 
Gentamycin also had a poor bioavailability after topical application due to 
poor corneal penetration resulting in a lack of detection of the antibiotic on 
the ocular surface 10 min after drop administration and 40 min after ointment 
application (Schaefer et al., 2001). First and second generation 
fluoroquinolones were introduced in the early 1990s as a monotherapy for 
bacterial keratitis with reduced corneal toxicity and broad-spectrum activity 
against Gram-positive and Gram-negative organisms. However, recent 
reports from India and the United States have identified resistance to both 
ciprofloxacin and ofloxacin in cases of bacterial keratitis with S. aureus 
resistance rising from 5.8% in 1993 to 35% in 1997 but by 2000 the 
resistance rate had risen as high as 82% (Tuft and Matheson, 2000; 
Schaefer et al., 2001; Shalchi et al., 2011). Third (levofloxacin) and fourth 
(moxifloxacin, gatifloxacin and tobramycin-cefazolin) generation 
fluoroquinolones were introduced for ophthalmic applications to combat this 
resistance in the early 2000s (Mather et al., 2002). Fourth generation 
fluoroquinolones have better efficacy against Gram-positive organisms than 
earlier generation fluoroquinolones and maintain broad spectrum 
susceptibility when administered against Gram-negative organisms. 
However, ciprofloxacin is still more effective against Gram-negative 
organisms. A recent study in Britain found that Gram-positive fluoroquinolone 
resistance had not increased over the previous 10 years and highlighted the 
upward trend of Gram-negative infection rates with P. aeruginosa as the 
predominant organism. This lead to the recommendation that ciprofloxacin 
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remained the first-line antibiotic therapy in Britain for bacterial keratitis 
(Shalchi et al., 2011; Wong et al., 2012). A similar study was carried out on 
clinical isolates in Toronto between 2000 and 2010 with the recommendation 
that dual therapy of vancomycin and tobramycin be administered. Gram-
negative organisms were more sensitive to tobramycin (98.2%) than 
ciprofloxacin (97.4%) and all Gram-positive organisms were sensitive to 
vancomycin. Coagulase negative Staphylococcus was the predominant 
organism isolated followed by P. aeruginosa and S. aureus with methicillin-
resistant S. aureus making up 1.3% of the isolates with again no upward 
trends in resistance identified (Lichtinger et al., 2012). Although ciprofloxacin 
is still the first-line antibiotic therapy research is continuing to identify future 
antibiotics and stay a step ahead of bacterial resistance. Multi-drug 
resistance is becoming an increasing problem to conventional treatments for 
microbial keratitis. A study at the Prasad Eye Institute in India from 2007 - 
2014 found that approximately 25% of all cases of Pseudomonas keratitis 
were caused by a multi-drug resistant strain of the pathogen. The main risk 
factors identified were the use of a preservative free ointment, a 
compromised epithelium and the use of bandage contact lenses. Clinical 
outcomes were generally worse for patients with keratitis from multi-drug 
resistant strains of Pseudomonas compared to those infected with 
responsive strains (Vazirani, Wurity and Ali, 2015). New research is 
investigating carbapenems as potential candidates for ocular infections. 
These β-lactams are resistant to hydrolysis via β-lactamases and as a result 
overcome a common pathogen resistance mechanism. Carbapenems are 
usually described as ‘antibiotics of last resort’ as they maintain the greatest 
potency and broadest spectrum against both Gram-negative and Gram-
positive organisms (Papp-Wallace et al., 2011). Meropenem is currently 
being investigated as a treatment for bacterial keratitis and is already 
approved by the Food and Drug Administration (FDA) to treat skin infections 
and bacterial meningitis. A study was conducted on bacterial keratitis clinical 
isolates to determine the minimum inhibitory concentration at which 90% of 
isolates died (MIC90) for a range of antibiotics including ciprofloxacin, 
moxifloxacin and meropenem. The MIC90 of meropenem was found to be 
lower than all the other antibiotics tested against coagulase negative 
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Staphylococcus, P. aeruginosa, E. coli and S. aureus (Sueke et al., 2010). 
Further work determined that meropenem had a low toxicity in vitro towards 
primary human keratocytes and a human corneal epithelial cell line (HCE-T). 
Furthermore, good corneal penetration achieved MIC90 levels of meropenem 
in the anterior chamber (Sueke et al., 2015). 
 
1.2.5.2 Fungal keratitis: 
Once fungal keratitis is confirmed and the pathogen identified an hourly 
treatment for 24 - 48 h of antifungal drops is administered with prolonged 
treatment for 6 weeks not uncommon or 12 weeks in severe cases involving 
filamentous fungi that have extended into the stroma. Current treatment for 
fungal keratitis is still inadequate mainly due to poor drug bioavailability as is 
the case for antibacterial drops. However, other reasons more specific to 
fungal keratitis include narrow spectrum of drug activity, high recurrence 
rates, ocular toxicity and increased cost due to the common practice of 
systemic use of the same antifungal that is topically administered (Thomas, 
2003; Neoh et al., 2014). Antifungal agents (Figure 1.9) can be classified into 
six groups: polyenes (natamycin and amphotericin B) that increase cell 
permeability; pyrimidines; imidazoles (miconazole) and triazoles (fluconazole 
and voriconazole) that inhibit fungal ergosterol biosynthesis; allylamines and 
echinocandins (Achiron and Hamiel, 2014; Neoh et al., 2014). 
 
Natamycin (5%) or amphotericin B (0.15%) are the current first-line therapy 
for cases of fungal keratitis caused by filamentous or yeast pathogens 
respectively. This may be followed by sub-conjunctival miconazole or oral 
administration of fluconazole if lesions are seen (Thomas, 2003; Dóczi et al., 
2004). As mentioned previously in section 1.2.2, recurrence is a greater issue 
with fungal keratitis than bacterial keratitis and can necessitate the need for 
keratoplasty. In some instances the recurrence rate can be as high as 31% 
(Lalitha et al., 2006). Generally recurrent keratitis will be given another 
chance to respond to treatment prior to keratoplasty with an example 
treatment regimen being the addition of fluconazole eye drops (0.5%) every 
30 min coupled with either amphotericin B (0.15%) or natamycin (5%) eye 
drops every 2 h and intravenous fluconazole (200 mg) once a day for 5 - 7 
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days. If the keratitis does not respond to the treatment then keratoplasty is 
initiated (Shi et al., 2010). 
 
Resistant strains of Fusarium implicated in keratitis have been identified and 
although resistance is rare compared to bacterial keratitis the end result 
could be more devastating (Edelstein et al., 2012). The cost associated with 
treatment of bacterial keratitis is already almost twice as costly to treat than 
non-infectious keratitis with costs of treatment for fungal keratitis almost 7 
times greater (Keay et al., 2006). These costs do not consider an increase in 
resistance and the more extensive treatment that this entails. 
 
 
 
 
 
 
 
Voriconazole has a broader spectrum and better bioavailability than most 
antifungal agents, with fewer side effects and a comparable efficacy to 
standard antifungal agents with some signs that a synergy approach between 
Figure 1.9: Mechanism of action of common antifungals. 
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a polyene and an azole may be beneficial as a future antifungal treatment 
(Bunya et al., 2007; Prajna et al., 2013). 
 
1.2.6 Limitations to current microbial keratitis treatments: 
Initial diagnosis requires application of local anaesthetic followed by several 
corneal scrapes to inoculate a range of nutrient agar. A lack of patient 
compliance can present problems with retrieval and handling of culture plates 
outside a controlled laboratory environment increases the risk of 
contamination. In less equipped eye care centres, particularly those in 
remote regions of the developed world, the full range of nutrient agar may not 
be available and may impede pathogen identification (Kaye et al., 2003).  
 
The mainstay of treatment for microbial keratitis is topical antibiotic drops or 
ointments with drops accounting for 90% of the administration routes. 
Antibiotic drops enable high local concentrations of drugs with minimal 
systemic side effects. The efficacy is, however, limited by a series of 
clearance mechanisms that usually protect the eye from foreign debris and 
infection (Ciolino, 2009; Morrison and Khutoryanskiy, 2014). 
 
 
 
Figure 1.10: Common limitations with antibiotic eye drop administration.  
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The majority of the drop either immediately drains down the cheek, is cleared 
down the nasolacrimal duct away from the eye or is absorbed through non-
target tissue such as the highly vascular conjunctiva or the eyelids (Figure 
1.10). The remainder is subject to non-specific absorption, continuous 
dilution by the tear film and reflex tearing or dispersed by blinking (Shell, 
1982; Ghate and Edelhauser, 2008; Tashakori-Sabzevar and Mohajeri, 
2015). As a result, only 1 - 7% of the drug reaches the target tissue and only 
a fraction of the dose will penetrate the deep layers of the corneal stroma 
where infections, particularly in cases of fungal keratitis, may extend (O’Day 
et al., 1984; Järvinen, Järvinen and Urtti, 1995; Manzouri, Vafidis and Wyse, 
2001; Ghate and Edelhauser, 2008). 
 
To overcome these limitations, prolong contact time with the cornea and 
achieve therapeutic drug concentrations, regular (hourly or half-hourly) 
instillation of drops is required (O’Day et al., 1984). Initially this includes 
throughout the night for patients with severe keratitis often requiring hospital 
admission. Although drop frequency decreases as the infection improves, 
regimes typically last for months (Johns and O’Day, 1988; Thomas and 
Kaliamurthy, 2013). Unsurprisingly, patient compliance is problematic 
(Yoltan, 2001). A drug release system which delivers sufficient quantities of 
drug to the cornea whilst increasing the contact time would improve drug 
efficacy and patient compliance. It may also have benefits in developing 
countries where access to healthcare may be limited or where lack of 
supervision of patients can lead to inadequate drop administration. 
 
 
1.3 Bandage Lenses 
 
Corneal bandages have been considered as epithelial wound healing devices 
for decades. Over time they have developed from standard contact lens 
materials such as poly-(methyl methacrylate) (pMMA) to more advanced 
polymers such as pHEMA in 1954 (Willoughby, Batterbury and Kaye, 2002; 
Alvarez-Lorenzo, Yanez and Concheiro, 2010). There were many drawbacks 
to the use of early contact lenses as bandage contact lenses ranging from a 
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poor ocular compatibility with the corneal epithelium to incompatibility with 
the tear film due to the hydrophobicity of the lenses. These complications 
often led to conditions such as allergic and infective conjunctivitis, corneal 
thinning and protein fouling of lenses (Hadassah et al., 2008). Modern 
corneal bandage materials include collagen shields; amniotic membrane 
derived materials and advanced hydrogel polymers containing silicone 
monomers or pHEMA hydrogels with additional hydrophilic monomers such 
as N-vinyl pyrollidone (NVP) and methacrylic acid (MAA) (Willoughby, 
Batterbury and Kaye, 2002; Saw et al., 2007; Alvarez-Lorenzo, Yanez and 
Concheiro, 2010; Dell et al., 2011). The purpose of a corneal bandage was 
originally to protect a post-operative wound on the surface of the eye and 
relieve discomfort caused by eyelid movement to the highly innervated 
cornea (Dell et al., 2011). However, research has now focussed on utilising 
bandage lenses as drug delivery devices for transporting and controlling the 
release of ocular drugs. 
 
1.3.1 Collagen shields: 
Collagen was first introduced for the management of wounds in the 1970s 
specifically as a wound healing device in the treatment of burns and skin 
ulcers. It was not until the 1980s that collagen was utilised in ophthalmic 
applications. In 1984, Fyodorov developed collagen shields as devices to 
protect post-operative wounds following photorefractive surgery and radial 
keratotomy (Willoughby, Batterbury and Kaye, 2002; Hadassah et al., 2008). 
 
Collagen is a readily available, natural material that is thought to have good 
biocompatibility with the corneal epithelium. It also possesses wound healing 
properties and can provide a good mechanical support for the healing 
epithelium (Hadassah et al., 2008; Chak, Kumar and Visht, 2013). Collagen 
shields (Figure 1.11a) have been studied as drug delivery devices whereby 
the shield is soaked in an appropriate drug solution. The collagen shield then 
performs as a drug reservoir after applying it to the cornea. The drug 
releases as the collagen shield degrades thereby providing a limited slow 
release mechanism that enables prolonged drug-contact time with greater 
bioavailability (Panda and Sudan, 2003; Kearns and Williams, 2009). 
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In some animal studies, high corneal and anterior chamber concentrations of 
gentamycin, vancomycin, heparin and pilocarpine were obtained after 
delivery via collagen corneal shields. Minimum inhibitory concentration (MIC) 
concentrations of tobramycin were obtained in the anterior chamber for 4 - 6 
h when delivered via collagen shields (Kleinmann et al., 2006). Another study 
found MIC concentrations of both gatifloxacin (2.3 μg cm-3) and moxifloxacin 
(3.1 μg cm-3) in the aqueous humor 3 h after application of antibiotic laden 
collagen bandages (Kleinmann et al., 2006). One example of a commercial 
collagen ophthalmic device is Soft Shield® collagen shields (Oasis Medical 
Inc., San Dimas, CA, USA). They are derived from bovine or porcine collagen 
and range in dissolution rates from 12 - 72 h. The dissolution rate is 
controlled via the degree of UV irradiation applied during the cross-linking 
process (Greenwald and Kleinmann, 2008; Dell et al., 2011). Although 
collagen shields have been trialled for drug delivery they are expensive, 
dissolve rapidly and have risks of xenogeneic disease transfer (Willoughby, 
Batterbury and Kaye, 2002). Visual acuity is also reduced to approximately 
6/60 which is less desirable in patients with early stage or milder keratitis who 
may otherwise maintain near normal vision (Friedberg, Pleyer and Mondino, 
1991; Wedge and Rootman, 1992). Additionally, this opacity requires the 
shield to be removed so the clinician can assess the cornea to monitor 
disease progression. Other drawbacks for collagen shields include the 
impermissible use of bovine and porcine collagen to patients of certain 
religious groups, biological incompatibility for individuals with specific 
allergies as well as concerns of initial discomfort upon insertion, foreign body 
a) b) c) 
Figure 1.11: a) Collagen bandage lens, reproduced with permission from Elsevier, b) 
amniotic membrane bandage lens. Image taken from www.biotissue.com, c) size 
comparison of a hydrogel contact lens and a hydrogel bandage lens. Image taken from 
www.focalpointeyecare.com. 
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sensation and irritation due to the acidic pH of collagen (Dell et al., 2011; 
Guzman-Aranguez, Colligris and Pintor, 2013). 
 
1.3.2 Amniotic membrane: 
The use of amniotic membrane as a suitable substrate for transplantation 
was first described by Davies in 1910 as a skin graft. A surge in publications 
describing its use as a substrate for transplantation followed with applications 
such as a bandage for dressing burns or non-healing skin ulcers as well as a 
substrate in hernia repair and prevention of tissue adhesion following surgery 
(Dua et al., 2004). However, it was not until de Rötth followed by Sorsby and 
Symons in the 1940s that amniotic membrane transplantation was described 
in ophthalmic applications. It was primarily described as a substrate for 
conjunctival plastic surgery and as a bandage for ocular chemical burns with 
some initial success, however, for unknown reasons further research was 
limited over the next five decades (Kruse, Rohrschneider and Völcker, 1999; 
Dua et al., 2004). Following conception, the amniotic membrane along with 
the placenta derives from the outer cell mass whilst the foetus develops from 
the inner cell mass. It consists of an epithelial layer in contact with a 
basement membrane and an avascular stromal layer with a varying thickness 
of between 20 µm and 500 µm (Azuara-Blanco, Pillai and Dua, 1999; Dua et 
al., 2004; Liu, Sheha and Fu, 2010). Several characteristics that make the 
amniotic membrane a suitable candidate for transplantation include anti-
inflammatory, bacteriostatic and anti-scarring properties, pain reduction and 
wound healing properties followed by a lack of immunogenicity (Azuara-
Blanco, Pillai and Dua, 1999; Fish and Davidson, 2010; Gheorghe et al., 
2016).  
 
Amniotic membrane transplantation was re-introduced by Kim and Tseng in 
1995 as a treatment for epithelial defects from corneal ulcers. They also 
further developed a method of preservation and storage that has established 
its role as a membrane for ophthalmic applications (Kruse, Rohrschneider 
and Völcker, 1999; Dua et al., 2004; Thatte, 2011). Amniotic membrane has 
since been developed as both a bandage lens material to reduce 
inflammation and as a sutured graft to replace a damaged ocular surface and 
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promote wound healing (Hanada et al., 2001). ProKera® (Bio-Tissue Inc., 
Doral, FL, USA) (Figure 1.11b) is one such commercial amniotic membrane 
device and was approved by the FDA in 2003 as a medical device in the 
treatment of bacterial keratitis, chemical injuries and Stevens-Johnson 
syndrome (Suri et al., 2013). The device is an amniotic graft surrounded by a 
16 mm polycarbonate ring that is placed on the surface of the eye by 
inserting between the upper and lower eye lids (Trattler, 2012). ProKera® can 
be applied as a sutureless bandage which reduces surgery time and costs, 
allows for topical anaesthesia and eradicates inflammation caused by the 
insertion of sutures (Liu, Sheha and Fu, 2010). In one study ProKera® 
relieved discomfort and reduced inflammation within 96 h of application in 
three cases of severe microbial keratitis followed by healing of the corneal 
ulcer (Sheha et al., 2009). However, in a more recent study where ProKera® 
was applied to eyes with microbial keratitis only 44% of those healed with 
partial or complete success (Suri et al., 2013). This variation in clinical 
success is thought to be due to the varying biologic composition of amniotic 
membrane and methods used in storage of amniotic membranes prior to 
procedures. The possibility of transmissible infections and tissue variability 
are two prominent reasons for the reduced availability of amniotic tissue for 
transplantation (Pratoomsoot et al., 2008). 
 
1.3.3 Hydrogel bandage contact lenses: 
Most of the drawbacks attributed to collagen shields and amniotic membrane 
as ocular bandage lens materials have been resolved with the development 
of advanced hydrogel lenses. These hydrogels are composed of non-animal 
derived materials with an improved visual acuity, coupled with greater 
comfort and oxygen permeability due to their increased water content (Dell et 
al., 2011). The idea that soft contact lenses could be used in a therapeutic 
setting as bandage lenses was conceived by Kaufman in the 1970s and were 
mainly used for the protection of corneal wounds. He discovered that 
diseased and damaged corneas would heal faster if a soft contact lens was 
applied (Stein, 2008; Mohammadpour et al., 2015). Present day use of 
hydrogel bandage contact lenses (Figure 1.11c) include but are not limited to 
pain management, provision of a barrier function to protect a wound from the 
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natural blinking mechanism and the external environment, promotion of re-
epithelialisation and most recently in the elution of ocular drugs (McMahon 
and Zadnik, 2000). 
 
 
 
- Hydrophobic 
- lowers water content 
and increase strength 
 
- Primary monomer 
for conventional 
contact lenses 
- Hydrophilic 
- Increases water 
content and 
wettability 
- Hydrophilic 
- Increases water 
content 
- Silicone monomer 
- Increases oxygen 
permeability 
 
 
 
Modern day hydrogel bandage contact lenses are either conventional HEMA 
or silicone-based hydrogels that conform to the surface of the eye (Figure 
1.12). Conventional hydrogel lenses are usually high water content polymers 
with oxygen transmissibility (Dk) corresponding to the water content. 
Unfortunately, no hydrogels meet the 87 Barrer Dk value required for a lens 
to be recommended for overnight wear. A typical high water content (74%) 
hydrogel has a Dk of 36 Barrer (Blackmore, 2010; Tashakori-Sabzevar and 
Mohajeri, 2015). Despite not meeting the recommendation for extended use, 
conventional hydrogel lenses remain the most common lenses used as 
bandage contact lenses (Grentzelos et al., 2009; Mohammadpour et al., 
2015). The introduction of hydrophobic silicone monomers into hydrogel 
lenses greatly enhanced the oxygen permeability. Once incorporated, the 
amorphous silicone bulk material creates space between the hydrogel’s 
polymer chains allowing for smaller molecules such as oxygen to pass 
through more freely (Nicolson and Vogt, 2008). Therefore, silicone hydrogel 
lenses have a greater oxygen transmissibility that allows more oxygen to 
Figure 1.12: Some of the most common hydrogel contact lens monomers. 
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reach the cornea resulting in less hypoxia and the potential for longer term 
wear (Blackmore, 2010). Lotrafilcon A has been FDA approved for 30 day 
continuous wear whilst a more recent iteration lotrafilcon B has gained FDA 
approval for 6 days of continuous wear (Grentzelos et al., 2009). Silicone 
hydrogel lenses also provide a greater mechanical protection; however, the 
increased elastic modulus provides less comfort than lower elastic moduli 
conventional hydrogel lenses. In the decade following the introduction of 
silicone hydrogel lenses, new generation silicone hydrogel lenses (senofilcon 
A and comfilcon A) are addressing this issue with lower elastic moduli and 
increased water contents whilst maintaining a similar degree of oxygen 
transmissibility as older generation silicone hydrogel materials (lotrafilcon A 
and balafilcon A) (Table 1.1).  
 
 
 
 
 
 
 
Figure 1.13: Addition polymerisation process used to make pHEMA hydrogels. Other 
monomers such as those in Figure 1.12 are usually added and result in co-polymers. I - 
Initiator, I* - free radical, M - monomer, M* - monomer free radical. 
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These new generation silicone hydrogels allow for greater comfort and less 
disruption of the tear film and cornea via hydrophobic interactions 
(Blackmore, 2010; Baenninger, 2014). This was mainly achieved with the 
incorporation of hydrophilic monomers such as PVP within the polymer 
matrix (senofilcon A) as opposed to plasma treatment (lotrafilcon A and 
balafilcon A) in improving wettability. Structural changes such as the addition 
of longer chain monomers (comfilcon A) has also helped to achieve lower 
moduli (Nicolson and Vogt, 2008; Tighe, 2013).  
 
Polymers in general are chemically synthesised by either addition or 
condensation polymerisation. However, in the case of hydrogel lens 
materials, addition polymerisation is the predominant method and occurs 
between vinyl groups (C = C) of monomers. This route requires heat or a UV 
source to form free radicals from a decomposed chemical initiator that in turn 
combines with monomers to form free radical monomers that react with other 
monomer units to form part of a growing polymer chain (Figure 1.13). The 
reaction components are usually contained within a solvent mixture to 
maintain solubility. The choice of initiator and reaction parameters are usually 
dictated by the method used to cast a lens which is either spin casting, 
lathing or the most widely used method, cast moulding. Lathed lenses are cut 
from solid dehydrated hydrogel buttons that have long polymerisation times. 
Thermal initiators with low activation energies are used so reaction 
temperatures can be set lower. Buttons are usually much greater in volume 
than the final lathed lens so they allow for any surface imperfections to be 
removed during processing. Spin casting normally involves short 
polymerisation times (≤ 1 h), however a diluent is required to ensure efficient 
mixing of monomers during polymerisation and the reaction is often purged 
with nitrogen to provide anaerobic conditions. Cast moulded lenses also 
involve relatively short polymerisation times whereby monomers are 
polymerised between two moulds with a rapid rise in temperature required 
during the curing process. Cast moulding is the current method of choice for 
disposable lens manufacture (Maldonado-Codina and Efron, 2003; Winterton 
and Su, 2005; Maldonado-Codina, 2017). 
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Hydrogel bandage contact lens use as a primary treatment for corneal 
abrasions was first described in the 1980s (Acheson, Joseph and Spalton, 
1987) with quicker healing times and most patients reporting less discomfort. 
Hydrogel bandage contact lenses have also been used to treat corneal 
abrasions on soldiers in a battlefield situation and in most cases this allowed 
them to remain on full duty due to retention of visual acuity and a reduction in 
pain. These factors could prove vital in a combat situation (Buglisi et al., 
2007). Recurrent corneal erosion is another condition that has been treated 
with hydrogel bandage contact lenses. It is usually characterised by repeated 
breakdown of the corneal epithelium and may progress from episodes of 
corneal abrasion and trauma. In one study 9 of 12 patients treated with a 
hydrogel bandage contact lens reported no recurrent corneal erosion 1 year 
later with only 1 of 12 patients reporting a recurrence of the condition 
(Fraunfelder and Cabezas, 2011).  
 
 
 
Hydrogel Monomers Name Water 
Content 
(%) 
Dk 
(Barrer) 
Elastic 
Modulus 
(MPa) 
Conventional Hydrogel 
Omafilcon 
A 
HEMA, 2-Methacryloxyethyl 
phosphorylcholine (PC) 
Proclear 
(Coopervision) 
62 27 0.49 
Lidofilcon A MMA, NVP Omniflex 
(Coopervision) 
70 32 0.31 
Silicone Hydrogel 
Lotrafilcon 
A 
TRIS, fluoroether macromer, 
dimethylacrylamide (DMA) 
AIROPTIX 
Night and Day 
(CIBA Vision) 
24 140 1.4 
Balafilcon 
A 
3-[Tris(trimethylsiloxy)silyl] 
propyl vinyl carbamate 
(TPVC), NVP 
PureVision 
(Bausch & 
Lomb) 
36 99 1.1 
Senofilcon 
A 
Modified 3-
[Tris(trimethylsiloxy)silyl] 
propyl methacrylate (TRIS), 
Poly-(vinylpyrrolidone) (PVP) 
Acuvue 
OASYS 
(Vistakon) 
38 103 0.73 
Comfilcon 
A 
Long-chain siloxane 
macromer 
Biofinity 
(Coopervision) 
48 128 0.75 
Lotrafilcon 
B 
TRIS, fluoroether macromer, 
DMA 
O2Optix 
(CIBA Vision) 
33 110 1.2 
Table 1.1: Comparison of mechanical and physical properties of conventional and 
silicone contact lens materials. Adapted from (Maldonado-Codina and Efron, 2003; 
Blackmore, 2010; Mohammadpour et al., 2015; Bhamra and Tighe, 2017). 
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Another area where hydrogel bandage contact lenses are used is post-
surgery and in particular after photorefractive keratectomy. In a study of 44 
patients, re-epithelialisation was reported to be complete 3 days after surgery 
in 75% (lotrafilcon A) and 72.7% (lotrafilcon B) of cases (Grentzelos et al., 
2009). 
 
The most common complication reported following the application of hydrogel 
bandage contact lenses in the treatment of ocular conditions is microbial 
keratitis. The increased risk comes from extended wear silicone hydrogel 
bandage contact lenses which comes as no surprise as the same trend is 
noted with extended wear vision correction silicone hydrogel lenses. An 
increase of 4.1 to 13.3 times risk of microbial keratitis has been observed for 
extended wear over daily wear lenses (Saini et al., 2013). In one study, pain 
reduction and better post-operative results were observed from patients 
wearing a lotrafilcon A silicone hydrogel bandage lens compared to those 
wearing the conventional hydrogel lens omafilcon A. However, less corneal 
infiltrates were observed in those patients wearing omafilcon A bandage 
lenses (Edwards et al., 2008). In another study the combined approach of 
antibiotics and the application of a silicone hydrogel bandage contact lens 
could not prevent the occurrence of microbial keratitis (Saini et al., 2013). 
Conventional hydrogel bandage lenses have also been implicated in cases of 
microbial keratitis and in one study 13% of patients were treated for microbial 
keratitis following the application of conventional hydrogel bandage lenses to 
treat corneal abrasions (Buglisi et al., 2007). 
 
 
1.4 Recent work around drug eluting bandage lenses 
 
Recently, studies have intensified into controlling the release of drugs from 
bandage lens materials to directly promote wound healing and lower the 
microbial burden at the site of an ocular wound. Several different methods of 
drug attachment to bandage lenses have been described including covalent 
attachment and ionic interaction of drugs to functional groups within the 
hydrogel bandage lens matrix, molecular imprinting, absorption of drugs into 
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the hydrogel or addition of drug loaded nanoparticles into the hydrogel matrix 
(Figure 1.14) (Ciolino et al., 2009; Garhwal et al., 2012; Guzman-Aranguez, 
Colligris and Pintor, 2013; Kakisu et al., 2013). The incorporation of drugs 
should not compromise the mechanical or optical properties of bandage 
contact lenses whilst also remaining non-toxic to the corneal epithelium after 
application of the lens (Ciolino, 2009). 
 
1.4.1 Absorption of drugs within a hydrogel matrix: 
Absorption of drugs into hydrogel networks is the simplest, conventional and 
most cost-effective method of hydrogel drug incorporation. It usually involves 
soaking of a hydrogel contact lens material in a solution of the drug of choice 
for a period of time to allow drug saturation of the lens (Maulvi, Soni and 
Shah, 2016). Drug concentration is usually dependant on and limited by the 
water content of the hydrogel as the absorption of the drug is a simple 
equilibrium of the drug concentration in the soaking solution and the 
concentration within the hydrogel. After application of the hydrogel to the eye 
the drug releases via simple diffusion from the hydrogel into the post-lens 
tear film (Filipe et al., 2016; Maulvi, Soni and Shah, 2016). This is aided by 
the blink cycle, as the anterior surface of the lens becomes dry immediately 
after blinking this allows for the diffusion of up to 5 times greater amounts of 
drugs to the post-lens tear film than to the replenished lachrymal fluid at the 
anterior surface of the lens (Alvarez-Lorenzo, Yanez and Concheiro, 2010). 
The hydrogel performs like a drug reservoir ensuring greater drug contact 
time with the tear film and cornea allowing for greater concentrations to be 
achieved.  
 
Absorption of drugs via a soaking method has been tested for decades. 
Ruben and Watkins (1975) described the elution of pilocarpine from soft 
contact lenses and in more recent times Maulvi et al. (2015) described the 
release of hyaluronic acid from hydrogel contact lenses for the treatment of 
dry eye syndrome. Other examples include the loading and elution of the 
antimicrobial cationic peptide melimine. Willcox et al. (2008) reported an 80% 
reduction in viable P. aeruginosa and S. aureus when cultured in the 
presence of an etafilcon A lens loaded with melimine. 
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Some of the limitations associated with this method of drug incorporation 
include a limited drug loading capacity determined by the water content and 
thickness of the lens combined with the drug soaking time, a short release 
time of usually < 2 h coupled with a ‘burst’ release profile that sees much of 
the drug released almost immediately after application of the hydrogel 
followed by a slower release of much lower concentrations of the drug. These 
initial high concentrations of drugs can cause toxicity to the corneal 
epithelium. Current research is focussing on drug release that follows ‘zero-
order’ kinetics i.e. a slower release of drugs at constant concentrations 
(Xinming et al., 2008; Ciolino, 2009; Chauhan, 2015). Another limitation is 
that high molecular weight and hydrophobic drugs cannot penetrate the 
aqueous portion of the hydrogels and tend to remain on the surface thereby 
limiting their uptake (Maulvi, Soni and Shah, 2016). 
 
Figure 1.14: Methods currently used for incorporation of drugs and their controlled 
release from contact lens materials. 
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1.4.2 Attachment of drugs to functional groups in a hydrogel: 
Another method of drug loading involves attachment of ionic drugs to 
functional groups within the hydrogel matrix. This is similar to the soaking 
method but a stronger bond is formed either ionically or with additional cross-
linking chemistry resulting in a more permanent covalent bond between drug 
molecule and hydrogel. Ionic attachment of drugs to a hydrogel results in an 
anionic/cationic drug-hydrogel complex. Drug release is facilitated by ionic 
components within the tear film such as sodium and chloride that gradually 
displace the drug from the hydrogel over time (Chauhan, 2015). Covalent 
attachment of drugs to hydrogels result in a more local drug concentration as 
it remains attached to the hydrogel for longer than ionic binding allows. 
Cleavage of attached biomolecules is initiated by hydrolytic enzymes and can 
result in a slower release profile (Filipe et al., 2016). 
 
Some examples of drug adsorption to hydrogels include a pHEMA-co-MAA 
hydrogel with a relatively low water content (38%) and an elastic modulus 
within the range of commercial lens materials (0.76 MPa). A high loading of 
gatofloxacin was obtained (11.78 μg mg-1) and was released slowly over 24 h 
without an initial burst release profile. The drug loading was threefold greater 
than that obtained from a pHEMA only and a commercial pHEMA based 
hydrogel that included NVP, ethyl methacrylate (EMA) and glycidyl 
methacrylate (GMA) (Shi et al., 2013). Melimine has also been covalently 
attached to etafilcon A lenses (152 μg lens-1) and the antimicrobial activity 
measured. A reduction in both P. aeruginosa (3.1 log) and S. aureus (3.9 log) 
was observed as well as a 2 log reduction in multi-drug resistant strains of 
the same organisms. A significant reduction in adhesion of viable organisms 
was also observed compared to the non-melimine coated control (Dutta et 
al., 2013). 
 
The drug attachment approach has similar limitations to drug absorption 
(section 1.4.1) in that associated drugs have a short release profile but this 
may be prolonged with the addition of covalently attached drugs or the 
addition of functional monomers to the hydrogel to add a much higher loading 
of the drug of choice. In one case a pHEMA lens with NVP and aminopropyl 
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methacrylamide (APMA) functional monomers increased loading of ibuprofen 
and diclofenac by 10- and 20-fold followed by a release that lasted 24 h and 
1 week respectively (Andrade-Vivero et al., 2007). Any additional molecules 
must not modify the optical, physical or mechanical properties of the lens. 
Another limitation that can be rectified with the addition of further ionic 
monomers is the swell and contraction of the hydrogel network after 
disassociation of the drug and association of various salts such as chlorides 
from the surrounding tear film (Xinming et al., 2008).  
 
1.4.3 Colloidal nanoparticles: 
The incorporation of drug-laden colloidal systems such as nanoparticles, 
micro-emulsions, micelles and liposomes into hydrogels during 
polymerisation are aimed at increasing the overall drug loading capacity and 
control of the release time (Maulvi, Soni and Shah, 2016). Upon insertion on 
the eye the drug diffuses away from the colloidal nanoparticles and towards 
the post-lens tear film. This diffusion is slowed due to the drug having to 
diffuse through nanoparticles into the lens and then from the lens into the 
tear film and in turn providing a continuous release for extended periods of 
time (Xinming et al., 2008). Encapsulating the drug in colloidal nanoparticles 
protects the drug from the initial polymerisation of the hydrogel but once 
inserted on the eye it can prevent enzymatic degradation from lysozymes 
and other enzymes in the tear film (Maulvi, Soni and Shah, 2016). The choice 
of colloidal nanoparticle system can also greatly enhance drug delivery by 
overcoming the effective barriers of the corneal epithelium and stroma that 
inhibit hydrophilic and hydrophobic drugs, respectively. The corneal 
epithelium mucosa is negatively charged and therefore cationic molecules 
are more permeable at physiological pH. To overcome this, cationic 
liposomes have been found to be more effective at delivering drugs such as 
penicillin G and tropicamide than anionic and neutral liposomes (Gaudana et 
al., 2010).  
 
Silica based nanoparticles laden with the hydrophobic drug lidocaine have 
been polymerised inside a pHEMA hydrogel. The introduction of the 
nanoparticles reduced the light transmittance of the hydrogel to 78% 
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compared to an 88% transmittance through a pHEMA hydrogel without 
nanoparticles incorporated. An initial drug loading of 0.23 mg g-1 was 
obtained and a release of lidocaine was observed over an 8 day period 
(Gulsen and Chauhan, 2004). Polycaprolactone nanospheres have been 
formulated to contain ciprofloxacin prior to incorporation into pHEMA lenses. 
Of the total amount of ciprofloxacin released (274.9 μg) from the hydrogels 
the majority (255.9 μg) was released in the first 24 h. This was sufficient to 
prevent proliferation of both P. aeruginosa and S. aureus for 3 days after 
application of the lens (Garhwal et al., 2012). 
 
Several limitations are associated with this method of drug loading including 
a decrease in water content, lower refractive index and an increase in elastic 
modulus due to the introduction of particles within the hydrogel matrix 
(Maulvi, Soni and Shah, 2016). This may result in undesirable properties 
such as an increase in discomfort of the lens, decreased oxygen permeability 
and a loss of visual acuity. Another limitation may the instability of the drug 
within the colloidal nanoparticles during storage and transportation resulting 
in diffusion into the hydrogel matrix. This would effectively nullify any slow, 
continuous release properties from the colloidal nanoparticles and rely solely 
on diffusion of the drug through the hydrogel (Xinming et al., 2008).  
 
1.4.4 Molecular imprinting: 
Molecular imprinting technology was first developed in 1972; however, it is a 
relatively new method in the controlled release of drugs from hydrogel 
bandage contact lenses (Wulff, 1995; Tashakori-Sabzevar and Mohajeri, 
2015). Molecular imprinting seeks to optimise the spatial distribution of 
functional monomers to increase the efficiency of the interactions between 
the hydrogel and the drug. This is achieved by mixing functional monomers 
and the drug together to form self-assembled complexes that are then 
polymerised within the hydrogel. The drug is then removed to leave imprinted 
cavities and bonding preferences that allow a greater affinity for a specific 
drug (Xinming et al., 2008; Chauhan, 2015). There are two approaches to 
molecular imprinting either covalent or ionic interaction of the target 
molecule-functional monomer matrix. Ionic interaction is preferred in drug -
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polymer situations as this allows faster binding and release properties 
(Alvarez-Lorenzo, Yanez and Concheiro, 2010; Tashakori-Sabzevar and 
Mohajeri, 2015). A reported two- to threefold increase in drug loading 
capacity compared to absorption alone has been reported via this method 
(Kearns and Williams, 2009). 
 
Numerous studies have identified molecular imprinting technology as having 
greater loading and slower drug release capacities than absorption or the 
chemical attachment of drugs alone. A 4- to 50-fold greater mean residence 
time of ketotifen was observed from imprinted pHEMA lenses compared to a 
non-imprinted control (Tieppo et al., 2012). Other studies have noted smaller 
increases of two- to threefold greater concentrations of timolol in the tear fluid 
from imprinted lenses compared to their non-imprinted lens controls (Hiratani 
et al., 2005). High molecular weight molecules such as hyaluronic acid have 
also been molecularly imprinted and the release controlled from poly-(vinyl 
alcohol) (PVA) lenses. The ratio of functional monomers was increased to 
prolong the release of the hyaluronic acid from the lenses. Hyaluronic acid 
was released at a rate of 6 μg h-1 over a 24 h period (Ali and Byrne, 2009). 
 
A few limitations have been noted with molecular imprinting technology for 
ophthalmic applications including swelling and contraction of the hydrogel 
network due to interactions with the tear film. This distorts the imprinted 
cavities which thereby inhibits the drugs affinity to these areas within the 
hydrogel (Alvarez-Lorenzo, Yanez and Concheiro, 2010). The water content 
may also be reduced due to the swelling and contraction resulting in 
increased discomfort and reduced oxygen permeability (Maulvi, Soni and 
Shah, 2016). Drug loading is dependent on the functional monomers and the 
target molecules that have been used to imprint the cavities and it is difficult 
to control drug release (Xinming et al., 2008). 
 
1.4.5 Layer-by-layer platforms: 
A less widespread technique to control drug release from hydrogel contact 
lenses involves the incorporation of poly-(lactic-co-glycolic acid) (PLGA) films 
coated with a drug into contact lenses. Drug elution is determined by the ratio 
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of drug - PLGA which can be easily altered prior to incorporation (Maulvi, 
Soni and Shah, 2016). Ciolino and co-workers have developed pHEMA 
hydrogels with drug covered PLGA layers incorporated into the matrix. In one 
instance, they incorporated econozole into PLGA films prior to forming a 
pHEMA hydrogel with results indicating fungicidal activity towards C. albicans 
in vitro. In another instance the glaucoma drug, latanoprost, was incorporated 
in the same way and results showed an early burst release followed by a 
slow release of the drug for a further month (Ciolino et al., 2009, 2011, 2014). 
Several limitations with this layer-by-layer method are yet to be addressed 
including a lack of transparency due to the drug - PLGA films, alterations to 
the mechanical properties of the pHEMA hydrogels, reduced oxygen 
permeability and an increase in protein fouling of the lens (Maulvi, Soni and 
Shah, 2016).   
 
1.4.6 Diffusion barriers: 
The inclusion of diffusion barriers is another lesser known method of 
regulating drug elution from hydrogels. The most common diffusion barrier is 
the hydrophobic molecule vitamin E. The hydrophobic nature of the barrier 
minimises the rapid diffusion of drug molecules from within the hydrogel to 
the external solution. Contact lenses loaded with 30% vitamin E were able to 
extend elution time of dexamethasone by 7 - 9 days from hydrogel contact 
lenses which is a 9- to 16-fold increase over hydrogels without vitamin E 
added (Filipe et al., 2016). The inclusion of diffusion barriers still have some 
limitations to overcome including reduced mechanical properties and oxygen 
permeability as well as increased protein fouling and reduced water content 
due to the hydrophobicity of vitamin E (Maulvi, Soni and Shah, 2016). 
 
 
1.5 SpheriTech Ltd. hydrogels 
 
The peptide based polymer in this study has previously been developed in 
macroporous form as a wound dressing and a 3-D scaffold for tissue 
engineering applications (Wellings and Gallagher, 2012) (Figure 1.15). The 
polymer is based on poly-ε-lysine (pεK) cross-linked with bis-carboxylic acids. 
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A feature which makes this hydrogel unique is the incorporation of two 
naturally occurring non-animal derived components, pεK and short to 
medium chain bis-carboxylic acids. PεK is an edible, non-toxic, cationic 
homo-poly-amino acid composed mostly of 25 - 35 lysine residues with an 
amide linkage between the α-carboxyl and the ε-amino groups. It is currently 
used as an emulsifier and preservative in foodstuffs and has been classified 
as ‘generally regarded as safe’ (GRAS) by the FDA since 2004 (Nishikawa 
and Ogawa, 2006; Shih, Shen and Van, 2006; Hyldgaard et al., 2014). PεK 
was first isolated by Shima and Sakai (1977) from the soil bacterium 
Streptomyces albulus 346 during screening for Dragendorff positive 
substances (Bankar and Singhal, 2013).  
 
 
 
 
 
 
The pεK molecule is highly soluble in aqueous media and stable at high 
temperatures including after autoclaving at 120 °C for 20 min (Shih, Shen 
and Van, 2006; Li et al., 2014). PεK is antimicrobial against a broad spectrum 
of Gram-positive and Gram-negative bacteria, yeasts and mould with MICs of 
< 100 µg cm-3 for most organisms tested including E. coli (8 µg cm-3), S. 
aureus (16 µg cm-3) and C. albicans (54 µg cm-3) (Zhou et al., 2011; Ye et al., 
2013). Furthermore, the natural pεK has been found to be less toxic and 
more antimicrobial than the synthetic poly-α-lysine (pαK) which has been 
used more commonly for biological applications (Shima et al., 1984; Shih, 
Figure 1.15: a) Macroporous pεK/tridecanedioic acid 10 cm2 wound dressing, b) early 
prototype pεK/decanoic acid hydrogel. 
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Shen and Van, 2006). Short to medium chain bis-carboxylic acids are found 
in both plants and animals. In the latter they are products of the ω-oxidative 
degradation of longer chain mono-carboxy fatty acids (Passi et al., 1983; 
Volkman, 2006). Medium chain bis-carboxylic acids have greater water 
solubility than their mono-carboxy fatty acid equivalents due to the carboxylic 
functional groups at each end of the molecule (Grego and Mingrone, 1995). 
Short to medium chain bis-carboxylic acids have been administered as 
treatments for several disorders including melisma, toxic melanoderma, acne 
and in killing malignant melanocytes in humans without having cytotoxic 
effects on normal healthy cells (Passi et al., 1983). Furthermore, they are β-
oxidised by the mitochondria and peroxisomes to acetyl-CoA, malonyl-CoA 
and succinyl-CoA to become substrates for lipogenesis and gluconeogenesis 
(Kølvraa and Gregersen, 1986; Grego and Mingrone, 1995; Houten et al., 
2012). 
 
 
 
 
 
 
 
 
 
 
 
The proposed nature of the cross-linking involved in the polymerisation of the 
pεK/bis-carboxylic acid polymer has been detailed (Figure 1.16). The α-
amino group of the lysine residues of pεK are cross-linked to form an amide 
bond with either end of a bis-carboxylic acid residue via condensation 
polymerisation (Figure 1.17). The cross-linking is mediated by 1-Ethyl-3-(3-
Figure 1.16: Proposed nature of the cross-linking between pεK and bis-carboxylic acids. 
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dimethylaminopropyl) carbodiimide (EDCI)/ N-hydroxysuccinimide (NHS) to 
introduce a zero-length cross-link between the pεK and bis-carboxylic acid 
under aqueous conditions (Grabarek and Gergely, 1990). This method of 
cross-linking is well established as carbodiimides were identified over 100 
years ago followed by NHS esters in the 1960s and have since been used in 
peptide synthesis and bioconjugation techniques (Wilchek and Miron, 1987; 
Nakajima and Ikada, 1995). EDCI in the presence of a carboxylic acid will 
form an intermediate O-acylisourea which subsequently reacts with NHS to 
form the more stable NHS ester of the carboxylic acid. The ester upon 
reaction with a primary amine forms an amide bond with reconstituted NHS 
and isourea as the by-products (Hermanson, 2013b). 
 
 
 
 
 
The very nature and degree of the cross-linking that results in the formation 
of a hydrogel allows for the potential attachment of other biomolecules to the 
polymer backbone. A possibility is to attach (absorb, ionic, covalent) an array 
of biomolecules for the diagnosis and treatment of conditions such as 
microbial keratitis. 
 
Figure 1.17: Cross-linking chemistry used to form an amide bond between pεK and bis-
carboxylic acids. 
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A pεK/methacrylamide hydrogel has been previously described that is non-
cytotoxic to human primary keratinocytes that has an antimicrobial activity 
against a broad spectrum of organisms including P. aeruginosa, S. aureus 
and C. albicans. The hydrogels described had an elastic modulus between 
0.1 - 0.2 MPa and suggested as potential antimicrobial coatings for medical 
devices (Zhou et al., 2011). These previous findings suggest that a viable 
antimicrobial hydrogel based on pεK may be possible. The elastic modulus of 
pεK hydrogels has already been described as similar to commercial contact 
lens materials. Another pεK hydrogel with dextran aldehyde has been 
described as a non-viral gene carrier for gene therapy with the 
biodegradability of the polymer identified as a potential for controlling release 
(Togo et al., 2013). Biodegradable polymersomes composed of decanedioic 
acid and polyethylene glycol have been investigated with encapsulating 
calcein and a degradation time of 2 weeks was observed. These 
polymersomes have been suggested for drug carrier applications (Najafi and 
Sarbolouki, 2003). Both pεK and bis-carboxylic acids have been included as 
components of drug carriers for delivery and the slow release of drugs. 
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1.6 Hypothesis/aims 
 
The hypothesis was that a hydrogel with antimicrobial properties could be 
produced from a pεK/bis-carboxylic acid polymer and have comparable 
mechanical and physical properties to commercial contact lens materials. 
 
The aims were: 
- To investigate and optimise the mechanical and physical properties (water 
content, transparency, etc.) of the polymer to attain similar values as those 
already described for commercial contact lens materials. 
 
- To investigate the natural antimicrobial activity towards Gram-positive and 
Gram-negative bacteria and further enhance this activity with the addition of 
antimicrobial biomolecules. 
 
- Determine the antifungal capacity of the hydrogel after the sorption of a 
model antifungal compound. 
 
- Demonstrate how the sorption of an AMP with environmentally sensitive 
fluorophores could be used to identify Gram-positive and Gram-negative 
bacteria. 
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2. MATERIALS AND METHODS 
 
2.1 Hydrogel Characterisation 
 
The hydrogel variants were manufactured in the laboratories of SpheriTech 
Ltd. (Runcorn, England). The following materials were used in this part of the 
study; N,N-dimethylaminopyridine (DMAP) A13016, 1,10-decanedioic 
acid A14158, N-methylmorpholine (NMM) A12158, sodium octane 
sulfonate A11243 and piperidine A12442 (Alfa Aesar, Haverhill, MA, USA), 
NHS FH02165, 1-hydroxybenzotriazole (HOBt) FH02087 and EDCI 
FD05800 (Carbosynth Ltd., Compton, England), 0.45 µm syringe filter 
F2502-1 (Crawford Scientific Ltd., Strathaven, Scotland), trifluoroacetic 
acid (TFA) 008708 (Fluorochem Ltd., Hadfield, England), N,N-
diisopropylcarbodiimide (DIC) 222116 (Manchester Organics, Runcorn, 
England), phosphate buffered saline (PBS) BR0014 (Oxoid Ltd., 
Hampshire, England), hexanedioic acid 02130, octanedioic acid S5200, 
P2O5 79609, NaH2PO4 17844, phosphoric acid 04107, N,N-dimethyl 
formamide (DMF) 33120 and diethyl ether 32203 (Sigma-Aldrich, St Louis, 
MO, USA), nonanedioic acid A1318 and heptanedioic acid P0435 (TCI 
Europe, Zwijndrecht, Belgium), tween 80 28830, NaClO4·H2O 27988, NaOH 
28244, HCl 20252, high-performance liquid chromatography (HPLC) 
water 23595 and MeCN 20060 (VWR International Ltd., Lutterworth, 
England), pεK (Zhengzhou Bainafo Bioengineering Co., Ltd., Zhengzhou 
City, China). All HPLC and peptide synthesis equipment was supplied by 
SpheriTech Ltd whilst all other equipment and reagents were provided by the 
University of Liverpool unless otherwise stated. 
 
2.1.1 Poly-ε-lysine characterisation: 
A reverse phase HPLC technique modified from Hirohara et al. (2007) was 
used to determine the chain length distribution of each batch of pεK . 
Samples were run on a SpectraSYSTEM AS3000 (Thermo Scientific, 
Waltham, MA, USA) with a Luna C18 column, 4.6 x 100 mm, 3 µm particle 
size (Phenomenex, Torrance, CA, USA), kept at room temperature (Figure 
2.1). Solvent A was composed of NaH2PO4 (10 mmol dm-3), NaClO4·H2O 
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(100 mmol dm-3) and sodium octane sulfonate (10 mmol dm-3) in HPLC H2O 
and solvent B was composed of NaH2PO4 (20 mmol dm-3), NaClO4·H2O (200 
mmol dm-3), sodium octane sulfonate (20 mmol dm-3) in 50:50 HPLC 
H2O:MeCN. Both buffers were adjusted to pH 2.6 with dropwise addition of 
concentrated phosphoric acid. Each analysis was run over 105 min at a flow 
rate of 0.6 cm3 min-1 with 70 - 100% solvent B over the first 95 min and 100% 
solvent B for a further 10 min. A 30 min column wash of 90:10 MeCN:H2O 
(solvent C) was added at the end of each run. Samples were detected at 215 
nm on a SpectraSYSTEM UV100 detector (Thermo Scientific, Waltham, MA, 
USA). 
 
The following adjustment was made after the inclusion of a new Luna C18(2) 
column 4.6 x 100 mm, 3 µm particle size (Phenomenex, Torrance, CA, USA). 
Each analysis was run over 70 min at a flow rate of 0.6 cm3 min-1 with a 
solvent program of 50 - 80% solvent B over the first 60 min then 80% solvent 
B for 10 min followed by 80 - 100% solvent B for 10 min and finally 100% 
solvent C for a further 20 min.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Analysis of the peak area and percentage of oligomer residues > 20 was 
carried out using the integration feature on the supplied Azur software 
(Kromatek Ltd., Great Dunmow, England). 
Figure 2.1: HPLC equipment used in experiments.  
Buffers 
Autosampler 
Column chamber Mixing pumps 
UV detector 
Azur software 
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2.1.1.1 Poly-ε-lysine synthetic oligomer synthesis: 
Synthetic oligomers of pεK were synthesised via solid phase peptide 
synthesis using fluorenylmethyloxycarbonyl (Fmoc) chemistry at 5, 10, 15, 
20, 25 and 30 residues long as standards to identify the correct chain lengths 
within each chromatogram (Figure 2.2). A 500 mg aliquot of a 0.8 mmol g-1 
SpheriTide®™ solid support resin (SpheriTech Ltd., Runcorn, England) was 
added to a glass Bϋchner filter funnel with integrated No. 2 glass sinter 
(Scientific Glass Laboratories Ltd., Stoke-on-Trent, England) and swollen in 
50:50 H2O:DMF overnight prior to a 1 h neutralisation with 20 v/v% 
piperidine in DMF. The resin was washed 10 x DMF. A 4-hydroxymethyl 
phenoxyacetic acid (HMPA) linker was attached to the resin to provide a 
carboxylic acid terminal to the oligomers upon cleavage from the resin. 
HMPA (1.2 mmol, 218 mg) and HOBt (2.4 mmol, 367 mg) were added as 
solids prior to DIC (1.6 mmol, 252 mm3). DMF was added until the resin was 
covered with reaction solution and left for 2 h. A Kaiser test was used to 
determine reaction completion by comparing with a Kaiser test prior to HMPA 
attachment with a negative result signalling reaction completion. The first 
residue of Boc-Lys(Fmoc)-OH (AGTC Bioproducts Ltd, East Riding, England) 
was double coupled by adding Boc-Lys(Fmoc)-OH (562 mg) and DMAP (5 
mg) as solids followed by DIC (186 mm3). The reaction mixture was covered 
by adding extra DMF and leaving for 1 h. The reaction components were 
removed and the resin washed 10 x DMF. The coupling was repeated, the 
resin washed 10 x DMF and the Fmoc protecting group removed by washing 
with 20 v/v% piperidine in DMF for 3 min followed by a further 7 min wash. 
The resin was again washed 10 x DMF followed by a Kaiser test to detect for 
the presence of amine functional groups from the now de-protected lysine 
residue. With a positive Kaiser result the reaction continued. A single 
coupling of Boc-Lys(Fmoc)-OH was repeated a further 29 times with resin 
removed every 5 residues for cleavage to give the desired oligomer chain 
lengths.  
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2.1.1.2 PεK oligomer work-up: 
After every 5 residues of lysine were added a portion of the peptide resin was 
removed for cleavage from the peptide resin. The resin was added to a glass 
Bϋchner filter funnel with integrated No. 2 glass sinter and dried in a step-
wise fashion using mixtures of DMF:diethyl ether from 75:25 to 50:50 to 
25:75 and finally 100% diethyl ether. A cleavage solution of TFA:H2O (40 
cm3, 95:5) was added to the dried resin in a round bottom flask and left for 2 
h. A glass Bϋchner filter funnel with integrated No. 2 glass sinter and a 
collection vessel were set up and washed through with TFA prior to filtering 
the peptide. The cleavage solution/peptide resin was filtered and the filtrate 
collected. The retentate was washed 4 x TFA (20 cm3) to collect as much 
peptide as possible. The filtrate was rotary evaporated until all liquid had 
been removed before washing 4 x diethyl ether and decanting each wash. 
The peptide was left in diethyl ether overnight. Finally, the diethyl ether was 
decanted and the peptide left to air dry before a final weight and yield was 
obtained. 
 
2.1.2 Hydrogel design: 
The hydrogel material used in this study was composed of pεK cross-linked 
with a bis-carboxylic acid using an NHS/EDCI mediated cross-linking 
technique (Figure 1.17). Alterations to the level of cross-linking and the 
density of the polymer produced different variants of the hydrogel. These 
alterations were achieved by varying the molar concentrations of either pεK 
Figure 2.2: Peptide synthesis set up. 
 
Reaction 
vessel 
 
Collection 
vessel 
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itself or the bis-carboxylic acid cross-linker. An Excel spreadsheet was 
prepared to facilitate the calculations and provide the polymer compositions 
(Appendix 8.1). C, H and N elemental analysis (Butterworth Laboratories 
Ltd., Teddington, England) was carried out to determine the amine content 
(mmol g-1) of pεK for this study. The quantity of bis-carboxylic acid added to 
the polymer mix directly correlated to the percentage of amine groups to be 
cross-linked. All the polymer compositions for the investigation into the 
optimal bis-carboxylic acid cross-linker and density are provided below 
(Tables 2.1 - 2.5). 
 
For a 20 cm3 final polymer solution pεK was dissolved in water (5 cm3). The 
bis-carboxylic acid (500 mmol dm-3) pre-dissolved with a 2:1 molar ratio of 
NMM, was added to the pεK with 5 v/v% Tween 80 (200 mm3) and topped up 
to a final volume (10 cm3) with water. NHS and EDCI were weighed into a 
separate tube and topped up with water to a final volume (10 cm3) and 
allowed to mix for 5 min. All solutions were filtered to 0.45 µm using a syringe 
filter. The two solutions were then mixed together to a total volume (20 cm3) 
and inverted 5 times before aliquots (10 cm3) were poured into 10 cm2 
polystyrene weigh boats (175-1414-250, Elkay Laboratory Products Ltd., 
Basingstoke, England). The polymer was left to polymerise for a minimum of 
5 h. The hydrogels were then removed from incubation and washed 10 x in 
water before storing in water prior to use in experiments. 
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Reagent 
PεK / hexanedioic acid hydrogels 
60 mol% cross-
linked, 0.1 g 
cm-3 
60 mol% cross-
linked, 0.067 g 
cm-3 
80 mol% cross-
linked, 0.1 g 
cm-3 
80 mol% cross-
linked, 0.067 g 
cm-3 
PεK 2.19 g       
(12.72 mmol) 
1.46 g       
(8.48 mmol) 
2.05 g      
 (11.89 mmol) 
1.36 g    
 (7.92 mmol) 
Hexanedioic 
acid 
0.56 g       
(3.82 mmol) 
0.37 g       
(2.54 mmol) 
0.69 g      
 (4.75 mmol) 
0.46 g     
(3.17 mmol) 
NMM 1.39 cm3 0.93 cm3 1.30 cm3 0.87 cm3 
EDCI 3.66 g 
(19.08 mmol) 
2.44 g 
(12.72 mmol) 
4.56 g 
(23.77 mmol) 
3.04 g   
(15.85 mmol) 
NHS 0.73 g     
(6.36 mmol) 
0.49 g     
(4.24 mmol) 
0.68 g       
(5.94 mmol) 
0.46 g     
(3.96 mmol) 
 
 
 
 
Reagent 
PεK / heptanedioic acid hydrogels 
60 mol% cross-
linked, 0.1 g 
cm-3 
60 mol% cross-
linked, 0.067 g 
cm-3 
80 mol% cross-
linked, 0.1 g 
cm-3 
80 mol% cross-
linked, 0.067 g 
cm-3 
PεK 2.13 g       
(12.39 mmol) 
1.42 g       
(8.26 mmol) 
1.98 g      
 (11.50 mmol) 
1.32 g    
 (7.67 mmol) 
Heptanedioic 
acid 
0.59 g       
(3.72 mmol) 
0.40 g       
(2.48 mmol) 
0.74 g      
 (4.60 mmol) 
0.49 g     
(3.07 mmol) 
NMM 1.36 cm3 0.91 cm3 1.60 cm3 0.84 cm3 
EDCI 3.56 g 
(18.58 mmol) 
2.38 g 
(12.39 mmol) 
4.41 g 
(23.00 mmol) 
2.94 g   
(15.34 mmol) 
NHS 0.71 g     
(6.19 mmol)  
0.48 g     
(4.13 mmol) 
0.66 g       
(5.75 mmol) 
0.44 g     
(3.83 mmol) 
 
 
Table 2.2: PεK / heptanedioic acid hydrogel composition. 
Table 2.1: PεK / hexanedioic acid hydrogel composition. 
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Reagent 
PεK / octanedioic acid hydrogels 
60 mol% cross-
linked, 0.1 g 
cm-3 
60 mol% cross-
linked, 0.067 g 
cm-3 
80 mol% cross-
linked, 0.1 g 
cm-3 
80 mol% cross-
linked, 0.067 g 
cm-3 
PεK 2.08 g       
(12.07 mmol) 
1.39 g       
(8.05 mmol) 
1.92 g      
 (11.14 mmol) 
1.28 g    
 (7.43 mmol) 
Octanedioic 
acid 
0.63 g       
(3.62 mmol) 
0.42 g       
(2.41 mmol) 
0.78 g      
 (4.46 mmol) 
0.52 g     
(2.97 mmol) 
NMM 1.33 cm3 0.88 cm3 1.22 cm3 0.82 cm3 
EDCI 3.47 g 
(18.11 mmol) 
2.31 g 
(12.07 mmol) 
4.27 g 
(22.29 mmol) 
2.85 g   
(14.86 mmol) 
NHS 0.70 g     
(6.04 mmol) 
0.46 g     
(4.02 mmol) 
0.64 g       
(5.57 mmol) 
0.43 g     
(3.71 mmol) 
 
 
 
 
Reagent 
PεK / nonanedioic acid hydrogels 
60 mol% cross-
linked, 0.1 g 
cm-3 
60 mol% cross-
linked, 0.067 g 
cm-3 
80 mol% cross-
linked, 0.1 g 
cm-3 
80 mol% cross-
linked, 0.067 g 
cm-3 
PεK 2.03 g       
(11.77 mmol) 
1.35 g       
(7.85 mmol) 
1.86 g      
 (10.80 mmol) 
1.24 g    
 (7.20 mmol) 
Nonanedioic 
acid 
0.67 g       
(3.53 mmol) 
0.44 g       
(2.36 mmol) 
0.81 g      
 (4.32 mmol) 
0.54 g     
(2.88 mmol) 
NMM 1.29 cm3 0.86 cm3 1.19 cm3 0.79 cm3 
EDCI 3.39 g 
(17.66 mmol) 
2.26 g 
(11.77 mmol) 
4.14 g 
(21.61 mmol) 
2.76 g   
(14.41 mmol) 
NHS 0.68 g     
(5.89 mmol) 
0.45 g     
(3.92 mmol) 
0.62 g       
(5.40 mmol) 
0.42 g     
(3.60 mmol) 
 
 
Table 2.4: PεK / nonanedioic acid hydrogel composition. 
Table 2.3: PεK / octanedioic acid hydrogel composition. 
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Reagent 
PεK / decanedioic acid hydrogels 
60 mol% cross-
linked, 0.1 g 
cm-3 
60 mol% cross-
linked, 0.067 g 
cm-3 
80 mol% cross-
linked, 0.1 g 
cm-3 
80 mol% cross-
linked, 0.067 g 
cm-3 
PεK 1.98 g       
(11.49 mmol) 
1.32 g       
(7.66 mmol) 
1.80 g      
 (10.49 mmol) 
1.20 g    
 (6.99 mmol) 
Decanedioic 
acid 
0.70 g       
(3.45 mmol) 
0.47 g       
(2.30 mmol) 
0.85 g      
 (4.20 mmol) 
0.57 g     
(2.80 mmol) 
NMM 1.26 cm3 0.84 cm3 1.15 cm3 0.77 cm3 
EDCI 3.30 g 
(17.23 mmol) 
2.20 g 
(11.49 mmol) 
4.02 g 
(20.97 mmol) 
2.68 g   
(13.98 mmol) 
NHS 0.66 g     
(5.74 mmol) 
0.44 g     
(3.83 mmol) 
0.60 g       
(5.24 mmol) 
0.40 g     
(3.50 mmol) 
 
 
 
 
 
Reagent 
PεK / octanedioic acid hydrogels 
60 mol% cross-
linked, 0.067 g 
cm-3 
(Su 60 15) 
60 mol% cross-
linked, 0.071 g 
cm-3 
(Su 60 14) 
60 mol% cross-
linked, 0.077 g 
cm-3 
(Su 60 13) 
65 mol% cross-
linked, 0.067 g 
cm-3 
(Su 65 15) 
PεK 1.38 g       
(8.05 mmol) 
1.48 g       
(8.62 mmol) 
1.60 g      
 (9.29 mmol) 
1.36 g    
 (7.88 mmol) 
Octanedioic 
acid 
0.42 g       
(2.41 mmol) 
0.45 g       
(2.59 mmol) 
0.49 g      
 (2.79 mmol) 
0.45 g     
(2.56 mmol) 
NMM 0.88 cm3 0.95 cm3 1.02 cm3 0.87 cm3 
EDCI 2.31 g 
(12.07 mmol) 
2.48 g 
(12.94 mmol) 
2.67 g 
(13.93 mmol) 
2.46 g   
(12.83 mmol) 
NHS 0.46 g     
(4.02 mmol) 
0.50 g     
(4.34 mmol) 
0.53 g       
(4.60 mmol) 
0.45 g     
(3.91 mmol) 
 
Table 2.6: Su 60 15, Su 60 14, Su 60 13 and Su 65 15 hydrogel compositions. 
Table 2.5: PεK / decanedioic acid hydrogel composition. 
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The hydrogel composition was further modified to investigate variants (Su 60 
15, Su 60 14, Su 60 13 and Su 65 15) with octanedioic acid as the bis-
caboxylic acid (Table 2.6). 
 
The codes designated to the hydrogels are derived from their composition. 
For example, Su 60 14 is a pεK/octanedioic acid (Su for suberic acid) 
hydrogel cross-linked to 60% of the total amine groups available and at a 
density of 0.07 g cm-3 (14 for 14 cm3 g-1 which is the reverse of 0.07 g cm-3).  
 
2.1.3 Mechanical property analysis: 
Mechanical properties of the hydrogel variants were measured using a 
Linkam TST350 tensile tester (Linkam Scientific Instruments Ltd., Tadworth, 
England). Stress (σ), strain (ε) and elastic modulus (E) were determined for 
each sample.  
 
 
 
 
 
 
 
 
Figure 2.3: Linkam tensile tester. a) Linkam TST stage with some tools commonly used, 
b) hydrogel loaded onto the stage, c) hydrogel clamped into position immediately prior to 
test, d) a failed hydrogel after a tensile test. 
Sample borer 
Linkam TST350 stage 
Clamps 
Clamped sample 
20N force gauge 
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Hydrogel samples were removed from aqueous storage and cut to a 15 mm 
long dog bone shaped piece using a borer. The width and thickness of each 
sample was measured with an Absolute Digimatic caliper (Mitutoyo Ltd., 
Andover, England) and the readings recorded. The sample was then 
mounted in the Linkam tensile tester and secured in place with the provided 
clamps (Figure 2.3). The software was run and each sample was elongated 
until breakage point. A 20 N load cell was used for all mechanical analysis 
with a strain rate of 100 μm s-1. Results were recorded and analysed using 
the supplied Linksys32 software. 
 
2.1.4 Optimum polymerisation time and temperature: 
Hydrogel Su 60 14 was polymerised as in section 2.1.2 but with the following 
modifications. Samples to determine the optimum polymerisation 
temperature were incubated at three different temperatures (6, 21.5 and 37 
°C) for a total of 5 h. Polymerisation was halted by removing the hydrogel 
from the incubator and washing with water followed by aqueous HCl (0.25 
mol dm-3) for 30 min. Each sample was washed a further five times with 
water before being stored in water prior to mechanical testing.  
 
Samples in the polymerisation time study were incubated at 25 °C for 1, 3, 5 
18 and 24 h. The samples were worked up in the same way as for the 
polymerisation temperature study prior to mechanical testing. 
 
2.1.5 Refractive index measurements:  
Refractive index measurements were taken using an AR200 digital 
refractometer (Reichert Technologies, New York, NY, USA). The 
refractometer (Figure 2.4) was first calibrated with water. A hydrated sample 
of each hydrogel was cut (0.50 cm2) and padded dry on a piece of wet filter 
paper to remove surface water. The sample was then placed onto the glass 
prism of the refractometer and a measurement taken. Suitable controls were 
also used, water as a negative control and etafilcon A and narafilcon A as 
positive hydrogel controls.  
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Glass prism 
  
 
 
 
 
 
 
 
 
 
 
2.1.6 Percentage light transmittance: 
The percentage of light transmittance through the hydrogel variants was 
measured via a spectrophotometer at a wavelength within the visible light 
spectrum (485 nm). Each hydrogel sample was removed from water storage 
and circular discs (0.36 cm2) were cut using a 6 mm diameter trephine. The 
samples were placed in a 96-well plate and 100 mm3 H2O added to each well 
to maintain the hydrogels in their hydrated state. For any hydrogels not sitting 
flush on the bottom of the well they were gently manoeuvred into position 
with a pair of forceps. The 96-well plate was read at 485 nm on a FLUOstar 
Omega microplate reader (BMG LABTECH GmbH, Ortenberg, Germany) 
with an emission filter of 520 nm. The results were exported to Excel and the 
following formula was used to convert absorbance values to percentage light 
transmission: 
 
% Transmittance = (10^(-1*Abs))*100 
 
 
2.1.7 Percentage water content: 
Percentage water content of the hydrogel variants was determined following 
a gravimetric method. Each sample was removed from water storage and cut 
to approximately 1 cm2. The samples were padded dry on a piece of wet filter 
paper to remove surface water. A wet weight reading was recorded before 
the samples were placed in a desiccator overnight with P2O5 to expedite the 
Figure 2.4: Refractometer used in experiments. 
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removal of water. A reading was taken the next day to determine the dry 
weight of each sample. The following formula was used to determine the 
percentage water content of all the hydrogels tested:   
 
 
 
 
 
 
Other methods used to determine water content included the conversion of 
data obtained from the refractive index experiments (nD and Brix TC) using 
the refractometer in section 2.1.5. 
 
2.1.8 Dk values: 
Oxygen permeability (Dk) values were obtained for the hydrogels based on 
their equilibrium water content (EWC). A formula described by Morgan and 
Efron (1998) was used to convert the EWC to Dk: 
 
 
Dk = 1.67e0.0397EWC 
 
 
2.1.9 Contact angle analysis: 
The wettability of the hydrogels was determined by measuring the contact 
angle of a small water bead at the surface/liquid interface using a DSA 100 
(KRÜSS GmbH, Hamburg, Germany) (Figure 2.5). This technique is known 
as the sessile drop technique and it measures the static contact angle. 
Hydrogel samples were cut to size (7 cm2) and the surface dried by dabbing 
with a paper towel. The hydrogels were placed on a flat piece of glass on the 
stage of the DSA 100. The software was calibrated prior to imaging each 
sample. A drop of water (2 mm3) was dispensed from a syringe and an image 
captured by a goniometer. Four points per sample were measured and this 
was completed in triplicate for each hydrogel variant. A circle profile function 
was fitted to all water droplets. The contact angle was determined by 
wet weight - dry weight  
          wet weight               X 100                                                       
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measuring the angle of intersection between the baseline (surface of sample) 
and the circle profile. Poly-(tetrafluoroethylene) (PTFE) and glass were used 
as material controls. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
2.1.10 Degradation: 
The degradation of the hydrogel variants was investigated in different 
solvents over a 12 month period. Hydrogels Su 60 15, Su 60 14, Su 60 13 
and Su 65 15 were polymerised as described in section 2.1.2. 
 
Incubation solutions (10 cm3) of trypsin (1 mg cm-3), NaOH (0.25 M) and PBS 
were prepared. Hydrogel discs were cut (0.785 cm2) and incubated at 5 discs 
in a 7 cm3 vial with each incubation solution (5 cm3) at 37 °C for set time-
points of 1 week, 1, 6 and 12 months over 1 year. At each time-point samples 
were removed, padded dry on a piece of wet filter paper and a wet weight 
recorded to monitor weight loss. The samples were then placed in small vials 
(7 cm3) and covered with parafilm. The samples were frozen at -20 °C 
overnight, then placed on an Edwards Super Modulyo freeze dryer shelf 
(Edwards Ltd., West Sussex, England) at -35 °C. The vacuum was applied 
and the samples freeze dried for at least 4 h at 26 °C. The dried samples 
were mounted onto carbon tabs (Agar Scientific Ltd., Stansted, England) on 
a scanning electron microscope (SEM) specimen stub. Finally, the samples 
Figure 2.5: Krϋss DSA100 contact angle equipment. 
Sample  
stage 
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were observed using a Tabletop SEM TM3030 (Hitachi High-Technologies 
Europe GmbH, Berkshire, England) following the manufacturer’s protocol. 
  
2.1.11 Lens manufacture: 
Several techniques were investigated to try and make a lens shaped 
prototype of the pεK/bis-carboxylic acid hydrogel. Spin casting, immiscible 
solvents and various moulds were investigated as potential methods. 
 
2.1.11.1 Spin casting: 
Spin cast moulds (Figure 2.6a) were custom designed for SpheriTech Ltd. 
from a range of materials including polyoxymethylene, PVC, PTFE, PFA and 
glass. Polymer solution for hydrogel Su 60 14 was made up as described in 
section 2.1.2. Before adding the polymer mix to the moulds they were 
individually mounted onto an overhead stirrer that had been turned upside 
down. The moulds were rotated at between 400 - 900 RPM. Immediately 
after mixing the polymer solution it was pipetted into moulds with various 
volumes ranging from 60 - 120 mm3. The moulds were spun for 1 h before 
stopping and observing the mould for signs of a cast lens material. 
 
2.1.11.2 Immiscible solvent: 
Boiling tubes were secured upright and different volumes of polymer solution 
were added. Polymer solution for hydrogel Su 60 14 was made up as already 
described in section 2.1.2. Toluene (2.5 cm3) was added to the boiling tube 
after the polymer solution. The less dense immiscible solvent covers the 
polymer solution. The polymer was then left to set overnight before observing 
the cast lens material. 
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2.1.11.3 Contact lens moulds: 
Contact lens moulds were custom designed for SpheriTech Ltd. for spin 
casting (Figure 2.6a) and in a male/female format (Figure 2.6b). Polymer 
solution for hydrogel Su 60 14 was made up as described in section 2.1.2. It 
was added at various volumes (40 - 100 mm3) to the female mould before 
placing the male mould on top and snapping into place. The polymer 
polymerised overnight before observing the cast lens material. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.6: a) Spin cast moulds, b) male/female moulds. 
a) b) 
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2.2 HCE-T Cell Culture 
 
The following materials were also used in this part of the study; CCK-8 cell 
viability kit (Dojindo Laboratories, Kumamoto, Japan), PBS BR0014 (Oxoid 
Ltd., Hampshire, England), amphotericin B A2942, goat serum G9023, 
penicillin-streptomycin P4333, dimethyl sulfoxide (DMSO) D2650, fetal 
calf serum (FCS) F7524, Dulbecco’s Modified Eagle’s Medium/Ham’s 
F12 (DMEM/F12) D8062, trypsin-EDTA T3924, tryphan blue T8154, 
bovine serum albumin (BSA) and tween 20 P9416 (Sigma Aldrich, St 
Louis, USA), ethanol (SpheriTech Ltd., Runcorn, England), live/dead cell 
staining kit L3224, Hoechst 33342 H3570, 4',6-diamidino-2-phenylindole 
(DAPI) D1306, methanol and Mr Frosty™ (Thermo Fisher Scientific, 
Waltham, MA, USA). HCE-T cells donated by Kaoru Araki-Sasaki, Japan 
(Araki-sasaki et al., 1995). All other equipment and reagents were provided 
by the University of Liverpool unless stated.   
 
2.2.1 Hydrogel design: 
The base hydrogel used in this part of the study was Su 60 14 and the 
polymerisation protocol was followed from section 2.1.2. 
 
2.2.1.1 Hydrogel sterilisation: 
Hydrogel Su 60 14 was unsterile post-polymerisation so a suitable 
sterilisation protocol was required prior to cell culture. The aqueous storage 
media was decanted from the hydrogel material and replaced with a 70 v/v% 
aqueous ethanol solution. The hydrogels were soaked in the ethanol solution 
for 3 h. The vial containing the hydrogels was transitioned to the cell culture 
cabinet. The ethanol was decanted and replaced with sterile PBS and 
allowed to soak for 30 min. The PBS wash was repeated a further 2 times 
before the hydrogels were added to an appropriate tissue culture vessel and 
incubated with cell culture media overnight under standard cell culture 
conditions. The media was inspected for infection after decantation and prior 
to utilising the hydrogel in cell culture studies.  
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2.2.2 Cell recovery: 
After retrieval of the appropriate cryovial from liquid nitrogen storage it was 
placed in a water bath at 37 °C until only a small amount of frozen 
suspension remained in the tube. This was to ensure minimal toxicity from 
DMSO upon cell revival. During incubation, the cap of the cryovial was 
partially opened to allow any trapped nitrogen to escape without an explosive 
risk. The content of the cryovial was transferred to a centrifuge tube (15 cm3) 
and centrifuged with a Heraeus Multifuge X1 centrifuge (Thermo Fisher 
Scientific, Waltham, MA, USA) at 185 x g for 5 min. A pipette was used to 
remove the supernatant before replacing it with cell culture media (2 cm3). 
The cell pellet was suspended by aspirating with a pipette. The cell 
suspension was used to seed a T75 flask with an appropriate volume of 
DMEM/F12 (8 cm3) media containing 5% FCS with amphotericin B and 
penicillin - streptomycin. The flask was incubated at 37 °C with 5% CO2 prior 
to any cell culture experiments. 
 
2.2.3 Feeding cells: 
Fresh cell culture media (DMEM/F12 media containing 5% FCS with 
amphotericin B and penicillin - streptomycin) was pre-warmed to 37 °C in a 
water bath. HCE-T cells were transferred from the incubator to the tissue 
culture hood. A pipette was used to remove 80% of the spent media prior to 
replacing it with pre-warmed fresh media. The remaining 20% of spent media 
was left in the culture vessel to retain some of the macromolecules (i.e. 
growth factors) in the environment. Immediately prior to placing the HCE-T 
cells back in the incubator they were observed under a light microscope for 
confluency, morphology and any obvious signs of distress. If no other action 
was required, the cells were placed back in the incubator. The above process 
was carried out twice a week when cells were in culture. 
 
2.2.4 Passaging cells: 
When HCE-T cells reached approximately 75% confluency as determined by 
a visual check with a light microscope they were passaged. PBS, cell culture 
media and 10 v/v% trypsin-EDTA were pre-warmed to 37 °C in a water bath. 
HCE-T cells were transferred from the incubator to the tissue culture hood. 
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All the spent media was removed from the T75 flask containing the cells and 
replaced with pre-warmed PBS (4 cm3) that was swirled around the flask to 
remove any loose cells. The PBS was removed and immediately replaced 
with 10 v/v% trypsin-EDTA in PBS (4 cm3). The trypsin solution was swirled 
around the flask to cover the cell monolayer and placed back into the 
incubator at 37 °C for 3 - 4 min. The cells were then removed from the 
incubator and observed under a light microscope to ensure the majority had 
detached from the tissue culture plastic. If the cells had not detached they 
were incubated at 37 °C for a further 1 min before again checking for 
detachment. After most cells had detached from the flask they were 
transferred again to the tissue culture hood. A pipette was used to swirl the 
trypsin solution around the flask to detach any remaining cells before adding 
cell culture media (8 cm3) to inhibit the action of trypsin. The HCE-T cell 
suspension was removed from the flask and transferred to a centrifuge tube 
(15 cm3) before being centrifuged with a Heraeus Multifuge X1 centrifuge 
(Thermo Fisher Scientific, Waltham, MA, USA) at 185 x g for 5 min. A pipette 
was used to remove the supernatant without disturbing the cell pellet. The 
pellet was suspended in fresh cell culture media (4 cm3) and at this point the 
HCE-T cells were counted using a haemocytometer prior to seeding for 
experiments. To passage, the cell suspension (1 cm3) was transferred to a 
new, labelled T75 flask along with fresh cell culture media (9 cm3) and placed 
back in the incubator. The above process was carried out approximately 
once a week when cells were in culture. 
 
2.2.5 Cell freezing: 
The storage of cells followed the same procedure as in section 2.2.4 up to 
the point where a cell pellet was obtained. DMSO (10 v/v%) in cell culture 
media (6 cm3) was added to the cell pellet to suspend it. Aliquots of the cell 
suspension (1 cm3) were transferred to labelled cryovials before being added 
to a Mr Frosty™ container with isopropanol. The Mr Frosty™ was transferred 
to a -80 °C freezer overnight to control the cell freezing at -1 °C min-1. The 
next morning the cryovials were transferred to liquid nitrogen for long term 
storage at -196 °C. The above process was carried out in a timely manner to 
minimise the toxic effects of DMSO on the cells prior to freezing. 
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2.2.6 Tryphan blue cell viability: 
Prior to seeding cells in experiments or after a CCK-8 assay a test of their 
viability was undertaken. The dye tryphan blue was used and cells that 
excluded the dye remained viable whereas cells that stained with tryphan 
blue were non-viable as their compromised membrane allows the dye to pass 
through. An aliquot (100 mm3) of 0.4 v/v% tryphan blue in PBS was added to 
a similar volume of cell suspension. Aliquots (10 mm3) of the tryphan 
blue/cell suspension were added to a haemocytometer and a count of viable 
and non-viable cells was undertaken to determine the percentage of cell 
viability. 
 
 
% cell viability = [1.00 - (non-viable cells / total cell number)] x 100 
 
 
2.2.7 Monitoring hydrogel Su 60 14 Cytotoxicity: 
HCE-T cells were cultured under standard tissue culture conditions of 37 °C 
and 5% CO2. DMEM/F12 media containing 5% FCS with amphotericin B and 
penicillin - streptomycin supplementation was used. 
 
 
 
 Figure 2.7: Conversion of WST-8 forms the basis of the colorimetric CCK-8 assay. 
Reproduced with permission from Dojindo Laboratories, Kumamoto, Japan. 
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A CCK-8 assay (Figure 2.7) was used to monitor cell proliferation at various 
time-points during an 8 day cell culture period. A standard curve to determine 
cell number was carried out following the manufacturer’s guidelines. HCE-T 
cells were counted following the passaging protocol (section 2.2.4). An 
aliquot of the cell suspension was added to each well to achieve the 
appropriate cell number (Figure 2.8). Each well was filled to a total volume of 
500 mm3 with media before adding CCK-8 solution (50 mm3) and incubating 
under standard culture conditions for 2 h. An aliquot (3 x 100 mm3) of 
solution from each well was pipetted into labelled wells in a 96-well plate. 
Suitable controls included media and CCK-8 with no cells or media with cells 
and no CCK-8. The absorbance was read at 485 nm using a FLUOstar 
Optima plate reader (BMG Labtech, Ortenberg, Germany) with a background 
reading at 600 nm and the results recorded. A standard curve was plotted 
and used to determine HCE-T cell number in the cytotoxicity assays. 
 
 
 
 
 
To setup the cytotoxicity study an aliquot of DMEM/F12 media was incubated 
with hydrogel Su 60 14 and another aliquot was incubated without the 
hydrogel for 3 days. The incubated media aliquots were used to culture the 
HCE-T cells. The cells were incubated under standard culture conditions for 
4, 24, 48, 96, and 192 h after seeding with an initial density of 5 x 104 cells 
(Figure 2.9). At each time-point CCK-8 solution (50 mm3) was added to the 
Figure 2.8: CCK-8 standard curve plate layout. 
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media (500 mm3) in each well. The cells were incubated under standard 
culture conditions for a further 2 h. An aliquot (3 x 100 mm3) of solution from 
each well was pipetted into labelled wells in a 96-well plate. Suitable controls 
included media and CCK-8 with no cells or media with cells and no CCK-8 
and hydrogel controls included media with no hydrogel incubation and media 
incubated with hydrogel Su 60 14 PO4. The absorbance was read at 485 nm 
using a FLUOstar Optima plate reader (BMG Labtech, Ortenberg, Germany) 
with a background reading at 600 nm and the results recorded.      
          
 
 
 
                                     
2.2.8 Live/dead and Hoechst cell staining and imaging: 
A live/dead cell staining kit was used to determine cell viability and 
morphology. The cells were counterstained with Hoechst 33342. A stock 
solution of Hoechst 1:1000 (2 cm3) was made in PBS. An aliquot (500 mm3) 
of the stock solution was added to PBS (1486 mm3) with ethidium (10 mm3) 
and calcein (4 mm3). HCE-T cells were prepared for staining by removing 
media and washing with PBS (2 x 1 cm3) to remove any debris. An aliquot 
(250 mm3) of the staining solution was added to each well and the cells were 
incubated under standard culture conditions for 30 min. Controls used 
included cells cultured on tissue culture plastic and cells treated with 2% 
virkon for 5 min. The cells were imaged under dark conditions using a NIKON 
Eclipse TI-E inverted microscope (Nikon, Tokyo, Japan). 
Figure 2.9: Cytotoxicity assay plate layout.  
 
Figure 2.10: Illustration of the scratch assay protocol.Figure 2.9: Cytotoxicity assay plate 
layout. 
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2.2.9 Scratch assay: 
A scratch assay (Figure 2.10) was used to determine any effect that 
leachables from Su 60 14 may have on HCE-T cell re-epithelialisation. A 
confluent monolayer was obtained by seeding 2.5 x 104 cells in a 24-well 
plate and culturing for 3 - 4 days at which point all media was removed. A 
straight-lined scratch using a 200 mm3 pipette tip was made through the cell 
monolayer in each well. The cells were washed with culture media (2 x 1 
cm3). Hydrogel Su 60 14 was added to all the non-control wells before 750 
mm3 of media was removed to gently bring the hydrogel in direct contact with 
the cell monolayer. All wells contained culture media (250 mm3) which was 
replenished after 12 h if necessary. Controls used were a scratch with no 
hydrogel present and a no scratch control. Images were taken over a 23 h 
period at time-points 0, 5 and 23 h. TScratch software was used to determine 
the rate at which the HCE-T cells closed the scratch (Gebäck et al., 2008). 
 
 
 
 
 
Figure 2.10: Illustration of the scratch assay protocol. 
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2.2.10 Immunofluorescence staining: 
After the scratch assay the HCE-T cells were washed 3 x PBS before being 
incubated at -20 °C for 10 min with 100% methanol (500 mm3 per well).  
 
 
 Primary 
Antibody 
Concentration 2nd Primary 
Antibody 
Concentration Secondary 
Antibody 
Concentration 
1 
ZO-1 
(Invitrogen 
40-2200) 
 
2.5 μg cm-3 
 
/ 
 
/ 
 
GαR 488 
 
4 μg cm3 
2 
ZO-1 
(Invitrogen 
40-2200) 
 
2.5 μg cm-3 
Pan 
cytokeratin 
(Abcam 
ab52460) 
 
1 μg cm-3 
 
GαM 488 
GαR 568 
 
4 μg cm3          
4 μg cm3 
3 
Occludin 
(Abcam 
ab31721) 
1 μg cm-3 
Cytokeratin 
MNF116 
(Abcam 
ab756) 
1 μg cm-3 
 
GαM 488 
GαR 568 
 
4 μg cm3          
4 μg cm3 
 
 
 
For antibodies 1-3 (Table 2.7): Each well was washed 3 x 0.1 v/v% Tween 20 
in PBS before a 5 min PBS wash. A blocking agent containing 1 v/v% goat 
serum in PBS was applied to each well overnight (500 mm3). The following 
morning the blocking agent was removed and each well washed 3 x 0.1 v/v% 
Tween 20 in PBS. Primary antibody was made at a dilution of 1:100 in 1 v/v% 
BSA in PBS before being added to each well (200 mm3) and incubated at 37 
°C for 1 h. The primary antibody solution was removed and each well 
washed 3 x 0.1 v/v% Tween 20 in PBS. Secondary antibody Alexa Fluor was 
added to 1% BSA in PBS at a dilution of 1:500. It was then added to each 
well (200 mm3) and incubated under dark conditions for 1 h at room 
temperature. The secondary antibody was removed and each well washed 3 
x PBS. Controls used were no primary antibody and A19 cells or IgG instead 
of the primary antibody. Each sample was counter-stained with DAPI (200 
mm3 of 1:30,000 in PBS per well) for 5 min and imaged using a Nikon Ti-E 
fluorescent microscope (Nikon, Tokyo, Japan). 
 
Table 2.7: Antibodies used in immunofluorescence studies. 
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2.2.11 Microscopy 
All microscopy was carried out at the University of Liverpool using an in-
house Nikon Eclipse TiE inverted microscope and all images analysed with 
the associated NIS-Elements software (Nikon, Tokyo, Japan).    
 
2.2.11.1 Phase contrast light microscopy: 
Phase contrast imaging allowed for the real-time observation of cells without 
the need for staining procedures and was most useful for occasional health 
checks during cell culture and for imaging at set time-points during scratch 
assays. Microscope slides or tissue culture vessels containing cells were 
placed on the microscope stage and the various controls within the NIS-
Elements software or on the microscope itself were used to observe samples 
and/or take images. 
 
2.2.11.2 Fluorescence microscopy: 
The same principle was used for imaging fixed and stained mammalian and 
microbial cells via immunofluorescence. Prepared samples on microscope 
slides or in tissue culture vessels were placed on the microscope stage and 
the various controls within the NIS-Elements software or on the microscope 
itself were used to observe samples and/or take images. Filter sets with 
emission/excitation wavelengths of 360/460 nm (DAPI), 480/535 nm (FITC, 
fluorescein isothiocyanate) and 540/605 nm (TRITC, tetramethylrhodamine 
isothiocyanate) were used for all immunofluorescence with x10, x20 and x40 
objectives.  
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2.3 Antibacterial Activity 
 
The following materials were used in this part of the study; methyl orange 
A17604 and penicillin G F20Z009 (Alfa Aesar, Haverhill, MA, USA), Luria-
Bertani (LB)-Agar 110283 and LB broth 71753 (Merck Millipore Ltd., 
Watford, England), PBS BR0014 (Oxoid Ltd., Hampshire, England), acetic 
anhydride 320102 and resazurin R7017 (Sigma Aldrich, St Louis, MO, 
USA), pεK (Zhengzhou Bainafo Bioengineering Co., Ltd., Zhengzhou City, 
China). S. aureus Newman and E. coli MC1061 were supplied by the 
Institute of Integrated Biology, University of Liverpool. All other equipment 
and reagents were provided by the University of Liverpool unless otherwise 
stated.   
 
2.3.1 Bacterial cell culture:  
S. aureus Newman and E. coli MC1061 were revived from -80 °C storage 
and streaked using an inoculating loop onto an LB-Agar plate before 
incubating at 37 °C overnight. A single colony from the relevant streak plate 
was added to LB broth (10 cm3) in a 50 cm-3 Falcon tube and incubated at 37 
°C in a dark room with agitation (300 RPM) on an Innova 2300 platform 
shaker (Eppendorf GmbH, Hamburg, Germany) overnight. An aliquot of each 
culture (0.5 cm3) was added to fresh LB broth (10 cm3) and cultured again at 
37 °C until an OD600 of 0.5 - 0.6, measured using a Jenway 6705 UV/Vis 
Spectrophotometer (Bibby Scientific Ltd., Stone, England), was obtained. 
This was the working stock solution of bacteria for the subsequent assays. 
 
2.3.2 Hydrogel design: 
Several different hydrogel variations were investigated in this part of the 
study. These included Su 60 14, some cross-link variants Su 45 14 and Su 
75 14 (Table 2.8) as well as an acetylated variant of Su 60 14 and Su 60 14 
with biomolecules attached and Su PεK PO4. The polymerisation protocol 
was followed from section 2.1.2. 
 
 
 MATERIALS AND METHODS 74 
 
 
 
Reagent 
PεK / octanedioic acid hydrogels 
45 mol% cross-linked, 
0.071 g cm-3 
(Su 45 14) 
60 mol% cross-linked, 
0.071 g cm-3 
(Su 60 14) 
75 mol% cross-linked, 
0.071 g cm-3 
(Su 75 14) 
PεK 1.58 g       
(9.20 mmol) 
1.48 g       
(8.62 mmol) 
1.40 g      
 (8.12 mmol) 
Octanedioic 
acid 
0.36 g       
(2.07 mmol) 
0.45 g       
(2.59 mmol) 
0.53 g      
 (3.04 mmol) 
NMM 1.01 cm3 0.95 cm3 0.89 cm3 
EDCI 1.98 g 
(10.33 mmol) 
2.48 g 
(12.94 mmol) 
2.92 g 
(15.23 mmol) 
NHS 0.53 g     
(4.60 mmol) 
0.50 g     
(4.34 mmol) 
0.47 g       
(4.08 mmol) 
 
 
 
2.3.2.1 Acetylation of Su 60 14: 
Acetylation of the amine groups of hydrogel Su 60 14 was undertaken to 
investigate any effects on antimicrobial activity. The hydrogel was completely 
washed after polymerisation and drained of the final wash. A 10 v/v% acetic 
acid in DMF (50 cm3) solution was added to 1.5 Molar equivalents of NMM 
(8.15 cm3). The mixture was poured onto Su 60 14 and left for 2.5 h. The 
mixture was then decanted and the hydrogel sheet washed 5 x H2O. 
 
2.3.2.2 Biomolecule attachment: 
Biomolecule attachment (Figure 2.11) for antimicrobial analysis was either 
ionic interaction (penicillin G) or covalent coupling (pεK). In both instances, 
the biomolecules were attached post-polymerisation. Prior to attachment the 
hydrogel was washed 5 x 10 v/v% aqueous NMM (50 cm3) at 15 min per 
wash. This was followed by 5 x H2O (50 cm3) at 15 min per wash. Penicillin G 
was attached by soaking the hydrogel in an ionic solution (25 cm3 of 12.5 
Table 2.8: Su 45 14, Su 60 14 and Su 75 14 hydrogel compositions. 
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mmol dm-3 penicillin G in water) of the antibiotic for 3 h. The hydrogel was 
washed 2 x H2O for 5 min before being stored in H2O prior to sterilisation.  
 
PεK (3 g) was attached to hydrogels by dissolving in H2O (20 cm3) and 
adding to NHS (96 mg) and EDCI (610 mg) pre-dissolved in H2O (5 cm3). 
The solution was mixed and added to the hydrogel and incubated for 3 h. 
The hydrogel was then washed in H2O followed by 5 x 10 v/v% NMM (50 
cm3) at 15 min per wash followed by 5 x H2O (50 cm3) at 15 min per wash 
before finally storing in H2O prior to sterilisation. 
 
A positive control hydrogel was designed (for all subsequent assays) as a 
derivative of Su PεK with phosphate associated with the amine groups (Su 
PεK PO4). Su PεK was incubated in PBS (20 cm3, 10X concentration) for 1 h 
before being washed in 2 x H2O (20 cm3). The hydrogel was stored in H2O 
until required in the cytotoxicity assays.  
 
 
 
 
 
 
 
 
Figure 2.11: Schematic illustrating proposed biomolecule attachment to the hydrogel 
matrix. 
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2.3.2.3 Methyl orange amine quantification: 
The following method of amine quantification using methyl orange dye 
(Figure 2.12) was adapted from the original protocol (Itzhaki, 1972). A 
standard curve of methyl orange concentration against absorbance was 
produced using known pεK concentrations as standards. A 2 mM methyl 
orange solution was made up by dissolving (32.7 mg) in H2O (50 cm3). A 1.6 
mM pεK stock solution was also made up by dissolving (13.2 mg) in H2O (50 
cm3). This was then serial diluted with water to 800, 400, 200, 100 and 50 µM 
concentrations. The methyl orange stock (500 mm3) was added to each of 
the pεK concentrations (500 mm3) in a 1.5 cm3 centrifuge tube. These were 
mixed by adding them to a 50 cm3 Falcon tube and placing them on a roller 
for 30 min. Each 1.5 cm3 tube was centrifuged with a Heraeus Biofuge Pico 
at 5345 x g (Thermo Scientific, Waltham, WA, USA) for 5 min. The tubes 
were retrieved and an aliquot of the supernatant (150 mm3) removed and 
added to H2O (2.85 cm3) in a cuvette. The cuvette was inverted 3 times 
before measuring the absorbance at 465 nm using a Cecil CE292 UV 
spectrophotometer (Cecil Instruments Ltd., Cambridge, England) against a 
water blank. A standard curve was compiled and used to calculate the 
number of amino groups in a sample from the concentration of methyl 
orange. Each unknown sample was prepared in the same way as for the 
standards above. 
 
 
 
Figure 2.12: Methyl orange colour conversion. 
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2.3.2.4 Penicillin G elution: 
The elution of Penicillin G from the hydrogel prepared in section 2.3.2.2 was 
monitored with reverse-phase high-performance liquid chromatography (RP-
HPLC). Hydrogel discs were cut (0.785 cm2) and incubated at 3 discs in a 7 
cm3 vial with PBS (1 cm3) at 37 °C for set time-points of 5, 10, 15, 20, 25, 30, 
120, 180 and 260 min over 5 h. At each time-point the supernatant was 
removed for analysis and replaced with fresh PBS (1 cm3). Suitable controls 
included a 0 mg cm-3 and 1 mg cm-3 solutions of penicillin G in PBS. 
 
RP-HPLC was performed on a SpectraSYSTEM AS3000 (Thermo Scientific, 
Waltham, MA, USA) with a C18 Vydac column, 4.6 x 250 mm, 5 µm particle 
size (Hichrom Ltd., Reading, England). The column temperature was set at 
room temperature and 100 mm3 was the injection volume at a flow rate of 1 
cm3 min-1. The gradient was set to 20% - 70% B over 20 min with A: 0.1 v/v% 
TFA in H2O, B: 0.1 v/v% TFA in MeCN and a detection wavelength of 210 
nm.  
 
2.3.3 Antimicrobial activity assay:  
A protocol for utilising resazurin to measure bacteria metabolic activity was 
adapted (Pettit, Weber and Pettit, 2009) and used to determine bacterial 
burden on different hydrogels. Each sterilised hydrogel variant was placed in 
individual wells in a 24-well plate before being inoculated with S. aureus or E. 
coli inoculum (400 mm3 with approx. 5 x 105 cfu cm-3 cells) (Figure 2.13).  
 
 
 
 
 
 
1 2 3 4 5 6 7 8 9 10 11 12
A
B
C
D
E
F
G
H
Resazurin only
Reduced resazurin
LB media only
S. aureus  only
E. coli  only
Su 60 14
Su pεK
Su Pen G
Su Acetylated
LB agar
Process control
Figure 2.13: Antibacterial assay 96-well plate layout. 
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Hydrogels were removed at 2, 4 and 18 h time-points and washed in PBS 
before being placed in a fresh 24-well plate. Resazurin (400 mm3 at 0.01 mg 
cm-3 in LB broth) was added to each hydrogel and incubated at 37 °C for 45 
min. After incubation aliquots (100 mm3) were removed in triplicate from each 
well and pipetted into a 96-well plate. Autoclave reduced resazurin (resorufin) 
served as a positive control whilst stock resazurin prior to assay served as a 
negative control. Fluorescence intensity of resorufin formed from the 
reduction of resazurin was measured at 560 nm (excitation) and 592 nm 
(emission) using a FLUOstar Optima plate reader (BMG Labtech, Ortenberg, 
Germany) (Figure 2.14). 
 
Planktonic bacteria were measured with resazurin after removal of the 
hydrogel. The supernatant (360 mm3) was removed to a fresh 24-well plate 
and resazurin stock (40 mm3 of 0.1 mg cm-3) was added to finish with a 
resazurin concentration of 0.01 mg cm-3. The samples were incubated at 37 
°C for 45 min. After incubation aliquots (100 mm3) were removed in triplicate 
from each well and pipetted into a 96-well plate. Autoclave reduced resazurin 
(resorufin) served as a positive control whilst stock resazurin prior to assay 
served as a negative control. The fluorescence intensity was measured in the 
same way as for the hydrogels in this section. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.14: Resazurin reduction to resorufin. 
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2.3.4 Bacteria staining:  
Hydrogel variants were inoculated with S. aureus (400 mm3, OD600 0.05) and 
incubated at 37 °C for 4 h. The hydrogel was then removed and washed in 
PBS before a 5 min 50% ethanol wash, 10 min 100% ethanol wash and 2 x 
PBS washes prior to propidium iodide (PI) staining. The supernatant from the 
incubation was pipetted into 1.5 cm3 Eppendorf tubes and centrifuged at 
13,451 x g with an Eppendorf 5418 R centrifuge (Eppendorf Ltd., Stevenage, 
England) for 10 min. The supernatant was removed and replaced with 
LIVE/DEAD® BacLight™ (L7007, Invitrogen, Carlsbad, CA, USA) bacteria 
viability stain ((300 mm3 of dye (1.5 mm3 of SYTO 9 and PI in 1 cm3)). The 
pellet was aspirated in the dye and incubated for 15 min at room 
temperature. Finally, the tube was centrifuged again at 13451 x g for 10 min 
and the pellet aspirated in sterile water (100 mm3) before pipetting a sample 
on a microscope slide and applying a cover slip. The sample was observed 
using a Zeiss LSM 510 multiphoton confocal microscope (Zeiss, 
Oberkochen, Germany). 
 
2.3.5 Cytotoxicity of antibacterial hydrogels 
The modified hydrogels Su PεK and Su Pen G were investigated for any 
cytotoxicity towards the HCE-T cell line. Su PεK PO4 served as a positive 
control. A CCK 8 viability assay, scratch assay and an investigation of 
monolayer integrity were carried out as in section 2.2. 
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2.4 Antifungal Activity 
 
The following materials were also used in this part of the study; potato 
dextrose (PD) agar and PD broth (Formedium Ltd., Norfolk, England), PBS 
BR0014 (Oxoid Ltd., Hampshire, England), amphotericin B A2942 (Sigma-
Aldrich, St Louis, MO, USA). Candida albicans SC5314 was supplied by the 
Institute of Integrated Biology, University of Liverpool.  All other equipment 
and reagents were provided by the University of Liverpool unless otherwise 
stated.   
 
2.4.1 Candida albicans cell culture: 
Candida albicans SC5314 was revived from -80 °C storage and streaked 
using an inoculating loop onto a PD-Agar plate before incubating at 37 °C 
overnight. C. albicans was sub-cultured by inoculating a PD-agar streak plate 
with one colony taken from a previous PD-Agar plate and incubated 
overnight at 37 °C. Colonies were maintained on PD-Agar stored at 5 °C. 
Broth cultures were initiated by inoculating PD media (10 cm3) with one 
colony of Candida albicans taken from a PD Agar plate. Cultures were 
incubated overnight at 37 °C with constant shaking (100 RPM) on an Innova 
2300 platform shaker (Eppendorf GmbH, Hamburg, Germany). These were 
sub-cultured by taking an aliquot of C. albicans broth (500 mm3) and diluting 
it in PD (10 cm3). For experiments, overnight broth culture (500 mm3) was 
diluted with PD (10 cm3) and the OD600 was measured hourly with a Jenway 
6705 UV/Vis Spectrophotometer (Bibby Scientific Ltd., Stone, England). If an 
initial OD600 measured < 0.5 then it was monitored until an OD600 0.5 - 0.6 
was obtained. The broth was diluted 1:1 with PD prior to experiments. To 
homogenise the culture broth, it was sonicated regularly and for 15 min prior 
to experiments. 
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2.4.2 Hydrogel design: 
Hydrogel Su 60 15 (30 cm3) with 60% cross-linking and a polymer density of 
0.07 g cm-3 was prepared (Table 2.9). The polymerisation protocol was 
followed from section 2.1.2 with the following exceptions. 
 
- All solutions were filtered in a class II microbiology hood using a 0.2 µm 
syringe filter.  
- An aliquot of the polymer solution (5 cm3) was pipetted into each 63 cm2 
non-treated tissue culture dish (Greiner Bio-One GmbH, Kremsmϋnster, 
Austria).  
- Sheets of hydrogel were washed 5 x 10 v/v% aqueous NMM for 5 min 
followed by 10 x H2O (5 min per wash) to remove excess NMM. This 
dissociated the Cl- ion from the amine groups and these hydrogels were 
given the code -NH2. 
 
 
 
 
Reagent 
PεK / octanedioic acid hydrogel 
60 mol% cross-linked, 0.07 g cm-3 
(Su 60 15) 
PεK 2.08 g       
(12.09 mmol) 
Octanedioic 
acid 
0.63 g       
(3.63 mmol) 
NMM 1.33 cm3 
EDCI 3.47 g 
(18.12 mmol) 
NHS 0.70 g     
(6.08 mmol) 
 
 
Table 2.9: Su 60 15 hydrogel composition. 
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2.4.3 Biomolecule attachment: 
An investigation of the antifungal activity of the hydrogel was undertaken by 
associating the model antifungal amphotericin B (AmpB) with the hydrogel 
(Figure 2.15). AmpB (250 µg cm-3) was diluted in sterile PBS to 
concentrations 30, 25, 20, 15, 10, 5, 3 and 0 μg cm-3. Hydrogels (-NH2 and -
NH3Cl) were incubated in the various concentrations of AmpB for 1 h before 
being transferred to 96-well plates and used in the subsequent experiments.   
 
 
 
2.4.4 Minimum inhibitory concentration (MIC) data: 
To establish the fungicidal effect of AmpB and obtain an MIC, AmpB was 
serially diluted with PD 1:1 from a stock of PD containing 3 μg cm-3 AmpB 
such that each well of the 96-well plate contained 100 mm3 of solution. 
Twelve concentrations, ranging from 0 - 3 μg cm-3 AmpB, were assessed. 
Control wells contained PD only and PD with C. albicans. C. albicans broth 
(12.5 mm3) was added before overnight incubation at 37 °C. OD600 were 
measured 18 h later using a FLUOstar Optima plate reader (BMG Labtech, 
Ortenberg, Germany). Prior to measurement all samples were sonicated for 
15 min. The MIC was also analysed for AmpB activity against C. albicans in 
the presence of 10 v/v% horse serum in PD broth following the same protocol 
but replacing PD broth with 10 v/v% horse serum in PD broth. 
 
Figure 2.15: Schematic illustrating proposed mechanism of AmpB association with the 
hydrogel matrix. 
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2.4.5 Antifungal activity of hydrogel: 
AmpB (250 µg cm-3) was diluted in sterile PBS to concentrations 30, 25, 20, 
15, 10, 5, 3 and 0 μg cm-3. Hydrogels were incubated in the various 
concentrations of AmpB for 2 h before being transferred to 96-well microtiter 
plates. Control wells containing PD only and PD with C. albicans were used 
throughout all these experiments (Figure 2.16). Wells containing PD (100 
mm3) were inoculated with C. albicans (12.5 mm3). Microtiter plates were 
incubated overnight at 37 °C, and OD600 readings were taken after 18 h 
(Figure 2.17, step 1). 
 
 
 
 
 
 
The above protocol was repeated to include C. albicans with the addition of 
horse serum (10% v/v) to PD broth to promote differentiation and upregulate 
the expression of virulence genes (Martin, 1978; Blankenship et al., 2003). 
After the hydrogels were removed from the microtiter plate, they were 
individually washed in sterile PBS (5 cm3) to remove any loosely attached 
fungi and the wash solution collected (Figure 2.17, step 2). The hydrogels 
were extracted using sterile forceps and placed on PD agar plates to identify 
the presence of viable fungi. An aliquot of each PBS wash solution (20 mm3) 
was also plated (Figure 2.17, step 2). The agar plates were incubated at 37 
°C overnight before imaging and counting the colony forming units (Figure 
2.17, step 3). After the hydrogels were removed, the plates were incubated at 
37 °C for a second night to establish if there was any further growth of C. 
albicans. OD600 readings were taken after 24 h (Figure 2.17, step 3). 
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Figure 2.16: Antifungal assay 96-well plate layout. 
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2.4.6 AmpB elution: 
Discs of each hydrogel (0.36 cm2) were incubated in a 30 µg cm-3 AmpB 
solution for 2 h. The hydrogels (-NH3Cl and -NH2) were removed and 
incubated in PBS at 1 hydrogel 100 mm-3 for 24, 48, 72 and 96 h. At each 
time-point the supernatant was removed and used to monitor elution via 
HPLC. The PBS was replenished and the hydrogel samples were re-
incubated. Suitable controls included a 0 mg cm-3 and 1 mg cm-3 solutions of 
AmpB in PBS. 
RP-HPLC was performed on a SpectraSYSTEM AS3000 (Thermo Scientific, 
Waltham, MA, USA) with a C18 Vydac column, 4.6 x 250 mm, 5 µm particle 
size (Hichrom Ltd., Reading, England). The column temperature was set at 
room temperature and 200 mm3 was the injection volume at a flow rate of 1 
cm3 min-1. The gradient was set to 40% - 100% B over 15 min with A: 0.1% 
TFA in H2O, B: 0.1% TFA in MeCN and a detection wavelength of 380 nm. 
 
2.4.7 AmpB stability attached to the hydrogel: 
Discs of the -NH2 hydrogel (0.36 cm2) were stored at room temperature for 1, 
24 and 48 h after a 2 h incubation with a 30 µg cm-3 AmpB solution. The 
hydrogels were then placed in appropriate wells in a 96-well plate containing 
PD media (100 mm3). Incubation solution (12.5 mm3) was added to separate 
Figure 2.17: Schematic of methods used to monitor antifungal activity. Image provided 
courtesy of Prof. R.L. Williams (University of Liverpool). 
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wells in the 96-well plate along with PD media (100 mm3). Each well was 
inoculated with C. albicans (12.5 mm3) for 18 h and the OD600 readings taken 
and analysed. Suitable controls included a 0 mg cm-3 and incubation 
solutions of AmpB in PBS.  
 
2.4.8 Cytotoxicity of antifungal hydrogels 
The modified hydrogel Su 60 15 pre-incubated in 30 µg cm-3 AmpB solution 
was investigated for any cytotoxicity towards the HCE-T cell line. A CCK 8 
viability assay was carried out as in section 2.2.7. 
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2.5 Microbe Detecting Peptide 
 
The following materials were also used in this part of the study; methyl 
orange A17604 (Alfa Aesar, Haverhill, MA, USA), glutaric anhydride G3806 
(Sigma-Aldrich, St Louis, MO, USA), sodium bicarbonate BDH9280 (VWR 
International Ltd., Lutterworth, England). BAC ONE and BAC TWO peptides 
were supplied by the Queens Medical Research Institute (University of 
Edinburgh, Edinburgh, Scotland). HCE-T cells donated (Araki-sasaki et al., 
1995) whilst E. coli MC1061 and S. aureus Newman were supplied by the 
Institute of Integrated Biology, University of Liverpool. All other equipment 
and reagents were supplied by the University of Liverpool unless otherwise 
stated.  
 
2.5.1 Bacteria cell culture: 
S. aureus Newman or E. coli MC1061 was revived and cultured as in section 
2.3.1. 
 
2.5.2 Hydrogel design: 
Hydrogel Su 60 14 (50 cm3) was modified to convert it to a carboxyl moiety 
(Su 60 14 COOH) with 60% cross-linking and a polymer density of 0.07 g cm-
3. Su 60 14 was polymerised as in section 2.1.2 but with the following 
additional step. 
 
The hydrogels were washed 3 x H2O followed by 2 x 10 v/v% aqueous NMM 
(30 min per wash) to neutralise before 3 x H2O. This was followed by 3 x 0.1 
M sodium bicarbonate (5 min per wash). Glutaric anhydride (2 g) was 
dissolved in 0.1 M sodium bicarbonate (100 cm3) and aliquoted to each 
hydrogel (20 cm3) before a 2 h incubation. The hydrogels were washed 2 x 
0.1 M sodium bicarbonate (5 min per wash) prior to repeating the glutaric 
anhydride coupling. Finally, the hydrogels were washed 5 x H2O before 
storing in H2O prior to use. Immediately before use the hydrogels were 
sterilised in 70 v/v% aqueous ethanol overnight before washing 5 x sterile 
PBS and using them for experiments.  
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2.5.3 Methyl orange amine group determination: 
A standard curve of methyl orange concentration against absorbance was 
produced using known concentrations as standards as in section 2.3.2.3. A 2 
mM methyl orange solution was made up by dissolving 32.7 mg in water (50 
cm3). This was serial diluted to 1000, 500, 250 and 125 µM concentrations 
with water. The methyl orange stock (500 mm3) was added to a 1.5 cm3 
centrifuge tube. These were mixed by adding them to a 50 cm3 Falcon tube 
and placing them on a roller for 30 min. Each 1.5 cm3 tube was centrifuged 
with a Heraeus Biofuge Pico at 5345 x g (Thermo Scientific, Waltham, WA, 
USA) for 5 min. The tubes were retrieved and an aliquot of the supernatant 
(150 mm3) removed and added to water (2.85 cm3) in a cuvette. The cuvette 
was inverted 3 times before measuring the absorbance at 465 nm using a 
Cecil CE292 UV spectrophotometer (Cecil Instruments Ltd., Cambridge, 
England) against a water blank. A standard curve was compiled and used to 
calculate the number of amino groups in a sample from the concentration of 
methyl orange. Each unknown sample was prepared in the same way as for 
the standards above. 
 
2.5.4 Activity of SU 60 14 COOH/BAC peptides against E. coli or S. aureus: 
The hydrogel samples were cut to fit a well in a 96-well plate (28.26 cm2) 
using a 6 mm diameter trephine. A 200 µM stock solution of BAC ONE (5.33 
mg) or BAC TWO (1.02 mg) was prepared by dissolving the peptide in water 
(4 cm3). The stock was used to prepare incubation concentrations of 40, 20, 
10, 5 and 0 µM. Twelve discs of the hydrogel were incubated in each of the 
incubation concentrations (2 cm3) for 1 h. Once removed the hydrogels were 
added to a well in a 96-well plate containing LB media (100 mm3). The 
different concentrations of peptide solution were added to separate wells 
before inoculating them all with the test bacterium (100 mm3). Suitable 
controls included media with only bacteria or BAC peptides and media with 
no cells. Hydrogel controls included hydrogels incubated in 0 µM 
concentrations and S. aureus was used as a control Gram-positive organism 
in the BAC TWO assay as well as the incubation concentrations of each 
peptide. The plates (Figure 2.18) were incubated for between 30 min - 4 h 
prior to reading the fluorescence at 485 nm on a FLUOstar Omega 
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microplate reader (BMG LABTECH GmbH, Ortenberg, Germany) with an 
emission filter of 520 nm. The samples were fixed with 70 v/v% aqueous 
ethanol for 30 min prior to imaging with a FITC fluorescent filter on a Nikon 
TiE microscope (Nikon, Tokyo, Japan).  
 
 
 
 
 
 
2.5.5 Stability of SU 60 14 COOH with either BAC ONE or TWO: 
The same BAC ONE or TWO stock solution as in section 2.5.4 was used to 
prepare incubation concentrations of 40, 20, 10, 5 and 0 µM. Twelve discs of 
the hydrogel were incubated in each of the incubation concentrations (2 cm3) 
for 1 h. Once removed the hydrogels were added to a well in a 96-well plate 
containing LB media (100 mm3) prior to inoculating with the test bacterium 
(100 mm3). Suitable controls included media with only bacteria or BAC 
peptides and media with no cells. Hydrogel controls included hydrogels 
incubated in 0 µM concentrations. Time-points of 0.5, 1, 2, 4 and 21 h were 
used to monitor fluorescence. At each time-point the fluorescence was read 
at 485 nm on a FLUOstar Omega microplate reader (BMG LABTECH GmbH, 
Ortenberg, Germany) with an emission filter of 520 nm. 
 
2.5.6 HCE-T/bacteria co-culture with SU 60 14 COOH/BAC ONE or TWO 
present: 
HCE-T cells were seeded at a density of 2.5 x 104 in a 48-well plate and 
incubated with DMEM/F12 media for 3 days until they were confluent. The 
same BAC ONE or BAC TWO stock solutions as in section 2.5.4 were used 
to prepare incubation concentrations of 40 µM. The hydrogel discs (28.26 
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Figure 2.18: Microbial identification assay 96-well plate layout. 
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cm2) were incubated in the appropriate incubation concentration (2 cm3) for 1 
h prior to a 1 h incubation with HCE-T cells and the test bacterium (100 
mm3). Suitable controls included BAC peptides with only bacteria or BAC 
peptides with only HCE-T cells. Hydrogel controls included hydrogels 
incubated in 0 µM concentrations and S. aureus was used as a control 
Gram-positive organism in the BAC TWO assay. The samples were fixed 
with 70 v/v% aqueous ethanol for 30 min prior to imaging with a FITC 
fluorescent filter on a Nikon TiE microscope (Nikon, Tokyo, Japan). 
 
2.5.7 Ex vivo bacterial keratitis model: 
Porcine eyes were retrieved from the abattoir and prepared for dissection. 
Each eye was placed in a Petri dish and the eye lids, fatty tissue and muscle 
were trimmed with surgical scissors (Figure 2.19). The prepared eye was 
positioned so that an incision could be made with a scalpel to the sclera 
midway between the optic nerve and the cornea. Surgical scissors were 
placed in the incision and cut around the sclera until the eye was in two 
halves. The anterior portion of the eye was positioned with the cornea facing 
down. It was then cleaned by removing the vitreous humour and the lens 
using a pair of forceps. The black tissue of the ciliary body and the iris was 
gently removed from around the cornea by peeling it off with a pair of 
forceps. The area was gently scraped with a scalpel to further remove all 
remnants of the ciliary body. The prepared corneas were stored in PBS with 
penicillin-streptomycin and amphotericin B supplementation. 
 
The corneas were moved to a class II microbiology hood and removed from 
PBS storage and placed with the anterior portion facing down in a 6-well 
plate. Autoclaved 2% agar whilst molten was mixed 1:1 with DMEM cell 
culture media without antibiotic supplementation to finish with a 1% agar 
solution. The solution was promptly pipetted into the posterior portion of the 
cornea until it was filled. After 20 min and the agar had completely set the 
corneas were overturned and immersed with DMEM cell culture media 
without antibiotic supplementation. The corneas were incubated at 37 °C for 
24 h to allow diffusion of antibiotics from the corneal tissue into the media. 
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The media was removed along with the agar plug. The corneas were washed 
2 x PBS and then positioned with the anterior portion facing upwards. 
S. aureus Newman or E. coli MC1061 were cultured as in section 2.5.1. 
 
 
   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.19: Porcine eye dissection, a) removal of muscle and fatty tissue, b) cleaned 
eye ball and optic nerve, c) incision made and cut around to obtain two halves, d) removal 
of vitreous humor and lens to expose iris and cilliary body, e) iris and cilliary body 
removed to leave cornea and some sclera, f) corneas mounted with 1% agar.  
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The corneas were scored twice vertically and horizontally using a scalpel to 
represent ocular surface wounds. S. aureus or E. coli suspension (50 mm3 of 
0.5 OD600) was pipetted directly onto the cornea. DMEM without antibiotic 
supplementation was added to the well and filled to just below the cornea. 
The corneas were incubated again at 37 °C for 24 h to allow microbial 
infection of the ocular tissue to occur. 
 
After incubation, the supernatant was removed from the corneas and they 
were washed 2 x PBS. Hydrogels were incubated in BAC peptides as in 
section 2.5.4 at a concentration of 40 μM. The hydrogels were then placed 
on the infected corneas for 30 min and removed. The samples were fixed 
with 70 v/v% aqueous ethanol for 30 min prior to imaging with a FITC 
fluorescent filter on a Nikon TiE microscope (Nikon, Tokyo, Japan). 
  
2.5.8 Cytotoxicity of hydrogels with BAC peptides: 
The modified hydrogel Su 60 14 COOH pre-incubated in BAC ONE or BAC 
TWO solution (40 μM) was investigated for any cytotoxicity towards the HCE-
T cell line. A CCK 8 viability assay was carried out as in section 2.2.7 with 
cell morphology monitored at 24, 120 and 168 h. 
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2.6 Statistical Analysis 
 
Statistical analysis was performed using GraphPad Prism version 5.03 for 
Windows (GraphPad Software, San Diego, CA, USA). All statistical data was 
presented as means with +/- standard deviation of the mean. Statistical data 
was analysed for equality of variances and significance was measured with 
two-way ANOVAs followed by Bonferroni post-tests, unless otherwise stated. 
If required, a log transformation of the data was performed to meet ANOVA 
assumptions. A p-value of ≤ 0.05 was considered statistically significant.  
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3. RESULTS  
 
3.1 Hydrogel Characterisation 
 
An investigation of the mechanical and physical characteristics of the 
pεK/bis-carboxylic acid cross-linked hydrogel was undertaken to characterise 
the novel polymer. Mechanical properties and transparency were 
investigated primarily to obtain a hydrogel with similar properties to those of 
commercial contact lens materials. All other material and physical properties 
were investigated to further characterise the polymer developed in this 
project. 
 
3.1.1 Poly-ε-lysine characterisation: 
Prior to the beginning of this study three different batches of pεK were 
supplied, each with a slightly different amine content as determined by C, H 
and N elemental analysis (Butterworth Laboratories Ltd., Teddington, 
England). The hypothesis was that pεK with a greater ratio of short chain 
oligomers would produce a different polymer than pεK with a greater ratio of 
longer chain oligomers. An HPLC investigation of the pεK batches was 
followed by mechanical property analysis of hydrogel Su 60 14 polymerised 
using each of the pεK batches. 
 
A RP-HPLC system was used to characterise the three different batches of 
pεK. It was found that the ratio of pεK oligomers was different for each of the 
batches (Figure 3.1). The resulting mechanical analysis of hydrogels 
synthesised from each of the different batches showed that there was no 
significant difference in elastic modulus (Figure 3.2). The results show that 
the oligomer composition of pεK does not influence the mechanical 
properties of the final hydrogel. 
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Figure 3.1: RP-HPLC investigation of different pεK batches, a) pεK 5.71 mmol g-1 b) pεK 
5.81 mmol g-1 c) pεK 5.84 mmol g-1.  
 
Figure 3.8: a) pεK 5.71 mmol g-1 b) pεK 5.81 mmol g-1 c) pεK 5.84 mmol g-1. 
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PεK Batch Peak Area (mV) Residues > 20 (%) 
20110401 
(5.71 mmol g-1) 
46214 ± 1264 85.7% ± 1.7% 
20130712  
(5.81 mmol g-1) 
47024 ± 673 74.1% ± 0.7% 
20131015 
5.84 mmol g-1) 
47266 ± 1012 96.2% ± 1.1% 
 
 
 
Peak area calculations confirmed pεK concentrations for each batch tested 
(Table 3.1). A variation in pεK chain-length distribution (> 20 residues) was 
noted between the 3 batches (74.1% - 96.2%). 
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Figure 3.2: Tensile strength comparison of Su 60 14 using different pεK batches. A one-
way ANOVA with Tukey post-hoc analysis was performed. Error bars ±SD, N = 9. 
Table 3.1: Peak area calculations for pεK batches. ±SD, N = 4.  
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Figure 3.3: Short chain pεK oligomers to identify peak to chain-length residue 
association, a) pεK 5mer b) pεK 10mer c) pεK 5mer and 10mer overlays spiked with pεK. 
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Synthetic oligomers of pεK were synthesised in-house and were used as 
standards to identify the different oligomers in each batch of pεK (Figure 3.3). 
They confirmed that most pεK oligomers in each batch were between 25 - 35 
residues long. The most abundant oligomer of pεK was found to be 30 
residues of lysine in length. 
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PεK Batch Peak Area (mV) Residues > 20 (%) 
161201A 
(5.80 mmol g-1) 
33043 ± 163 85.6% ± 1% 
20160601A 
(5.77 mmol g-1) 
32870 ± 715 86.0% ± 1% 
20140401A 
(5.81 mmol g-1) 
33120 ± 509 98.0% ± 0% 
 
Figure 3.4: Optimisation of pεK HPLC analysis as a quality control SOP, a) old HPLC 
program on new Luna C18(2) column, b) pεK 161201A, c) pεK 20160601A, d) 
20140401A. 
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Table 3.2: HPLC peak area calculations for pεK batches. ±SD, N = 4. 
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Further optimisation of the pεK characterisation protocol was necessary 
following a change of HPLC column used in the analysis. This is an important 
consideration when trying to replicate the protocol on different HPLC 
systems. The most recent Luna C18(2) column (00D-4251-E0, Phenomenex, 
Torrance, CA, USA) was used with the same HPLC conditions as in section 
2.1.1. The result was a much quicker elution time of < 30 min for pεK (Figure 
3.4a). This allowed for a shorter run time to be used for the analysis (75 min). 
Three new batches of pεK were analysed with the new HPLC conditions 
(Figure 3.4b-d). Peak area calculations confirmed pεK concentrations for 
each batch tested (Table 3.2). Only a small variation in pεK concentration 
(5.77 - 5.81 mmol g-1) and chain-length distribution > 20 residues was 
observed between the 3 batches (85.6% - 98%). 
  
3.1.2 Bis-carboxylic acid cross-linker, polymer density and degree of cross-
linking for the Hydrogel: 
An initial study was carried out to determine which short to medium chain bis-
carboxylic acid would be best suited as a cross-linker for the hydrogel. 
Several factors were examined to identify suitability including transparency, 
solubility and the mechanical properties of the cross-linked hydrogels. The 
polymer density and degree of cross-linking were also optimised. 
 
The polymer first derived by cross-linking pεK with a bis-carboxylic acid was 
a fully cross-linked macroporous material. The bis-carboxylic acid cross-
linker was decanedioic acid and the polymer density was in the region of 0.04 
- 0.05 g cm-3. This polymer provided a starting point for the development of a 
hydrogel from the same polymer constituents. A preliminary hydrogel was 
polymerised with 60 mol% cross-linking with decanedioic acid and a polymer 
density of 0.067 g cm-3. It was noted that the transparency of the hydrogel 
would not be ideal using decanedioic acid. At this stage, longer chain bis-
carboxylic acids (dodecanedioic acid C12 and tridecanedioic acid C13) were 
discounted due to their long hydrophobic backbone resulting in poorer 
solubility and lack of transparency when polymerised. A study of four different 
polymer compositions (60 mol% cross-linked and 0.1 g cm-3, 60 mol% cross-
linked and 0.067 g cm-3, 80 mol% cross-linked and 0.1 g cm-3, 80 mol% 
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cross-linked and 0.067 g cm-3) cross-linked individually with five separate bis-
carboxylic acid cross-linkers ranging from hexanedioic acid (C6) up to 
decanedioic acid (C10) was undertaken. The mechanical properties were 
obtained for each hydrogel as well as a physical observation for 
transparency. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The tensile strength of the materials investigated significantly increased as 
the chain length of the bis-carboxylic acid increased from hexanedioic acid to 
nonanedioic acid (p < 0.05) before significantly reducing again for 3 of the 4 
hydrogel compositions with the decanedioic acid cross-linker (p < 0.05) 
(Figure 3.5a). Decanedioic acid was the least soluble of the five bis-
carboxylic acids investigated and resulted in the most opaque polymers of 
each composition. The polymer density had a greater effect on mechanical 
properties (p < 0.01) compared to the degree of cross-linking for each variant 
with the same bis-carboxylic acid. Minor differences were observed between 
the varying degrees of cross-linking but these were not statistically 
significant. These data suggest that the polymer density has a greater effect 
on polymer strength than the degree of cross-linking. The increase in bis-
Figure 3.5: a) A comparison of tensile strength of hydrogels cast with differing bis-
carboxylic acid cross-linkers and polymer densities -60 mol% cross-linked, 0.1 g cm
-3 
-60 
mol% cross-linked, 0.067 g cm
-3
 -80 mol% cross-linked, 0.1 g cm
-3
 -80 mol% cross-
linked, 0.067 g cm
-3
, b) Changes in transparency due to bis-carboxylic acid chain-length. 
Error bars ±SD, * p < 0.05, ** p < 0.01 N = 9. 
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carboxylic acid as previously suggested has a negative effect on the 
transparency of the hydrogel. These data coupled with a visual check for 
transparency (Figure 3.5b) led to octanedioic acid being chosen as the most 
appropriate bis-carboxylic acid to cross-link pεK and form the hydrogel. 
 
3.1.3 Optimal hydrogel composition and refractive index: 
Further tailoring of the hydrogel properties was investigated with octanedioic 
acid as the bis-carboxylic acid cross-linker. As expected the ultimate tensile 
strength increased with an increase in polymer density from 0.067 - 0.077 g 
cm-3 (Figure 3.6a).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The elastic modulus (Figure 3.6b) for hydrogel Su 60 13 (octanedioic acid 
cross-linker with a density of 0.077 g cm-3 and 60 mol% cross-linked) was 
significantly greater than the other hydrogels tested. However, transparency 
of this hydrogel was compromised significantly (p < 0.005) due to the 
increased polymer density, resulting in a refractive index (Figure 3.7a) of 
1.395 (AR200 digital refractometer (Reichert, New York, USA)). These data 
were further corroborated with light transmittance data (Figure 3.7b) for 
hydrogel Su 60 13 (79%) significantly lower than both Su 60 14 (88%) and 
Su 60 15 (92%). The hydrogel with the next greatest elastic modulus was 
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Figure 3.6: a) Comparison of stress between octanedioic acid hydrogel variants, b) 
comparison of the elastic modulus between octanedioic acid hydrogel variants. A one-
way ANOVA with Tukey post-hoc analysis was performed. Error bars ±SD, *** p < 0.005 
N = 9. 
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hydrogel Su 60 14 (octanedioic acid cross-linker with a density of 0.071 g cm-
3 and 60 mol% cross-linked) which, despite no significant difference in 
ultimate tensile strength compared to Su 60 13, was superior to both Su 60 
15 (octanedioic acid cross-linker with a density of 0.067 g cm-3 and 60 mol% 
cross-linked) and Su 65 15 (octanedioic acid cross-linker with a density of 
0.067 g cm-3 and 65 mol% cross-linked). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Hydrogel Su 60 14 possessed a refractive index of 1.390 making it closely 
associated with the 1.380 - 1.400 of the human cornea (Kim et al., 2004; 
Vasudevan, Simpson and Sivak, 2008). All the hydrogels tested had a 
significantly lower (p < 0.005) refractive index than the commercial contact 
lens etafilcon A at 1.412. Consequently, Su 60 14 was chosen as the 
hydrogel with superior mechanical properties whilst maintaining an 
acceptable transparency. 
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Figure 3.7: a) Refractive index measurements of octanedioic acid hydrogel variants, b) 
Light transmittance data of four hydrogel variants. A one-way ANOVA with Tukey post-
hoc analysis was performed. Error bars ±SD, *** p < 0.005 N = 9. 
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3.1.4 Polymerisation time: 
Hydrogel Su 60 14 was polymerised for five different time-points before the 
polymerisation was stopped and the mechanical properties analysed. The 
mechanical data were used to identify the optimal polymerisation time for the 
hydrogel cross-linking to reach completion. The results show a statistically 
significant increase (p < 0.05) in elastic modulus up to 5 h after 
polymerisation was initiated. The elastic modulus begins to plateau after 5 h 
(Figure 3.8a) with no significant change observed. These data suggest that 
after 5 h the polymer has reached a point where cross-linking has ceased.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
3.1.5 Polymerisation temperature: 
Hydrogel Su 60 14 was polymerised under three different temperatures to 
analyse the effect of reaction temperature on the final mechanical properties 
of the hydrogel. The polymerisation temperature data identified that hydrogel 
Su 60 14 polymerised at room temperature (21.5 °C) and physiological 
temperature (37 °C) for 5 h had a statistically significant increase (p < 0.01) 
in elastic modulus compared to Su 60 14 polymerised at 6 °C for the same 
length of time (Figure 3.8b). No significant difference was observed in elastic 
modulus between Su 60 14 polymerised at 21.5 °C and 37 °C.  
 
Figure 3.8: Investigation of the optimal polymerisation time (a) and temperature (b) for 
hydrogel Su 60 14. A one-way ANOVA with Tukey post-hoc analysis was performed. 
Error bars ±SD, * p < 0.05, ** p < 0.01, *** p < 0.005 N = 9. 
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3.1.6 Percentage water content: 
An important characteristic of a hydrogel is the water content, specifically in 
the development of contact lens materials where the oxygen permeability is 
directly associated with the amount of water the hydrogel contains. A 
gravimetric method was used to determine the volume of water contained 
within each hydrogel variant. It was discovered that the hydrogels 
polymerised in this study have a relatively high water content whilst retaining 
their optimal mechanical properties when compared to a range of commercial 
contact lens materials (Table 3.3). The water content of all the hydrogel 
variants tested are within the 67 - 73% range whilst the elastic modulus 
covers a greater range of the values noted for commercial contact lens 
materials (0.31 - 0.84 MPa).  
 
A comparison of methods (Figure 3.9) used to determine the water content of 
the hydrogels confirmed the data obtained via the gravimetric method. No 
statistically significant difference was observed between the methods tested. 
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Material % Water 
Content 
Elastic 
Modulus (MPa) 
Hydroxyethyl methacrylate / 
methacrylic acid 70 0.77 (+/- 0.11) 
Su 60 13 (60 mol% cross-linked, 
0.077 g cm
-3
 polymer density) 67 (+/- 3.4) 0.73 (+/- 0.12) 
Su 60 14 (60 mol% cross-linked, 
0.071 g cm
-3
 polymer density) 69 (+/- 0.8) 0.61 (+/- 0.07) 
Vinyl pyrrolidone / methyl 
methacrylate 70 0.49 (+/- 0.09) 
Su 65 15 (65 mol% cross-linked, 
0.067 g cm
-3
 polymer density) 71 (+/- 1.6) 0.46 (+/- 0.08) 
Hydroxyethyl methacrylate / 
vinyl pyrrolidone 55 0.36 (+/- 0.07) 
Su 60 15 (60 mol% cross-linked, 
0.067 g cm
-3
 polymer density) 70 (+/- 1.7) 0.31 (+/- 0.04) 
Su PεK (Su 60 14 with pεK 
covalently attached) 73 (+/- 0.9) 0.84 (+/- 0.29) 
Su Pen G (Su 60 14 with 
penicillin G ionically attached) 70 (+/- 0.8) 0.62 (+/- 0.12) 
Figure 3.9: Comparison of hydrogel water content determined via different methods. 
Error bars ±SD, N = 9. 
Table 3.3: Elastic modulus and water content of the hydrogel variants prepared for this 
report compared to commercial lens materials (Tranoudis and Efron, 2004). ±SD, N = 9. 
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3.1.7 Dk values: 
Dk values were converted from the previously obtained hydrogel water 
contents (section 3.1.6) using the formula from section 2.1.7 to create a 
standard curve (Figure 3.10).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The water content obtained for each of the hydrogel variants was compared 
to the graph to obtain the corresponding Dk value based solely on the water 
content of the hydrogel. 
 
 
 Su 60 15 Su 60 14 Su 60 13 Su 65 15 Su PεK Omafilcon 
A 
Lotrafilcon 
A 
Dk 26.89 25.85 23.87 27.98 30.29 27 140 
SD 1.79 1.72 1.91 1.78 1.73 - - 
 
 
 
The Dk values for the hydrogel variants are within a short range (24 - 30 
Barrer) and comparable to a conventional hydrogel contact lens (omafilcon 
A) but much lower than a silicone hydrogel contact lens (lotrafilcon A).  
 
Figure 3.10: Dk values from water content percentage. 
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Table 3.4: Dk values for hydrogel variants. ±SD, N = 9. 
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3.1.8 Contact angle analysis: 
An investigation of the contact angle of the hydrogel variants was undertaken 
as a measure of their wettability. This is an important aspect in contact lens 
design as the more hydrophilic materials allow a greater coverage and 
recovery of the tear film (Lin and Svitova, 2010). The advancing contact 
angle was captured and analysed via the sessile drop technique on a Krüss 
DSA100. The contact angles for the hydrogel variants ranged between 29 - 
31 ° with no significant difference observed between them (Figure 3.11). 
PTFE (96 °) and glass (78 °) had significantly greater (p < 0.005) contact 
angles than any of the hydrogels. These data highlight that the hydrogels 
have a high degree of wettability. 
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Figure 3.11: Contact angle analysis of the hydrogel variants. A one-way ANOVA with 
Tukey post-hoc analysis was performed. Error bars ±SD, *** p < 0.005 N = 9. 
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3.1.9 Degradation: 
Degradation of the hydrogel variants was monitored gravimetrically and with 
SEM images over a 12 month period. 
 
 Sample Start 
Weight 
1 
Week 
1  
Month 
6  
Months 
12  
Months 
P
B
S
 
Su 60 15 49.33 
± 4.83 
37.53 (76%) 
± 10.67 
31.93 (65%) 
± 3.15 
29.87 (61%) 
± 4.69 
29.67 (60%) 
± 4.32 
Su 60 14 50.07 
± 4.91 
36.30 (73%) 
± 4.30 
34.20 (68%) 
± 3.10 
31.77 (63%) 
± 3.13 
32.67 (65%) 
± 2.66 
Su 60 13 44.03 
± 9.05 
31.26 (71%) 
± 5.52 
30.90 (70%) 
± 5.43 
29.43 (67%) 
± 5.35 
29.07 (66%) 
± 4.00 
Su 65 15 41.47 
± 7.92 
29.93 (72%) 
± 5.89 
28.93 (70%) 
± 5.35 
27.06 (65%) 
± 5.18 
26.97 (65%) 
± 5.18 
Su PεK 44.63 
± 2.76 
28.10 (63%) 
± 0.63 
26.50 (59%) 
± 1.25 
26.00 (58%) 
± 0.40 
26.63 (60%) 
± 1.19 
Etafilcon A 47.9 
 ± 5.74 
39.67 (83%) 
± 5.75 
30.93 (65%) 
± 0.12 
30.03 (63%) 
± 0.45 
30.10 (63%) 
± 0.12 
PTFE 31.73 
± 0.58 
31.9 (101%) 
± 0.17 
31.53 (99%) 
± 0.47 
31.37 (99%) 
± 0.59 
31.57 (100%) 
± 0.06 
N
a
O
H
 
Su 60 15 53.36 
± 10.72 
59.66 (112%) 
± 13.41 
106.97 (200%) 
± 24.15 
  
Su 60 14 49.56 
± 5.53 
57.73 (117%) 
± 5.65 
103.63 (209%) 
± 11.26 
  
Su 60 13 43.53 
± 7.36 
54.03 (124%) 
± 9.25 
90.57 (208%) 
± 16.73 
  
Su 65 15 42.5 
± 5.08 
47.43 (112%) 
± 7.07 
82.87 (195%) 
± 11.64 
  
Su PεK 46.76 
± 3.54 
53.20 (114%) 
± 1.44 
108.66 (232%) 
± 3.41 
  
Etafilcon A 41.37 
± 1.00 
53.53 (129%) 
± 2.00 
77.90 (188%) 
± 0.17 
157.67 (381%) 
± 1.53 
 
PTFE 30.73 
± 1.16 
30.10 (98%) 
± 1.05 
30.07 (98%) 
± 1.06 
30.17 (98%) 
± 1.38 
30.13 (98%) 
± 1.27 
T
ry
p
s
in
 
Su 60 15 51.13 
± 7.85 
32.97 (65%) 
± 5.60 
33.47 (66%) 
± 5.73 
  
Su 60 14 50.07 
± 4.23 
35.23 (70%) 
± 3.39 
34.20 (68%) 
± 3.25 
  
Su 60 13 46.67 
± 9.21 
29.37 (63%) 
± 8.02 
32.73 (70%) 
± 5.32 
  
Su 65 15 42.77 
± 4.74 
30.37 (71%) 
± 3.21 
29.23 (68%) 
± 3.69 
  
Su PεK 49.30 
± 4.29 
29.53 (60%) 
± 1.40 
28.53 (58%) 
± 1.70 
  
Etafilcon A 40.13 
± 1.33 
30.90 (77%) 
± 1.80 
29.80 (74%) 
± 1.40 
  
PTFE 30.00 
± 0.30 
29.73 (99%) 
± 0.72 
29.7 (99%) 
± 0.87 
  
 Table 3.5: Degradation sample weights over 12 months (mg) and as a percentage of 
start weights. ±SD, N = 3. 
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Degradation is an important aspect of contact lens wear as long term 
degradation can lead to discomfort, reduced vision and signs of adverse 
ocular reactions (Tanner and Efron, 2018). For all the hydrogels stored in 
PBS or trypsin there was an initial decrease in weight observed after 1 week 
(Table 3.5). However, for each subsequent time-point there was no 
significant decrease in weight observed and the hydrogel variants tested 
followed a similar weight profile as the commercial contact lens material 
etafilcon A (Figure 3.12). All hydrogel variants stored in NaOH increased in 
weight until they had completely degraded after 1 month. A visual inspection 
confirmed that total degradation occurred between 1 - 3 months. Etafilcon A 
degraded fully after 6 months in NaOH and no degradation was observed 
from the negative control (PTFE) under any storage conditions. Incubation in 
trypsin was discontinued after 1 month as no difference was observed 
between trypsin storage and PBS and the activity of trypsin required daily 
replenishment.  
 
The SEM images taken at each time-point confirmed the findings from the 
gravimetric analysis of the hydrogel variants. Obvious signs of degradation 
were evident for all samples stored in NaOH after 1 month with 
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Figure 3.12: Weight loss from hydrogel samples stored in PBS over 12 months as a 
percentage of start weight. Error bars ±SD, N = 9. 
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Figure 3.13: SEM images of various time-points of the degradation study. Scale bar is 
100 µm 
 RESULTS 111 
 
100 μm voids evident in some samples (Su 60 15). However, most voids 
were smaller but still evident from the SEM images. Hydrogel variants stored 
in PBS only began to show minor signs of degradation after 12 months but 
the voids were more random and less ubiquitous than those found in 
samples stored in NaOH.  
 
3.1.10 Lens formation: 
Several attempts were made to cast the hydrogel in the shape of a bandage 
lens. Spin cast methods resulted in an uneven distribution of the polymer and 
never resulted in the formation of a viable lens material. The immiscible 
solvent technique resulted in a formed hydrogel with a curved shape and no 
obvious signs of trapped gas bubbles, however, it was not lens like nor 
reproducible (Figure 3.14a). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Polymerisation of the standard hydrogel Su 60 14 in a closed vessel 
male/female mould resulted in the entrapment of gas bubbles within the 
polymer, resulting in a weakened hydrogel matrix that tore as it polymerised. 
A reduction in NHS from 0.5 to 0.2 Molar equivalents to the amine groups 
within the polymer or replacing it with HOBt as the activation agent resulted 
in the formation of a hydrogel lens (Figure 3.14b). 
Figure 3.14: Hydrogel casting a) an immiscible solvent technique, b) male/female moulds. 
a) b) 
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3.2 Cytocompatibility of HCE-T Cells to Hydrogel Su 60 14 
 
The cytocompatibility of hydrogel Su 60 14 was investigated. A human 
corneal epithelial cell line (HCE-T) was chosen for in vitro studies because 
they behave and retain the morphology of primary corneal epithelial cells.  
 
3.2.1 Cytotoxicity: 
The cytotoxic response of HCE-T cells to the pεk/bis-carboxylic acid hydrogel 
material was investigated to determine cell viability. The 8 day growth curve 
of HCE-T cells cultured in standard media compared to those cultured in 
media pre-incubated with the pεk/bis-carboxylic acid hydrogel demonstrated 
there was no significant difference between cell viability at any of the time-
points analysed. This result suggests that hydrogel Su 60 14 does not affect 
HCE-T cell viability when compared to the control (Figure 3.15) and that any 
leachables from hydrogel Su 60 14 are non-cytotoxic towards the HCE-T cell 
line. 
 
 
  
 
 
 
 
 
 
 
 
    
 Figure 3.15: Cytotoxicity of leachables from hydrogel Su 60 14 towards the HCE-T cell 
line. Error bars ±SD, N = 9. 
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3.2.2 Cellular morphology: 
A qualitative investigation of cellular morphology when in direct contact with 
hydrogel Su 60 14 was undertaken to determine any cytotoxicity and 
complement the quantitative data obtained from the CCK-8 assay. HCE-T 
cells were seeded either directly underneath or on to the surface of the 
hydrogel and images were taken and analysed. After seeding HCE-T cells 
directly on top of hydrogel Su 60 14 very few attached to the surface and 
those that remained retained a spherical morphology after 48 h (Figure 
3.16a). The HCE-T cells cultured on tissue culture plastic directly underneath 
hydrogel Su 60 14 appear to have a more typical cobblestone morphology 
after 48 h as expected for this cell type (Figure 3.16b).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
A live/dead cell assay was carried out on HCE-T cells cultured directly 
underneath hydrogel Su 60 14 for 48 h. All the HCE-T cells stain positive for 
the live cell stain calcein with no ethidium bromide staining evident for dead 
cells. Cells were counterstained with the nuclear stain Hoechst 33342 (Figure 
3.17a). The hydrogel can be observed in the background of the brightfield 
image (Figure 3.17b). 
  
 
 
a) b) 
Figure 3.16: HCE-T cell morphology on hydrogel Su 60 14 (a) and TC plastic (b). Scale bar is 
50 µm. 
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These observations suggest that hydrogel Su 60 14 is hydrophilic enough 
without modification to prevent HCE-T cell attachment but is non-cytotoxic to 
HCE-T cells when in direct contact. 
 
3.2.3 Scratch assay: 
A wound model was set up to investigate if hydrogel Su 60 14 would 
influence the rate of re-epithelialisation of a scratch wound on a monolayer of 
HCE-T cells. A confluent monolayer was obtained after 3 days in culture; a 
linear scratch was made through the monolayer and the hydrogel placed on 
top of the cells. 
 
The re-epithelialisation of the wound was monitored over a 24 h period, 
however, no obvious difference was observed between the control and 
scratch wounds with the hydrogel present. All the scratch wounds closed 
within 23 h regardless of the hydrogel being present or not (Figure 3.18). 
 
 
 
 
 
 
 
Figure 3.17: Live/Dead assay (a) brightfield image (b) of HCE-T cells cultured directly 
underneath hydrogel Su 60 14. Scale bar is 50 µm. 
a) b) 
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Figure 3.18: Scratch wound closure over 23 h on (a-d) TC plastic and (e-f) hydrogel Su 
60 14. 
                     TC Plastic                             Su 60 14 
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Scratch wound closure was quantified using TScratch software (Figure 3.19) 
and identified no significant difference in the rate of scratch wound closure 
with (36% to 1% open area) or without (38% to 0.3% open area) the hydrogel 
present. These data suggest that the presence of hydrogel Su 60 14 in a 
HCE-T cell wound environment does not inhibit re-epithelialisation. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
3.2.4 Monolayer Integrity/Immunocytochemistry: 
HCE-T cell monolayers were found to re-epithelialise within 24 h of the initial 
scratch wound. However, what was not determined was whether there was 
tight junction formation between cells. To investigate this HCE-T Cells were 
stained for zona occludens-1 (ZO-1) to identify any defects in the integrity of 
the monolayer and identify cell to cell contact through their tight junctions. 
Each of the monolayers appear to be intact and comparable to that of the no 
hydrogel control. No missing or physically disturbed junctions were observed 
(Figure 3.20). The results of the ZO-1 staining and the scratch assay suggest 
that hydrogel Su 60 14 does not inhibit or affect the formation of tight 
junctions in a HCE-T cell monolayer. 
 
Figure 3.19: Quantification of scratch wound closure. Error bars ±SD, *** p < 0.005 N = 12. 
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Figure 3.20: ZO-1 staining (green) of HCE-T cells following a 24 h scratch assay. The 
nuclei are counter-stained with DAPI (blue), a) hydrogel Su 60 14 present with scratch 
wound, b) no hydrogel present but scratch wound, c) hydrogel Su 60 14 present but no 
scratch wound, d) no hydrogel present or scratch wound, e) negative control (no primary 
antibody), f) positive control (IgG instead of primary antibody), g) A19 cell positive control. 
Scale bar is 50 μm. 
 RESULTS 118 
 
  
 
 
 
Figure 3.21: ZO-1 (red) and pan cytokeratin (green) staining of HCE-T cells following a 
24 h scratch assay. The nuclei are counter-stained with DAPI (blue), a) hydrogel Su 60 14 
present with scratch wound, b) no hydrogel present but scratch wound, c) hydrogel Su 60 
14 present but no scratch wound, d) no hydrogel present or scratch wound, e) negative 
control (no primary antibody), f) positive control (IgG instead of primary antibody), g) A19 
cell positive control. Scale bar is 50 μm. 
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Figure 3.22: Occludin (red) and cytokeratin MNF116 (green) staining of HCE-T cells 
following a 24 h scratch assay. The nuclei are counter-stained with DAPI (blue), a) 
hydrogel Su 60 14 present with scratch wound, b) no hydrogel present but scratch wound, 
c) hydrogel Su 60 14 present but no scratch wound, d) no hydrogel present or scratch 
wound, e) negative control (no primary antibody), f) positive control (IgG instead of 
primary antibody), g) A19 cell positive control. Scale bar is 50 μm. 
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HCE-T cells were also co-stained (Figure 3.21) with ZO-1 and pan 
cytokeratin to investigate tight junctions as well as staining for keratins 
specific to epithelial cells. Good tight junction staining was observed as well 
as positive cytoplasmic staining of keratins. Further analysis of the reformed 
tight junctions was observed by staining specifically for another tight junction 
protein, occludin. This was combined with another keratin stain, cytokeratin 
MNF116. Occludin and cytoplasmic keratin staining was positive in all 
reformed scratch assay samples confirming the cells were of epithelial cell 
lineage with tight junction formation between them (Figure 3.22). 
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3.3 Antibacterial Analysis 
 
A unique characteristic of pεK is its primary function as an antimicrobial 
compound produced by Streptomyces spp. as a defence mechanism. An 
initial study investigated the antimicrobial activity from several different 
hydrogel variants against both Gram-positive and Gram-negative bacteria. 
Further analysis of the hydrogels with the addition of antibacterial 
biomolecules was investigated to identify the potential of the hydrogel as a 
drug eluting bandage contact lens.   
 
3.3.1 Antimicrobial activity of hydrogels with different levels of cross-linking: 
Hydrogels with varying degrees of cross-linking were monitored over 18 h for 
any difference in antimicrobial activity. After 4 h resazurin reduction was at 
approximately 20% for each of the hydrogel variants which was much lower 
than LB agar (59%). At the 18 h time-point more resazurin was reduced by all 
hydrogel variants (37%), however, this was still significantly lower than the 
LB agar control (73%). Across all time-points there was no significant 
difference in resazurin reduction between the hydrogel variants (Figure 3.23). 
This result suggests that the alterations in cross-link percentages tested do 
not change the antimicrobial activity of the hydrogel.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.23: Reduction of resazurin by S. aureus when cultured in the presence of 
octanedioic acid hydrogels cross-linked at different percentages. Error bars ±SD, *** p < 
0.005 N = 9. 
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3.3.2 Biomolecule quantification: 
Biomolecule attachment was quantified via different methods depending on 
the nature of the chemical bond. Covalently bound pεK was quantified using 
the anionic dye methyl orange and ionically bound penicillin G was quantified 
by analysing elution rate with RP-HPLC. 
 
3.3.2.1 Methyl orange amine determination: 
The anionic dye methyl orange was used to quantify the amount of amine 
groups available from pεK within the hydrogel. A known concentration of 
methyl orange was incubated with the hydrogel followed by analysis of the 
excess solution to quantify how much methyl orange associated with the 
cationic amine groups of pεK within the hydrogel matrix. This was used to 
measure both the degree of cross-linking and the increased amount of pεK 
after re-attachment to the hydrogel post-polymerisation. The amine content 
for the three cross-link variants of the hydrogel varied between 93 µmol for 
Su 75 14 to 773 µmol for Su 45 14 with Su 60 14 at 143 µmol (Table 3.6). 
The addition of pεK greatly enhanced the amount of amine functionality on 
the polymer to 1660 µmol, a 12-fold increase from the unmodified Su 60 14. 
The orange anionic dye associated more with Su PεK than any other 
hydrogel variant (Figure 3.24) These data show that the addition of pεK to the 
hydrogel post-polymerisation greatly enhances the amine content of the 
hydrogel compared to an unmodified version. 
 
 
Hydrogel Amine 
(mmol) 
A465 
Su 60 14  143 1.003 
Su PεK  1660 0.184 
Su 45 14 773 0.663 
Su 75 14 93 1.03 
 
 
 
 
Table 3.6: Methyl orange determination of amino groups available on hydrogel variants. 
N = 3. 
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3.3.2.2 Penicillin G elution: 
The elution of penicillin G from hydrogel Su Pen G was quantified to 
investigate how long the antibiotic was associated with the hydrogel and to 
develop a drug release profile.  
 
 
 
 
Figure 3.24: Methyl orange assay in duplicate of Su PεK (a), Su 60 14 (b) and Su 
acetylated (c). 
Figure 3.25: Penicillin G elution from Su Pen G was monitored by HPLC over 5 h. 
a) 
b) c) 
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Su Pen G was incubated in PBS at 37 °C for set time-points before the 
supernatant was removed and analysed by RP-HPLC (Figure 3.25). Results 
indicate that most of the penicillin G eluted over the initial 30 min of the assay 
but elution continued for 5 h before the compound became undetectable by 
HPLC (Figure 3.26).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
3.3.3 Antimicrobial activity of hydrogels with biomolecules attached: 
A resazurin based cell metabolic activity assay was used as a method to 
determine microbial cell viability. S. aureus and E. coli were cultured in the 
presence of the hydrogel variants for a period of 18 h with resazurin readings 
taken at time-points in between. The most notable differences were observed 
after 4 h in culture when for both organisms resazurin reduction was 
significantly less (p < 0.005) when the organisms were cultured in the 
presence of Su Pen G and Su PεK.  
 
Figure 3.26: Penicillin G elution from Su Pen G. 
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After 18 h in culture with E. coli resazurin reduction with the Su Pen G (0.7%) 
and Su PεK (5%) hydrogels present was significantly less (p < 0.005) than 
hydrogels Su 60 14 (49%), Su Acetylated (30%) and the LB agar control 
(69%). The same trend was observed at the earlier 2 and 4 h time-points, 
however, significantly less (p < 0.005) resazurin reduction was observed for 
the LB agar control at 2 and 4 h compared to Su 60 14 and Su acetylated. No 
significant difference was observed between Su PεK and Su Pen G or Su 
Acetylated and Su 60 14 at any of the time-points investigated (Figure 3.27). 
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 Figure 3.28: Reduction of resazurin by S. aureus when cultured in the presence of the 
octanedioic acid hydrogel variants. Error bars ±SD, *** p < 0.005 N = 9. 
Figure 3.27: Reduction of resazurin by E. coli when cultured in the presence of the 
octanedioic acid hydrogel variants. Error bars ±SD, *** p < 0.005 N = 9. 
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After 18 h in culture with S. aureus resazurin reduction with the Su Pen G 
(5%) and Su PεK (3%) hydrogels present was significantly less (p < 0.005) 
than hydrogels Su 60 14 (31%), Su Acetylated (51%) and the LB agar control 
(73%). The same trend was observed at the earlier 2 and 4 h time-points, 
however, significantly less (p < 0.005) resazurin reduction was observed for 
the LB agar control at 2 h compared to Su 60 14 and Su acetylated 
hydrogels. No significant difference was observed between hydrogels Su PεK 
or Su Pen G at any time-point (Figure 3.28). 
 
These data suggest that the hydrogels with biomolecules attached (Su Pen G 
and Su PεK) can reduce the metabolic activity of both organisms tested when 
compared to LB agar and unmodified hydrogel controls. 
 
3.3.4 Detailed analysis of hydrogel antimicrobial activity towards S. aureus: 
After identifying hydrogels Su Pen G and Su PεK as potential antimicrobial 
materials, a more detailed analysis was undertaken. The efficacy of the 
hydrogels was tested against both planktonic and attached S. aureus and log 
differences determined by direct cell counts.  
 
Against planktonic S. aureus at all time-points a statistically significant (p < 
0.005) decrease in bacterial cell number was observed when cultured in the 
presence of the Su Pen G and Su PεK hydrogels. This was most apparent 
after 18 h when Su Pen G (2.8 log reduction) and Su PεK (1.8 log reduction) 
were compared to the LB agar control. Su Pen G was also significantly (p < 
0.01) more effective at reducing planktonic S. aureus compared to Su PεK at 
each time-point. No significant difference in S. aureus cell number was 
observed between Su 60 14 and the process control at any time-point. After 
18 h a similar increase in S. aureus cell number to the seeding density was 
observed for Su 60 14 (1.08 log), the process control (1.16 log) and the LB 
agar control (1.11 log) (Figure 3.29). 
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Figure 3.29: Log increase/decrease of planktonic S. aureus in the presence of various 
hydrogel. Error bars ±SD, *** p < 0.005 N = 9. 
Figure 3.30: Log number of S. aureus attached to hydrogel variants after 18 h culture 
period variants. Error bars ±SD, *** p < 0.005 N = 9. 
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Against S. aureus attached to the hydrogel a statistically significant (p < 
0.005) decrease in bacterial cell number was observed with the Su Pen G 
and Su PεK hydrogels after 18 h. The greatest reduction was observed when 
Su Pen G (1.1 log reduction) and Su PεK (2.3 log reduction) were compared 
to the LB agar control. No significant difference in S. aureus cell number was 
observed between Su 60 14 and the process control and both these 
hydrogels significantly reduced (p < 0.005) S. aureus cell number compared 
to the LB agar control (Figure 3.30). 
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These data suggest the hydrogels with biomolecules attached can 
significantly reduce S. aureus cell number on the hydrogel when compared to 
LB agar and unmodified hydrogel controls. 
 
3.3.5 Bacteria staining: 
Bacteria cell staining was used to further analyse S. aureus attached to the 
hydrogels. Propidium iodide was used to stain S. aureus in situ on the 
hydrogel surface whereas a LIVE/DEAD® BacLight™ stain was used to stain 
live (green) and dead (red) S. aureus retrieved from the hydrogels post-
culture. 
 
Propidium iodide staining of S. aureus attached to the surface of the Su PεK 
hydrogel revealed that the bacteria were arranged as smaller clusters or 
possibly singular cocci whereas on the other hydrogel surfaces (Su 60 14 
and Su Pen G) their eponymous clustered growth conformation was 
observed (Figure 3.31 a-c). The conformational differences were confirmed 
by the LIVE/DEAD® BacLight™ stain as well as identifying differences 
between the amounts of live or dead S. aureus (Figure 3.31 d-f). Both Su 
Pen G (76%) and Su PεK (74%) kill a significantly greater (p < 0.005) number 
of S. aureus compared to the unmodified Su 60 14 hydrogel (10%) after 18 h 
(Figure 3.32). 
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Figure 3.31: a-c) Propidium iodide staining of S. aureus on the antimicrobial hydrogels, 
d-f) LIVE/DEAD® BacLight™ staining of S. aureus retrieved from the hydrogel. Scale bar 
is 25 μm. 
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These data highlight conformational differences of S. aureus attached to the 
hydrogel variants as well as identifying a greater killing efficacy from the Su 
Pen G and Su PεK hydrogels compared to hydrogel Su 60 14.   
 
3.3.6 Cytotoxicity: 
The cytotoxicity of the antibacterial hydrogel materials to the HCE-T cell line 
were investigated with a CCK-8 cytotoxicity assay as in section 3.2.1. The 4 
day growth curve of HCE-T cells cultured in standard media compared to 
those cultured in media pre-incubated with the Su Pen G or Su PεK 
hydrogels resulted in some cytotoxicity becoming significant (p < 0.005) after 
24 h in culture when compared to the no hydrogel control (Figure 3.33). 
Leachables from the Su PεK (PO4) hydrogel showed significantly greater (p < 
0.005) cytotoxicity towards the HCE-T cell line than any of the other materials 
tested and this was apparent after 2 h in culture. Leachables from hydrogel 
Su 60 14, used here as a control, were again non-cytotoxic to the HCE-T cell 
line. These data suggest that leachables from hydrogel Su Pen G and Su 
PεK have some cytotoxicity towards the HCE-T cell line after 24 h but it does 
not result in cell death to the degree of the positive control Su PεK (PO4). 
Figure 3.32: Percentage live/dead S. aureus retrieved from the hydrogel variants. Error 
bars ±SD, *** p < 0.005 N = 5. 
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3.3.7 Scratch assay: 
A wound model was again set up as in section 3.2.3 to investigate if hydrogel 
Su Pen G and Su PεK would influence the rate of re-epithelialisation of a 
scratch wound on a monolayer HCE-T cells. A confluent monolayer was 
obtained after 3 days in culture; a linear scratch was made through the 
monolayer and the hydrogel aligned along the surface.  
 
 
 
 
Figure 3.33: Cytotoxicity of leachables from the hydrogel variants towards the HCE-T 
cell line. Error bars ±SD, N = 6. 
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The re-epithelialisation of the wound was monitored over a 23 h period, 
however, no obvious difference was observed between the no hydrogel 
control and scratch wounds with Su Pen G and Su PεK present. All the 
scratch wounds except for hydrogel Su PεK (PO4) closed within 23 h 
regardless of the hydrogel being present or not (Figure 3.34). Scratch wound 
closure was quantified using TScratch software (Figure 3.35) which identified 
a statistically significant increase (p < 0.005) in scratch wound open area with 
the presence of Su PεK (PO4) at 5 h (116%) and 23 h (231%) compared to 
all other hydrogels tested. No significant difference was observed between 
scratch wound open area for Su Pen G (73%), Su PεK (61%), Su 60 14 
(60%) and the no hydrogel control (52%) after 5 h. All the scratch wounds 
apart from Su Pen G closed after 23 h, however, this was not significant. 
 
 
 
 
 
 
Figure 3.34: Percentage scratch closure with/without hydrogels present at 5 h and 23 h 
after initial scratch at 0 h ----. Error bars ±SD, *** p < 0.005 N = 9. 
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Figure 3.35: Scratch closure of a HCE-T monolayer after 0 h, 5 h and 23 h with hydrogel 
variants present. Scale bar is 100 μm.  
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These data suggest that the presence of the Su Pen G and Su PεK 
hydrogels in a HCE-T cell wound environment does not inhibit re-
epithelialisation. 
 
3.3.8 Monolayer integrity: 
HCE-T cell monolayers were found to re-epithelialise within 23 h of the initial 
scratch wound for all materials except Su PεK (PO4). However, what was not 
determined was whether tight junctions had reformed within the monolayer. 
To investigate this HCE-T Cells were stained for zona occludens-1 (ZO-1) to 
identify any defects in the integrity of the monolayer and identify cell to cell 
contact through their tight junctions. The monolayers with Su Pen G, Su PεK 
and Su 60 14 appear to be intact and similar to that of the no hydrogel 
control. No physically disturbed junctions were observed (Figure 3.36). 
However, the monolayer with Su PεK (PO4) present is incomplete with lots of 
unattached HCE-T cells evident. The results of the ZO-1 staining and the 
scratch assay suggest that the Su Pen G and Su PεK hydrogels do not 
physically inhibit or affect the HCE-T cell monolayer.  
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Figure 3.36: ZO-1 staining (green) of HCE-T cells following a 24 h scratch assay in the 
presence of the hydrogel variants. The nuclei are counter-stained with DAPI (blue). Scale 
bar is 100 μm. 
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3.4 Antifungal Analysis 
 
Further analysis of the antimicrobial potential of the hydrogel was 
investigated with focus on a more clinical application in the fight against 
fungal keratitis. The hydrogel was investigated for its potential to elute an 
ionically attached antifungal, AmpB with focus on its killing efficacy, stability 
and elution rate. 
 
3.4.1 Minimum inhibitory concentration of AmpB against C. albicans: 
C. albicans was cultured in PD media or PD media supplemented with 10 
v/v% horse serum with a range of concentrations of AmpB. The OD600 was 
measured after 18 h and used to determine the concentration of AmpB that 
inhibited C. albicans growth. The MIC of AmpB that significantly inhibited C. 
albicans growth was found to be between 0.094 and 0.188 μg cm-3 for both 
PD (p < 0.005) and PD with 10% horse serum (p < 0.05) (Figure 3.37). No 
significant difference was found in the MIC for C. albicans when cultured in 
PD supplemented with 10 v/v% horse serum compared to PD alone. 
 
 
Figure 3.37: MIC for AmpB against C. albicans cultured in different growth media, potato 
dextrose and potato dextrose supplemented with 10% horse serum. Error bars ±SD, * p < 
0.05, *** p < 0.005 N = 9. 
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3.4.2 Fungicidal effects of the -NH3Cl and -NH2 hydrogels: 
AmpB was loaded onto the hydrogels by soaking them in various 
concentrations of the drug. The OD600 was measured after 18 h and used to 
determine the efficacy of AmpB eluted from the hydrogels towards C. 
albicans. The loading of AmpB and its release from the hydrogels 
significantly reduced (p < 0.005) the growth of C. albicans compared to no 
AmpB (Figure 3.38). However, there was no statistically significant difference 
between concentrations of AmpB or between the different materials (i.e -
NH3Cl, -NH2, -NH2 hydrogel cultured in PD + 10 v/v% horse serum) when 
compared across all concentrations. These data suggest that the -NH3Cl and 
the -NH2 hydrogels loaded with all concentrations of AmpB are effective at 
inhibiting C. albicans growth. 
 
 
0 3 5 10 15 20 25 30
0.0
0.2
0.4
0.6
0.8
1.0
1.2
1.4
1.6
***
NH3Cl hydrogel
NH2 hydrogel
NH2 hydrogel (cultured in
PD + 10% horse serum)
AmpB (g cm
-3
)
C
a
n
d
id
a
 G
ro
w
th
 (
O
D
6
0
0
)
 
 
 
 
 
Figure 3.38:  Fungicidal effects of hydrogels pre-incubated in various concentrations of 
AmpB under different growth conditions.  Error bars ±SD, *** p < 0.005 N = 9. 
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3.4.3 Viability of fungi attached or loosely adhered to the hydrogel:  
An investigation of any remaining viable fungi attached or loosely attached to 
the hydrogel after the antifungal assay was undertaken. After the OD600 was 
measured at the 18 h time-point (section 3.4.2) the -NH2 and -NH3Cl 
hydrogels were compared. Loosely attached viable C. albicans were 
recovered from the wash of the -NH3Cl hydrogel pre-incubated in 3 μg cm-3 
AmpB. Whereas, no loosely attached viable fungi were recovered from the -
NH2 hydrogel wash of the same concentration. Similar results were noted 
with hydrogels placed directly on PD-Agar; no growth was observed on -NH2 
gel with some growth surrounding the -NH3Cl hydrogel pre-incubated with 3 
μg cm-3 AmpB (Figure 3.39). Separately, the -NH2 hydrogels cultured in PD 
broth and PD broth supplemented with 10% horse serum were removed and 
washed prior to being plated on PD agar with an aliquot of the wash (Figure 
3.40). Almost no growth of C. albicans was observed on the -NH2 hydrogels 
or the washes across all the pre-incubation concentrations of AmpB. The 
only visible growth was observed around the -NH2 hydrogel and wash not 
pre-incubated with AmpB. 
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Figure 3.39:  a) hydrogels and washes plated on PD agar for 0 + 3 μg cm-3 AmpB NH2 
hydrogel b) hydrogels and washes plated on PD agar for 25 + 30 μg cm-3 AmpB NH2 
hydrogel c) hydrogels and washes plated on PD agar for 0 + 3 μg cm-3 AmpB NH3Cl 
hydrogel d) hydrogels and washes plated on PD agar for 25 + 30 μg cm-3 AmpB NH3Cl 
hydrogel. 
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3.4.4 AmpB elution from the hydrogel: 
Elution of AmpB was monitored over 96 h with RP-HPLC immediately after 
incubation in a solution of AmpB (30 µg cm-3) for 2 h.  
 
The main AmpB peak was obtained after 12 min, however, there was a small 
peak after 5 min that was also associated with AmpB (Figure 3.41). A 
standard curve was plotted from AmpB standard concentrations (Figure 
3.41c) and used to determine AmpB eluted from the hydrogels at each time-
point. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.40: a) hydrogels plated on PD agar for 0 + 3 μg cm-3 AmpB NH2 hydrogel 
cultured in PD broth and PD broth supplemented with 10% horse serum, b) washes 
plated on PD agar for 0 + 3 μg cm-3 AmpB NH2 hydrogel cultured in PD broth and PD 
broth supplemented with 10% horse serum. PD: hydrogel cultured in PD broth, HS: 
hydrogel cultured in PD broth supplemented with 10% horse serum. 
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Figure 3.41: a) AmpB elution from -NH2 hydrogels over a 48 h period, b) AmpB elution 
from -NH3Cl hydrogels over a 48 h period, c) AmpB standards of different concentrations. 
 
b) 
 
c) 
 
a) 
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A therapeutic dose of AmpB (1.058 - 0.185 µg cm-3) eluted from the -NH2 
hydrogel for a period of 72 h with a smaller dose after 96 h (0.134 µg cm-3). 
The amount of AmpB eluted from the -NH3Cl hydrogel remained clinically 
relevant for 48 h (0.436 - 0.175 µg cm-3) before being undetectable after 72 h 
(Figure 3.42). Significantly (p < 0.005) more AmpB was eluted from the -NH2 
hydrogel at all time-points compared to the -NH3Cl hydrogel. These data 
suggest more AmpB is associated with the -NH2 hydrogel compared to the -
NH3Cl hydrogel and releases the drug over a longer period.  
 
 
 
 
 
 
 
3.4.5 AmpB stability and efficacy after attachment to the hydrogel: 
The -NH2 hydrogel was incubated with AmpB (30 µg cm-3) for 2 h prior to 
incubating at 25 °C for various time-points. The -NH2 hydrogels were then 
tested for their killing efficacy towards C. albicans. AmpB associated with the 
-NH2 hydrogel remained stable and produced a killing effect against C. 
Figure 3.42: AmpB elution from -NH2 and -NH3Cl hydrogels over a 96 h period. Line ----- 
denotes the MIC for C. albicans determined in this report. Error bars ±SD, *** p < 0.005 
N = 4. 
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albicans for at least 48 h (Figure 3.43). There appeared to be less C. 
albicans killed at 48 h when compared to the earlier time-points, however this 
was not statistically significant. There was no difference between the efficacy 
of the AmpB hydrogels and the 30 µg cm-3 AmpB incubation solution at each 
time-point in terms of the eradication of C. albicans. These data suggest that 
AmpB is stable at 25 °C for at least 48 h after attachment to the -NH2 
hydrogel. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.43: Effectiveness of AmpB -NH2 hydrogel at killing C. albicans after pre-
incubation for set time-points prior to inoculation with C. albicans. Error bars ±SD, *** p < 
0.005 N = 6. 
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3.4.6 Cytotoxicity of the -NH2 hydrogel to the HCE-T cell line: 
A cytotoxicity study of the leachables from the -NH3Cl and -NH2 hydrogels 
pre-incubated in AmpB (30 µg cm-3) was undertaken. A CCK-8 assay was 
used as a measure of the metabolic activity of the HCE-T cells. The HCE-T 
cells were also cultured in standard tissue culture media as a positive control. 
No significant difference in HCE-T activity was observed at any of the time-
points when comparing -NH2 and -NH3Cl hydrogels pre-incubated in AmpB to 
standard cell culture media (Figure 3.44). These data suggest that the -
NH3Cl and -NH2 hydrogels incubated with the highest concentration of AmpB 
used in the antifungal study were non-cytotoxic to the HCE-T cell line. 
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Figure 3.44: Cytotoxicity of AmpB -NH2 and -NH3Cl hydrogels towards the HCE-T cell 
line. Error bars ±SD, N = 8. 
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3.5 Microbial Identification Peptides 
 
The hydrogel bandage contact lens was investigated for its ability to 
associate other biomolecules for different applications other than 
antimicrobial activity. Bacterium identifying peptides were associated with the 
hydrogel to investigate the potential to align the peptide to a site of infection 
with view to determining whether the pathogen was Gram-positive or Gram-
negative. This approach could potentially lead to a quicker diagnosis and 
more effective treatment of ocular infections especially when combined with 
more directed and controlled hydrogel release mechanism. 
 
3.5.1 Hydrogel design: 
The Su 60 14 hydrogel was polymerised in the same way as 2.1.2 but an 
anhydride attached to the amine groups to convert it to a carboxyl moiety. 
The efficacy of the conversion was measured post-modification. A blue 
positive ninhydrin stain was observed for the unmodified hydrogel; however, 
a dark yellow colour was obtained for Su 60 14 COOH (Figure 3.45a). This 
qualitative analysis suggested the conversion to a carboxyl moiety was 
successful. A methyl orange amine quantification assay was used to confirm 
the ninhydrin results and give an approximate value of the amount of amine 
groups still present (Figure 3.45b). It was determined that there was a 60% 
reduction in amine groups on the Su 60 14 COOH hydrogel (50 µM amine) 
compared to the unmodified Su 60 14 hydrogel (120 µM amine) (Table 3.7). 
These data suggest that the amount of amine groups on the modified 
hydrogel was reduced and replaced by a carboxyl moiety. 
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Hydrogel Amine 
(mmol) 
A465 
Su 60 14  120 1.043 
Su 60 14 
COOH  
50 1.125 
Figure 3.45: Quantification of amine groups present within the hydrogel matrix, a) 
qualitative evaluation with Kaiser reagent and b) methyl orange amine quantification of the 
pre (left) and post (right) carboxy functionalised hydrogel. 
Table 3.7: Methyl orange determination of amino groups available on hydrogel variants. 
N = 3. 
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3.5.2 BAC ONE: 
 
3.5.2.1 Qualitative BAC ONE efficacy analysis: 
The BAC ONE peptide was incubated with hydrogel Su 60 14 COOH prior to 
testing its efficacy at identifying both Gram-positive and Gram-negative 
bacteria in culture. Nitrobenzodiazole (NBD) fluorescence from the peptide 
associated with hydrogel Su 60 14 COOH (Figure 3.46a) and from the 
peptide alone (Figure 3.46b) was observed at incubation concentrations of 5 
- 40 μM in the presence of S. aureus. However, less fluorescence was 
obvious from the peptide associated with hydrogel Su 60 14 COOH when 
incubated with E. coli (Figure 3.46c). Fluorescence was only observed at > 
20 μM incubation concentration when the peptide alone was incubated with 
E. coli (Figure 3.46d). Some background auto-fluorescence was observed 
from the hydrogel when present. These data suggest the Su 60 14 COOH 
hydrogel with BAC ONE can be used to label Gram-positive bacteria without 
hindering its activity. 
 
3.5.2.2 Quantification of BAC ONE fluorescence: 
The fluorescence of the peptide for the range of incubation concentrations 
was quantified to confirm the observations in section 3.5.2. A microplate 
reader was used to measure the fluorescence intensity. A statistically 
significant (p < 0.005) increase in fluorescence was observed from the BAC 
ONE peptide (at 40 μM) associated with hydrogel Su 60 14 COOH in the 
presence of S. aureus when compared to a no microbe control. The BAC 
ONE peptide incubated with S. aureus alone gave the greatest fluorescence 
signal with statistical significance (p < 0.005) over the Su 60 14 COOH 
hydrogel between 20 - 40 μM incubation concentrations (Figure 3.47). BAC 
ONE also labelled E. coli when associated with the hydrogel and this was 
statistically greater (p < 0.05) than the no microbe control at concentrations 
of 10 - 40 μM. A much greater fluorescence signal was observed when 
incubated with E. coli with/without the hydrogel present when compared to 
the corresponding data for S. aureus. These data suggest the hydrogel 
capable of delivering a sufficient quantity of the peptide when pre-incubated 
in the greater BAC ONE concentration (40 μM). 
 RESULTS 147 
 
 
 
 
 
 
 
 
Figure 3.46: Evaluation of BAC ONE efficacy after attaching to hydrogel Su 60 14 COOH 
with different incubation concentrations, a) Su 60 14 COOH with BAC ONE cultured with 
S. aureus b) BAC ONE cultured with S. aureus c) Su 60 14 COOH with BAC ONE 
cultured with E. coli d) BAC ONE cultured with E. coli. Scale bar is 100 μM. 
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3.5.2.3 BAC ONE stability after attachment to the hydrogel: 
An investigation of the stability of the peptide after association with the 
hydrogel was undertaken to determine what time peak fluorescent intensity 
was observed and when that signal began to deteriorate. The fluorescent 
signal from the peptide was measured over a 21 h period. It was determined 
that the BAC ONE peptide associated with the hydrogel was stable across all 
incubation concentrations for at least 21 h. No significant reduction in 
fluorescent intensity was observed for any of the incubation concentrations 
over 21 h (Figure 3.48). These data suggest that optimal fluorescence is 
maintained for 21 h from initial application. 
 
Figure 3.47: Quantification of fluorescence from the BAC ONE peptide attached to 
hydrogel Su 60 14 COOH. Error bars ±SD, * p < 0.05, *** p < 0.005 N = 6. 
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3.5.2.4 BAC ONE staining of non-target cells: 
A co-culture of HCE-T cells and S. aureus or E. coli was set up to determine 
if the BAC ONE peptide would label the mammalian cells. It was identified 
that BAC ONE associated with hydrogel Su 60 14 COOH successfully 
labelled S. aureus or E. coli in a co-culture system but some non-specific 
labelling of HCE-T cells was evident (Figure 3.49). Although some non-
specific staining of HCE-T cells was evident, the bacteria was still identifiable 
as the fluorescence intensity was greater. 
 
 
Figure 3.48: Stability of the fluorescent signal from the BAC ONE peptide attached to 
hydrogel Su 60 14 COOH after 21 h incubation with S. aureus. Error bars ±SD, N = 6. 
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Figure 3.49: Investigation of BAC ONE efficacy in a co-culture of HCE-T cells and S. 
aureus or E. coli, a) Su 60 14 COOH with BAC ONE cultured with HCE-T and S. aureus, 
b) BAC ONE cultured with S. aureus, c) BAC ONE cultured with HCE-T and S. aureus, 
d) Su 60 14 COOH with BAC ONE cultured with HCE-T and E. coli, e) BAC ONE 
cultured with E. coli, f) BAC ONE cultured with HCE-T and E. coli g) Su 60 14 COOH 
with BAC ONE cultured with HCE-T. Scale bar is 100 µm. 
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3.5.3 BAC TWO: 
 
3.5.3.1 Qualitative BAC TWO efficacy analysis: 
The BAC TWO peptide was incubated with hydrogel Su 60 14 COOH prior to 
testing its efficacy at identifying the Gram-negative E. coli in culture. NBD 
fluorescence from the BAC TWO peptide associated with hydrogel Su 60 14 
COOH was observed at incubation concentrations of 10 - 40 μM (Figure 
3.50a). Fluorescence was observed across all concentrations of the peptide 
when it was not associated with the hydrogel (Figure 3.50b). No fluorescence 
was observed from the peptide in the presence of the Gram-positive 
organism S. aureus (Figure 3.50c). Some background auto-fluorescence was 
observed from the hydrogel when present. These data suggest the Su 60 14 
COOH hydrogel can be used to deliver the BAC TWO peptide without 
hindering its activity. 
 
3.5.3.2 Quantification of BAC TWO fluorescence: 
The fluorescence of the peptide for the range of incubation concentrations 
was quantified to confirm the observations in section 3.5.3.1. A microplate 
reader was used to measure the fluorescence intensity. A statistically 
significant (p < 0.005) increase in fluorescence was observed from the BAC 
TWO peptide (at 40 μM) associated with hydrogel Su 60 14 COOH when 
compared to a no microbe or S. aureus control (Figure 3.51). The peptide 
incubated with E. coli alone gave the greatest fluorescence signal with 
statistical significance (p < 0.005) over the Su 60 14 COOH hydrogel 
between 10 - 40 μM incubation concentrations. These data suggest the 
hydrogel capable of delivering a sufficient quantity of the peptide when pre-
incubated in the greater BAC TWO concentration (40 μM).  
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Figure 3.50: Evaluation of BAC TWO efficacy after attaching to hydrogel Su 60 14 COOH 
with different incubation concentrations, a) Su 60 14 COOH with BAC TWO cultured with 
E. coli b) BAC TWO cultured with E. coli c) Su 60 14 COOH with BAC TWO cultured with 
S. aureus d) Su 60 14 COOH with BAC TWO only. Scale bar is 50 μm. 
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3.5.3.3 BAC TWO stability after attachment to the hydrogel: 
An investigation of the stability of the peptide after association with the 
hydrogel was undertaken to determine what time peak fluorescent intensity 
was observed and when that signal began to deteriorate. The fluorescent 
signal from the peptide was measured over a 21 h period. It was determined 
that the BAC TWO peptide associated with the hydrogel was stable across all 
incubation concentrations for at least 4 h. The stability of the peptide was 
significantly reduced (p < 0.005) at 20 and 40 μM incubation concentration 
after 21 h (Figure 3.52). These data suggest that optimal fluorescence is 
observed between initial application and 4 h. 
 
 
 
 
 
Figure 3.51: Quantification of fluorescence from the BAC TWO peptide attached to 
hydrogel Su 60 14 COOH. Error bars ±SD, *** p < 0.005 N = 6. 
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3.5.3.4 BAC TWO staining of non-target cells: 
A co-culture of HCE-T cells and E. coli was set up to determine if the BAC 
TWO peptide would label the mammalian cells. It was identified that BAC 
TWO associated with hydrogel Su 60 14 COOH successfully labelled E. coli 
in a co-culture system with HCE-T cells without labelling the mammalian cells 
(Figure 3.53). This result suggests that the peptide will not label corneal 
epithelial cells in a co-culture with E. coli. 
 
 
Figure 3.52: Stability of the fluorescent signal from the BAC TWO peptide attached to 
hydrogel Su 60 14 COOH over 21 h incubation with E. coli. Error bars ±SD, *** p < 0.005 
N = 6. 
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Figure 3.53: Investigation of BAC TWO efficacy in a co-culture of HCE-T cells and E. 
coli, a) Su 60 14 COOH with BAC TWO cultured with HCE-T and E. coli, b) Su 60 14 
COOH cultured with HCE-T and E. coli, c) BAC TWO cultured with E. coli, d) Su 60 14 
COOH with BAC TWO cultured with HCE-T, e) HCE-T and E. coli co-culture, f) BAC 
TWO cultured with HCE-T and E. coli. Scale bar is 50 µm. 
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3.5.4 Ex vivo bacterial keratitis model: 
An ex vivo bacterial keratitis model was setup utilising porcine corneas to test 
the efficacy of the BAC hydrogel systems in identifying Gram-positive and 
Gram-negative bacteria (Figure 3.54). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.54: Micrographs of bacteria identified by the BAC/hydrogel system in an ex vivo 
model of bacterial keratitis. Scale bar is 50 μm. (a) Ex vivo corneal model of microbial 
keratitis, (b) hydrogel and BAC ONE with E. coli, (c) Hydrogel and BAC ONE with S. 
aureus, (d) BAC ONE with E. coli and (e) Hydrogel and BAC ONE with no infection. (f) 
Hydrogel and BAC TWO with S. aureus, (g) Hydrogel and BAC TWO with E. coli, (h) BAC 
TWO with E. coli and (i) Hydrogel and BAC TWO with no infection. Scale bar is 100 µm. 
BAC hydrogel on 
keratitis model 
Ex vivo cornea  
with no infection 
Ex vivo cornea  
with infection 
BAC ONE BAC TWO 
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Staining was observed for both E. coli and S. aureus from BAC ONE 
associated with the hydrogel, however, it was much more evident for S. 
aureus. BAC ONE peptide alone also stained S. aureus in the ex vivo model. 
Staining was observed for E. coli when BAC TWO was associated with the 
hydrogel, with no staining for S. aureus evident. BAC TWO peptide alone 
also stained S. aureus in the ex vivo model.  
 
3.5.5 Cytotoxicity of the BAC hydrogels to the HCE-T cell line: 
A cytotoxicity study of the leachables from the modified Su 60 14 COOH 
hydrogels pre-incubated in BAC ONE or BAC TWO peptide solution (40 µM) 
was undertaken to investigate BAC peptide cytotoxicity against HCE-T cells. 
A CCK-8 assay was used as a measure of metabolic activity and HCE-T cells 
were cultured in standard tissue culture media as a control. No significant 
difference in HCE-T viability was observed at any of the time-points when 
comparing the hydrogels with BAC peptides associated to standard cell 
culture media (Figure 3.55).  
 
 
 
0 20 40 60 80 100 120 140
-0.2
0.0
0.2
0.4
0.6
0.8
1.0
1.2
1.4
1.6
No Material
Hydrogel + BAC ONE
Hydrogel + BAC TWO
Su PK PO4
Su 60 14 COOH
Time (h)
C
e
ll
 V
ia
b
il
it
y
 (
O
D
4
8
5
)
 
 
 
 
 
 
 
Figure 3.55: Cytotoxicity of the BAC hydrogels towards the HCE-T cell line. Error bars 
±SD, N = 8. 
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Figure 3.56: Micrographs of HCE-T cells at various intervals during the cytotoxicity study. 
Scale bar is 100 μm. 
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Analysis of the micrographs taken at various intervals during the cytotoxicity 
study confirm the results from the CCK-8 assay (Figure 3.56). A monolayer of 
HCE-T cells was still visible in those cultured in leachables from the Su 60 14 
COOH hydrogel after 168 h.  
 
These data suggest that the Su 60 14 COOH hydrogels incubated with the 
highest concentration of BAC ONE or TWO were non-cytotoxic to the HCE-T 
cell line. 
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4. DISCUSSION 
 
The principle objective of this work was to investigate and optimise the 
mechanical and physical properties of a pεK/bis-carboxylic acid hydrogel to 
attain similar values as those already described for commercial contact lens 
materials. This was followed by detailed investigations of the efficacy of 
biomolecules attached to the polymer in antibacterial and antifungal activity 
and the identification of microbes implicated in microbial keratitis. The 
overarching aim of this study was to develop a novel hydrogel bandage 
contact lens capable of improving current treatments in the fight against 
microbial keratitis. 
 
Microbial keratitis is a common condition prevalent in both developed and 
developing countries and can often result in blindness due to inadequate 
treatment. The organism implicated in infection varies with geographical 
location and therefore so does the treatment regimen. Current treatments 
are, in the most part, inefficient due to minimal absorption of the drug at the 
site of injury and results in the need for multiple applications of antibiotics to 
resolve the condition. However, in the developing world, ineffective treatment 
regimens due to patient non-compliance and proximity to treatment centres 
can result in disease reoccurrence. This exacerbates the condition and can 
ultimately result in the need for keratoplasty. In most clinical applications, a 
bandage lens is applied to provide comfort and protect the wound site. An 
improvement to current treatments could come in the form of a drug loaded 
hydrogel bandage lens that could aid the slow release of antimicrobials to the 
site of injury without the need for the continuous manual administration of the 
treatment. Therefore, the efficiency of drug delivery may improve and a 
reduction of patient non-compliance may be observed.   
 
This work has shown that a pεK/bis-carboxylic acid hydrogel can be designed 
with mechanical and physical properties comparable to commercial contact 
lens materials. Furthermore, the hydrogel can be loaded with biomolecules 
covalently, ionically and by simple absorption to provide an antibacterial 
activity. The model antifungal, AmpB, was ionically associated with the 
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hydrogel to investigate any antifungal activity. Finally, optical sensing 
peptides with the environmentally sensitive NBD fluorophore attached were 
ionically associated with the hydrogel and investigated for their efficacy in 
labelling Gram-positive and Gram-negative bacteria in vitro and ex vivo as a 
fast-tracked identification system for bacterial pathogens of microbial 
keratitis. 
 
    
4.1 Hydrogel Characterisation 
 
The preliminary stage for the development of an antimicrobial bandage 
contact lens was to characterise the polymer both physically and 
mechanically. Firstly, an investigation of the raw materials and how they 
affect the subsequent polymer was initiated followed by the mechanical and 
physical investigation of the hydrogel in comparison to commercially 
available contact lens materials. 
 
4.1.1 PεK characterisation: 
PεK is a naturally occurring homopolymer of the amino acid L-lysine that is 
produced on a multi tonne scale via microbial fermentation, predominantly 
from Streptomyces albulus (Shih, Shen and Van, 2006). All the raw materials 
for the hydrogels in this report can be acquired from multiple sources with 
purities of ≥ 99% except for pεK. As a polymer and a product of fermentation, 
its purity and heterogeneous chain-length distribution can vary from batch to 
batch so it was imperative to develop analytical procedures for each batch to 
determine the amine content (mmol g-1) so as calculation adjustments to the 
polymer mix could be made (Shih, Shen and Van, 2006). 
 
From the literature natural pεK is described as having a high ratio of longer 
chain oligomers with the majority between 25 - 35 residues in chain length 
(Shih, Shen and Van, 2006). It has been described that desirable properties 
of pεK such as its antimicrobial activity or flavour as a food additive may be 
altered by varying the chain length ratio. PεK with longer chain oligomers 
have been known to impart more bitterness to the flavour of the substance. 
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This is of particular importance to the food industry where it is used as an 
important preservative (Nishikawa and Ogawa, 2006). A way of imparting the 
vary degrees of oligomer chain lengths on natural pεK is with the use of the 
pεK degrading enzyme produced naturally by the same organism, 
Streptomyces albulus, as a natural self-defence mechanism against pεK 
(Yoshida and Nagasawa, 2003). Longer chain oligomers > 10 residues have 
been identified as having much greater antimicrobial activity as opposed to 
shorter chain oligomers (Shima et al., 1984).  
 
An RP-HPLC system modified from Hirohara et al. 2007 was used to 
characterise three different batches of pεK that were acquired for this study. 
It was identified that the ratio of pεK oligomers was different for each batch. 
The main component of each batch (20 - 35 residues) has a similar pεK 
profile and elution time; however, each sample also has a varying degree of 
differing chain length oligomers as identified in the earlier running material. 
Short chain oligomers (5mer and 10mer) of pεK were synthesised in-house 
and subsequently used as standards to confirm the representative chain 
length of each peak on the chromatogram. Furthermore, pεK/bis-carboxylic 
acid hydrogels were polymerised using the three different batches of pεK. To 
ensure no other factors could interfere with the cross-linking C, H and N 
elemental analysis of the three batches was used to determine the amine 
content (mmol g-1). This ensured the correct amount of reaction components 
were added to give the same level of cross-linking. The mechanical 
properties of the hydrogels were compared with no significant difference 
observed between them. Although no difference in mechanical properties 
was observed between hydrogels produced from the different batches of pεK 
it led to the development of an effective analytical process for the quality 
control (QC) of pεK. The oligomer chain length ratio appears to vary 
depending on the final application of the pεK product with some companies 
offering batches of pεK, with oligomers ≥ 20 residues long, as pharmaceutical 
grade. However, whether there is a correlation between chain-length 
distribution and the grade offered has not been determined and may solely 
be a consequence of how the pεK was manufactured and processed.  
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The RP-HPLC method developed in this study has been optimised to use 
peak area as an in-house replacement for C, H and N analysis in determining 
the peptide content, and thereby the amine content of individual pεK batches. 
It is now a standard operating procedure (SOP, SP0027) used for QC of all 
pεK batches under SpheriTech’s International Organisation for 
Standardisation (ISO) 9001 quality management system. 
  
4.1.2 Optimal bis-carboxylic acid cross-linker and reaction parameters: 
The hydrogel developed in this study is a polymer of pεK cross-linked with a 
bis-carboxylic acid. The primary constituent of the polymer, pεK, was already 
established and no alternative sought as this formed the basis of the patents 
to the polymer. The second major constituent of the polymer, bis-carboxylic 
acids, were analysed to identify which one would give the final polymer 
optimal physical and mechanical properties. 
  
Several of the short chain bis-carboxylic acids are produced on a multi tonne 
scale via the ozonolysis or hydrolysis of unsaturated fatty acids in castor oil 
(octanedioic acid and decanedioic acid) or oleic acid (nonanedioic acid) and 
have uses in the production of nylon derivatives as well as plasticisers and 
lubricants. Heptanedioic acid is produced via the oxidation of unsaturated 
fatty acid but is the least used bis-carboxylic acid described in this text 
(Cornils, Lappe and by Staff, 2014). Almost 81% of total hexanedioic acid 
produced worldwide via the nitric acid oxidation of cyclohexanol is used to 
make Nylon 6,6 (Musser, 2014). Generally, as the chain-length of the bis-
carboxylic increases so too does the cost. The short chain bis-carboxylic 
acids described here have a low systemic toxicity and are readily β-oxidised 
by the mitochondria and peroxisomes or eliminated from the body via urine 
(Fiordeliso, Bron and Kohn, 1995; Grego and Mingrone, 1995). Hexanedioic 
acid is described as GRAS by the FDA for use as a food additive (Castellan, 
Bart and Cavallaro, 1991). 
 
An initial hydrogel was polymerised using decanedioic acid to cross-link as 
this was used as standard for other polymers based on the same 
constituents (Wellings and Gallagher, 2012). It was clear from the start that 
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optical clarity was not good enough using decanedioic acid so longer chain 
bis-carboxylic acids (dodecanedioic acid and tridecanedioic acid) were 
discounted and shorter chain bis-carboxylic acids (hexanedioic acid, 
heptanedioic acid, octanedioic acid, nonanedioic acid and decanedioic acid) 
were investigated. Of the bis-carboxylic acids investigated, decanedioic acid 
was the least soluble acid due to the longer hydrophobic backbone compared 
to shorter chain bis-carboxylic acids. A reduction in transparency was 
observed as the bis-carboxylic acid chain increased and an increase in 
tensile strength was observed from hexanedioic acid to nonanedioic acid. A 
significant reduction in tensile strength was noted for most hydrogels with 
decanedioic acid as the bis-carboxylic acid cross-linker. The increased 
hydrophobicity possibly results in a less homogenous hydrogel network 
resulting in a more opaque polymer that contributes to the weakened 
mechanical properties and lack of transparency when polymerised (Refojo 
and Yasuda, 1965; Metters and Lin, 2007; Hou et al., 2011). As density of the 
polymer increases so too does tensile strength. Only marginal differences 
were observed between the varying degrees of percentage cross-linking 
when the polymer was a similar density. This suggested that polymer density 
was more important than degree cross-linking at the levels investigated when 
trying to improve the polymer strength.  
 
Octanedioic acid provided optimal mechanical properties whilst maintaining 
transparency and was mid-range when it came to economic considerations. 
A degree of opacity was observed from nonanedioic acid and decanedioic 
acid cross-linked hydrogels making them unsuitable and hydrogels with 
hexanedioic and heptanedioic acid cross-linkers have less desirable 
mechanical properties. These data led to octanedioic acid being chosen as 
the bis-carboxylic acid to cross-link pεK within the hydrogel matrix. 
 
Immediately prior to developing the hydrogel further some important reaction 
parameters were standardised. By controlling these parameters at near 
optimal conditions the energy consumed can be minimised and the reaction 
can be as cost and energy efficient as possible. Both the reaction time and 
temperature are easily controlled with optimal reaction times being as short 
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as possible and the temperature as close to room temperature as possible to 
ensure no need for incubation under extreme cold or warm conditions. The 
hydrogels were polymerised for different lengths of time and separately at 
different temperatures. Mechanical analysis of the hydrogels made under 
different conditions was used to indicate the polymerisation end-point. In the 
optimal polymerisation time study elastic modulus increased gradually from 1 
h to 5 h with statistical significance before reaching a plateau that continued 
to 24 h. The increase in elastic modulus is related to the continuing cross-
linking up to the 5 h time-point thereby determining that a polymerisation time 
of at least 5 h was required to allow cross-linking to reach completion. An 
increase in the rate of the reaction can lead to the development of cleaner 
more economical reaction processes (Ameta et al., 2013). During the 
polymerisation temperature study, no significant difference was found in the 
elastic modulus between hydrogels incubated at 21.5 °C and 37 °C. Both 
these hydrogels showed a significant increase in elastic modulus from the 
hydrogel that was polymerised at 6 °C. This may be directly associated with 
improved reaction kinetics combined with thermodynamic instability of the 
reaction. Every 10 °C rise in temperature is associated with two- to threefold 
increase in rate of reaction (Upadhyay, 2006). This suggests that the reaction 
had come to completion within 5 h of polymerising at these temperatures. It 
was determined from these data that the most reproducible mechanical 
properties were obtained when hydrogel Su 60 14 was polymerised at room 
temperature. An incubator was setup to keep polymerisation temperature 
constant. The manufacturer’s recommendation was a running temperature of 
3 °C above room temperature so the incubator was set to 25 °C and all 
subsequent hydrogels polymerised at that temperature. 
 
4.1.3 Optimal mechanical and physical properties of the hydrogel: 
Following optimisation of the reaction parameters and the bis-carboxylic acid 
cross-linker several hydrogel variants were investigated as potential 
candidates for bandage contact lenses. Su 60 15 (pεK 60 mol% cross-linked 
with octanedioic acid and a density of 0.067 g cm-3), Su 60 14 (pεK 60 mol% 
cross-linked with octanedioic acid and a density of 0.071 g cm-3), Su 60 13 
(pεK 60 mol% cross-linked with octanedioic acid and a density of 0.077 g cm-
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3) and Su 65 15 (pεK 65 mol% cross-linked with octanedioic acid and a 
density of 0.067 g cm-3) were investigated for their mechanical and physical 
properties. 
 
The elastic modulus for hydrogel Su 60 13 was significantly greater than the 
other hydrogels tested. However, optical clarity of this hydrogel was 
compromised as the increased polymer density results in a refractive index of 
1.395. The hydrogel with the next greatest elastic modulus was hydrogel Su 
60 14 which had no significant difference in stress or strain compared to Su 
60 13. It also had a refractive index of 1.390 more closely associated to the 
1.380 of the human cornea (Kim et al., 2004). Similarly, light transmittance 
data measured at 544 nm for Su 60 13 (79%) was much lower than that 
obtained for Su 60 14 (88%) and Su 60 15 (92%) which were more closely 
aligned to the human cornea (90%) (Beems and Van Best, 1990). Hydrogel 
Su 60 14 was chosen as the hydrogel with the greatest mechanical 
properties whilst maintaining an acceptable optical clarity. The elastic 
modulus for all the hydrogels were in the range of 0.31 - 0.73 MPa 
comparable to commercial lens materials whilst maintaining a relatively high 
water content of between 67 - 73% regardless of the polymer composition. 
This may be extremely beneficial in that the mechanical properties may be 
tailored without significantly reducing the water content of the lens. This 
characteristic is important for both oxygen permeability and comfort of the 
lens to the wearer (Guzman-Aranguez, Colligris and Pintor, 2013). Another 
interesting finding was the difference in both water content and refractive 
index of the antimicrobial hydrogels. Su PεK had a higher water content and 
lower refractive index compared to Su Pen G. This may correspond with the 
increased water absorption capacity of Su PεK due to the increased amounts 
of hydrophilic amino groups allowing for an increase in water molecule 
absorption (Leeder and Watt, 1965).  
 
The measurement of oxygen permeability of contact lens materials has 
become more important in recent years with the advent of extended wear 
silicone contact lenses through which silicone becomes the main oxygen 
carrier over water of conventional contact lenses (Efron et al., 2007). An 
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increased understanding of the implications of a decreased oxygen supply to 
the avascular cornea such as hypoxia that can lead to oedema or microbial 
keratitis has also increased the importance of Dk values (Holden and Mertz, 
1984; French, 2005). As the hydrogels in this study were not modified in any 
way to increase oxygen permeability the water content was therefore used to 
determine their Dk values. This may not be the optimal method as there are 
two ISO standard methods for the determination of oxygen permeability of 
contact lens materials (ISO 18369-4:2006). The measurements are taken via 
a polarographic method or the coulometric method. The polarographic 
method was developed by Fatt in the 1970s and is most applicable for the 
measurement of hydrogel lenses with a Dk between 0 - 145 Barrer. The 
coulometric method was developed in the advent of the development of high 
oxygen permeable silicone lenses (Morgan and Efron, 1998; Morgan, 
Brennan and Alvord, 2001).  
 
Realistically, all hydrogel lenses induce some degree of hypoxia to the 
cornea. Hydrogel lenses with lower Dk values (≤ 20 Barrer) cause increased 
oedema and vascularisation with higher Dk value (≥ 20 Barrer) lenses 
causing minimal changes to the cornea (Brennan and Morgan, 2009). The 
theoretical maximum Dk of hydrogels based on a water content of 100% is 
88. However, the hydrogels described in this report have Dk values of 
between 24 - 30 Barrer and are comparable to conventional hydrogel lens 
materials such as omafilcon A (27 Barrer) and lidofilcon A (32 Barrer) 
(Blackmore, 2010).  
 
Wettability measurements are used as a measure of the comfort of a contact 
lens material and is mainly determined by measuring the contact angle via 
the sessile drop, captive bubble or Wilhelmy plate methods (Campbell, 
Carnell and Eden, 2013). Improving wettability has become more important in 
recent years with the increased usage of more hydrophobic silicone lenses. 
These have been improved with the addition of hydrophilic monomers such 
as NVP. The hydrogels described in this report have an average contact 
angle of 30 ° making them highly hydrophilic. A hydrophilic contact lens 
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material ensures tear film stability, improved optical quality and comfort 
(Ketelson, Meadows and Stone, 2005; Keir and Jones, 2013). 
 
 
4.2 Cytocompatibility of Hydrogel Variants In Vitro 
 
The HCE-T cell line was chosen as the ideal candidate for the in vitro 
analysis of cytotoxicity from the hydrogels. A measure of the cytotoxicity was 
important to ensure the hydrogel variants were cytocompatible to human 
corneal epithelial cells in vitro. The HCE-T cell line displays excellent 
morphological and molecular similarities to corneal epithelial cells in vivo 
(Rönkkö et al., 2016). However, as with all cell lines variations in gene 
expression and general cell biology have been observed. Gene expression 
can be either up or down regulated when compared to primary corneal 
epithelial cells with some keratins only expressed by the cell line (Huhtala et 
al., 2003; Rönkkö et al., 2016). 
 
An initial investigation of the interaction of HCE-T cells with hydrogel Su 60 
14 determined there was no negative impact of direct contact on cells 
cultured directly underneath the hydrogel. However, when HCE-T cells were 
seeded on top of the hydrogel they remained spherical and failed to adhere. 
The hydrogels described in this report have an average contact angle of 30 ° 
making them too hydrophilic for optimal cell attachment. A material that does 
not promote cell adhesion may be more suitable as a bandage lens applied 
to a healing corneal epithelium. An optimal contact angle for cell adhesion 
has been suggested to be between 40 - 70 ° for a range of cell types with 
materials outside this range generally too hydrophobic or too hydrophilic 
(Figure 4.1) to allow optimal cell adherence (Wachem et al., 1987; Tamada 
and Ikada, 1993; Dowling et al., 2011). ECM protein deposition on hydrophilic 
materials results in loosely attached proteins due to the polar and highly 
charged surface of the material and protein attraction to the surrounding 
water molecules. Hydrophobic surfaces are more favourable to protein 
deposition via hydrophobic interactions, however, the attractions can be 
irreversible resulting in the denaturation and loss of bioactivity of the protein 
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that ultimately results in less cell adhesion (Guney et al., 2013). Many other 
factors affect cell adhesion to materials including surface functionality, 
surface topography, mechanical properties and the behaviour of the 
particular cell type investigated, however, material hydrophilicity is still 
identified as the most prominent factor (Chang and Wang, 2011). 
 
 
 
 
 
 
4.2.1 Unmodified hydrogel Su 60 14: 
An indirect cytotoxicity assay was carried out to determine if any leachable 
from the hydrogel Su 60 14 influenced HCE-T cells in vitro. Over the period 
of an 8 day culture no significant effects to cell viability was observed when 
compared to the control. This suggests that leachables from the hydrogel are 
non-cytotoxic to the HCE-T cell line and provided the initiative to investigate 
what effects direct contact may have on HCE-T cell behaviour. 
 
Figure 4.1: A general representation of mammalian cell adherence in relation to the 
contact angle of a material. 
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A scratch assay was used to determine the rate of re-epithelialisation of a 
HCE-T cell monolayer when in direct contact underneath the hydrogel 
material. Most scratch wounds with the hydrogel present had closed by 23 h. 
This was also true of the control and no significant difference was observed 
in scratch wound closure rates when quantified with TScratch software. The 
scratch wound closure rate is comparable with HCE-T cell scratch wound 
closure rates of 24 h stated in the literature (Movahedan et al., 2012; Hou et 
al., 2013). This suggests the Su 60 14 hydrogel does not inhibit HCE-T cell 
re-epithelialisation when in direct contact. The rate of wound healing is of 
great importance when considering a bandage lens material ensuring an 
unhindered healing process and less discomfort for the patient from the 
protective barrier it provides (Grentzelos et al., 2009). 
 
A more in-depth investigation of the closed scratch assays via 
immunofluorescence staining was undertaken. A reformed epithelial 
monolayer should stain positive for tight junction proteins between cells. Tight 
junction proteins are made up of a family of transmembrane and membrane 
associated proteins that regulate cell to cell contact and the functioning of the 
epithelial barrier (Figure 4.2). ZO-1 is a 220 kDa cytoplasmic protein that is 
associated with the membrane and involved in the formation of tight junctions 
that are expressed around the cell membrane when a cell monolayer is intact 
and the epithelial barrier functioning. ZO-1 is located within the superficial 
layer of the corneal epithelium and has also been implicated in cell signalling 
during proliferation and differentiation (Ko, Yanai and Nishida, 2009; Chen et 
al., 2012). Occludin is a 65 kDa transmembrane protein and along with 
claudin and junction adhesion molecules is directly involved in the formation 
of tight junctions. Short adhesive strands of the proteins help form the 
paracellular barrier and mediate the transfer of ions and small molecules 
(Ryeom, Paul and Goodenough, 2000; Cummins, 2012; Fanning and 
Anderson, 2013). A compromised corneal epithelial barrier may result in a 
route of infection. Specifically staining for these tight junction proteins 
identifies whether the epithelial barrier function of the reformed monolayers 
are physically compromised in any way (Chen et al., 2012). Strong ZO-1 and 
occludin fluorescence signals were obtained for each of the different samples 
 DISCUSSION 171 
 
of closed scratch wounds. This suggested that the presence of the hydrogel 
had no adverse effect on the reformation of a HCE-T cell monolayer. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Keratins are water insoluble proteins that form intermediate filaments in most 
epithelial cells. Staining for keratins is often used as an epithelial cell marker. 
The 10 nm diameter intermediate filaments provide the structural framework 
to the cell cytoplasm of mammalian cells. Over 50 keratins have been 
discovered in the last 30 years and are divided into two groups, type I (acidic) 
and type II (basic) (Schermer and Galvin, 1986; Karantza, 2011; Merjava et 
al., 2011). Of these, keratin 3 and 12 are specific to the cornea and often 
found as a dimer (Huhtala et al., 2003; Coutinho et al., 2011). In a previous 
study the HCE-T cell line was found to express keratins 3, 7, 8, 18 and 19. 
Keratins 7, 8 and 19  not normally found in the cornea and more specific to 
Figure 4.2: Location and interaction of cell adhesion proteins investigated with 
immunofluorescence staining on HCE-T cells. 
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simple epithelial cells were also identified in the HCE-T cell line (Huhtala et 
al., 2003). In this study keratins 8 and 18 were identified by staining with the 
antibodies pan cytokeratin (anti-keratins 4, 5, 6, 8, 10, 13 and 18) and 
cytokeratin MNF116 (anti-keratins 1, 2, 3, 4, 5, 6, 7 and 8) and confirmed the 
identity of the cells in this report as cells of an epithelial lineage.  
 
These data coupled with data for scratch wound closure and cytotoxicity 
suggest that the hydrogel has no negative effects on HCE-T cells in vitro, 
suggesting it is cytocompatible with this cell type. However, conventional 
bandage lens materials are evolving and more research is focussing on the 
inclusion of a drug delivery capacity to help prevent or aid the treatment of 
ocular infections. 
 
4.2.2 Hydrogels with biomolecules associated: 
A repeat of the cytocompatibility tests on the hydrogels after the association 
of antimicrobials highlighted several novel insights. Minor cytotoxicity arising 
from the covalent attachment of pεK (Su Pεk) and the ionic association of 
penicillin G (Su Pen G) to the hydrogels was observed after 24 h in culture 
and may be due to pH changes in the media from biomolecule elution or 
insufficient neutralisation of salts associated with the hydrogels. To highlight 
this, a hydrogel soaked in x10 PBS (Su PεK PO4) to associate phosphate salt 
with the amine groups showed the most cytotoxicity and was evident after 
only 2 h. This toxicity was most likely due to the phosphate salt leaching from 
the hydrogel into cell culture media. Consideration of the effect of hydrogel-
associated molecules may be necessary with extra neutralisation steps a 
possible requirement prior to cell culture. A repeat of the HCE-T scratch 
assay and ZO-1 staining found no difference in re-epithelialisation when Su 
PεK and Su Pen G hydrogels were present compared with the Su 60 14 
hydrogel and tissue culture plastic control. ZO-1 staining was evident for all 
the hydrogels, except with Su PεK PO4 where no monolayer was present and 
almost all cells were detached after 23 h. The toxicity observed after 24 h 
from Su PεK and Su Pen G hydrogels may not have a negative impact in vivo 
as the natural flushing mechanism associated with blinking would maintain 
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the tear film turnover surrounding the cornea epithelium (Wong, Wan and 
Kaye, 2002). 
 
The non-covalent association of AmpB with hydrogel Su 65 15 and the BAC 
peptides with hydrogel Su 60 14 COOH were investigated for cytotoxicity to 
the HCE-T cell line. All the modified hydrogels were non-cytotoxic towards 
the HCE-T cell line compared to the no material control. Further investigation 
(scratch assay or antibody staining) of these hydrogels was deemed 
unnecessary as no negative impact on HCE-T cell viability was observed and 
the cytocompatibility of the unmodified Su 60 14 and Su PεK and Su Pen G 
were already well characterised. 
 
 
4.3 Efficacy of Hydrogel Variants against a Model of Bacterial Keratitis 
 
Model strains of both Gram-positive (S. aureus Newman) and Gram-negative 
(E. coli MC1061) bacteria were chosen as candidates to examine the 
antibacterial affect from the hydrogels as wild type strains of both organisms 
are implicated in bacterial keratitis (Rhem et al., 2000; Ferrari et al., 2009; 
Karsten, Watson and Foster, 2012). However, the prevalent organism 
implicated in bacterial keratitis can vary over time and depending on 
geographical location (Orlans, Hornby and Bowler, 2011). Both organisms 
are identified as susceptible to the model antibiotic used in this part of the 
study, penicillin G (Korsak, Liebscher and Vollmer, 2005; Baba et al., 2008). 
PεK is well documented as having an efficacy against a broad range of 
microbes due to the polycationic nature of the molecule with an MIC of 12.5 
μg cm-3 against both E. coli and S. aureus (Shima et al., 1984; Hyldgaard et 
al., 2014; Li et al., 2014). 
 
4.3.1 Antimicrobial activity from hydrogel cross-link variants: 
An investigation of antibacterial activity from hydrogels with varying amounts 
of amine groups available in the polymer backbone was undertaken. The 
cross-link density of the hydrogel (Su 60 14) was either increased to 75% (Su 
75 14) or reduced to 45% (Su 45 14) to change the number of free amine 
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functional groups that contribute towards antimicrobial activity. The metabolic 
activity of the S. aureus was measured with a resazurin assay. There was 
approximately 40% less resazurin reduction for all hydrogels after 4 h and 18 
h when compared with the LB agar control. However, there was no significant 
difference in resazurin reduction when comparing hydrogels of different 
cross-link densities. These data suggest there may not be enough difference 
between the amounts of free amino group’s side-by-side within the polymer 
backbone to make a significant difference to antimicrobial activity evident 
between the three hydrogels with differing cross-link densities. This outcome 
may correlate with the 100-fold decrease in antimicrobial activity that pεK, 
with < 9 lysine residues has when compared with longer chain oligomers 
(Shima et al., 1984; Yoshida and Nagasawa, 2003).  
 
4.3.2 Antimicrobial activity from hydrogels with biomolecules: 
PεK was covalently attached to the hydrogel post-polymerisation as longer 
chains to test the hypothesis that longer chain oligomers of pεK would have a 
greater antimicrobial activity than shorter chain oligomers found in the 
polymer backbone of the hydrogel cross-link variants. Following a methyl 
orange assay, it was determined that a 12-fold increase in amine groups was 
achieved after pεK attachment. Minimal reduction of resazurin was observed 
for both S. aureus and E. coli in the presence of the Su PεK hydrogel at the 2 
h and 4 h time-points and only a minor resazurin reduction at the 18 h time-
point for both S. aureus (3%) and E. coli (5%). The unmodified hydrogel 
performed marginally better than the LB agar control at the 2 h and 4 h time-
points with both bacteria. After 18 h the resazurin reduction by both bacteria 
in the presence of Su PεK was approximately half of that of the LB agar 
control. These data suggest that the increased amount of amine groups have 
a positive impact on the antibacterial activity of the hydrogel. 
 
A more detailed investigation into improving the antimicrobial activity of the 
hydrogel by either the ionic attachment of penicillin G or the covalent 
attachment of pεK was undertaken with focus on S. aureus as the model 
pathogen. Immediately after penicillin G attachment an elution study 
determined that release from hydrogel Su Pen G occurred over 5 h but an 
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initial burst release profile (Figure 4.3) was observed over the first 30 min. 
The burst release of compounds from drug delivery hydrogels is a common 
phenomenon when no specific modifications are made to control drug 
release (Huang and Brazel, 2001; Hoare and Kohane, 2008). However, a 
burst release is not ideal due to possible toxic concentrations of drugs 
released immediately followed by less than therapeutic amounts. Commercial 
considerations are also commonly involved as wastage of valuable drugs is 
not commercially viable and a lack of controlled release may result in 
performance inconsistencies that could result in regulatory problems 
(Omidian et al., 2012). Some examples of methods used to control drug 
release include a layer by layer technique to incorporate ciprofloxacin in a 
pHEMA hydrogel and resulted in zero order release of the drug over 4 weeks 
or the incorporation of nanoparticles loaded with lidocaine incorporated into a 
pHEMA hydrogel that resulted in controlled release of the drug over a few 
days (Gulsen and Chauhan, 2004; Ciolino et al., 2009). Possibilities to 
control drug release from hydrogel Su Pen G could include penicillin G 
loaded microparticles of the hydrogel that could be incorporated into the 
polymer mix prior to polymerisation. These may provide a two-stage release 
of the drug with a slower release of penicillin G from the microparticles 
following the initial burst release from the hydrogel matrix. Another example 
could include multiple dosing of the hydrogel by adding topical drops of the 
drug to the hydrogel at set time-points. The difficulty with this method is that 
the drug may reach below therapeutic levels during the dosing regimen 
coupled with spikes in drug concentrations following replenishing the 
hydrogel with topical drops (Omidian et al., 2012). 
 
The subsequent antimicrobial activity was assessed against both planktonic 
and attached S. aureus on the Su PεK and Su Pen G hydrogels. The assay 
of planktonic S. aureus revealed the greatest log reduction of 2.8 was 
observed from Su Pen G which may be explained from the fact that penicillin 
G was attached ionically and therefore becomes more bioavailable in the 
culture media when it’s released from the hydrogel thereby having a greater 
effect than Su PεK on planktonic bacteria. Activity towards S. aureus 
attached to hydrogel Su PεK revealed the greatest log reduction of 2.3. This 
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may be due to the covalent attachment of cationic pεK to the hydrogel 
promoting interaction with the net negative charge of S. aureus at the 
hydrogel surface. The covalent attachment of antimicrobial components to 
biomaterials for the prevention of biofilm formation and increased 
antibacterial activity has been well described. These range from synthetic 
and natural coatings such as pHEMA and chitosan to AMPs such as 
melimine (Rasul et al., 2010; Costa et al., 2011; Dutta et al., 2013). 
 
 
 
 
 
4.3.3 Bacteria viability and morphology: 
Propidium iodide staining of S. aureus attached to the surface of the 
hydrogels revealed that the bacteria were arranged as singular cocci where 
they were attached to Su PεK as opposed to the other hydrogel surfaces 
where their eponymous clustered growth conformation was observed. The 
expected electrostatic interaction between the negatively-charged S. aureus 
surface and the highly cationic Su PεK hydrogel may be strong enough with 
this species to disrupt growth compared with other microbes (Haaber et al., 
2012). This interaction disrupts aggregation, biofilm formation and disrupts 
the integrity of the cell wall leaving the microbes more susceptible to 
antimicrobial agents (Figure 4.4) (Hall-Stoodley, Costerton and Stoodley, 
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Figure 4.3: Typical drug release profiles observed from drug delivery devices. Line ----- 
denotes the therapeutic dose for the drug. 
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2004; Hyldgaard et al., 2014). Further staining with LIVE/DEAD® BacLight™ 
of S. aureus retrieved from the hydrogel supports the conformational 
differences previously observed with the propidium iodide staining. There 
was also confirmation of significantly greater S. aureus death when in contact 
with both the Su PεK and Su Pen G hydrogels compared with the unmodified 
Su 60 14 hydrogel, underpinning an increased antimicrobial activity after 
biomolecule attachment.  
 
 
  
 
 
 
 
 
 
 
 
 
 
This study demonstrates the effectiveness of antimicrobials that can either be 
attached via covalent bonding or electrostatic attachment to the amine 
groups and therefore should work for other more clinically relevant 
Figure 4.4: Schematic illustration of the proposed mechanism of action of pεK against 
bacteria. (A) Untreated cell wall with intact outer membrane (OM), peptidoglycan 
layer (PG), and inner membrane (IM), (B) electrostatic forces between pεK and LPS 
results in LPS layer removal, (C) pεK could interact with the peptidoglycan layer or move 
through the peptidoglycan layer and interact electrostatically with the 
inner membrane, thereby initiating the nonspecific carpet-like mechanism, (D) when pεK 
reaches a threshold concentration on the inner membrane, it enforces 
the negative curvature of one (dashed line at lower leaflet) or both (solid line at lower 
leaflet) leaflets of the membrane, (E) pεK thins the membrane, (F) a hole in the inner 
membrane allows pεK access to the cytoplasm where it can cause further damage.  
Figure adapted from Hyldgaard et al., 2014 and reproduced with permission from the 
American Society of Microbiology. 
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antimicrobials with these properties. Other agents may possibly be 
incorporated and released via dissolution in the aqueous phase of the 
hydrogel. 
 
 
4.4 Efficacy of AmpB Loaded Hydrogels against a Fungal Keratitis 
Model 
 
Wild-type C. albicans strain SC5314 was used to model a fungal keratitis 
infection as it is the most prevalent fungus in temperate climates and the 
particular strain is the most well studied strain of Candida (Thomas and 
Kaliamurthy, 2013). A hydrogel lens material was produced with a 60% 
cross-link density and a polymer density of 0.07 g cm-3 (Su 60 15). Like 
hydrogel Su 60 14 it has a positive charge due to the remaining uncross-
linked amine groups within the polymer matrix. After synthesis, the amine 
groups were associated with Cl- ions that could hinder their interaction with 
potential drug molecules. It was demonstrated that a post-synthesis 
treatment with NMM removed the Cl- ions via neutralisation. AmpB was used 
as the antifungal agent given that it is the first-line choice against C. albicans 
(Singh, 2015) and has a carboxyl group which can promote attachment of the 
drug molecule to the free amine groups on hydrogel Su 60 15 (Baginski and 
Czub, 2009). 
 
4.4.1 Antifungal capacity of the AmpB loaded hydrogel:  
An MIC was obtained for AmpB to determine its efficacy against C. albicans 
SC5314 in vitro. The MIC was found to be between 0.094 and 0.188 μg cm-3 
against C. albicans cultured in both PD and PD with 10% horse serum and 
correlates with MIC data for ocular isolates from the literature of 0.06 - 1 µg 
cm-3 (Monte Mascaro et al., 2003; Therese et al., 2006). A concentration of 
AmpB well above the MIC is necessary to ensure adequate dosing to the 
cornea considering that ≤ 7% reaches the target tissues. Using serial 
dilutions of the stock AmpB solution we demonstrated that AmpB 
incorporated into the hydrogels significantly reduced the growth of C. 
albicans compared to no AmpB independent of the solution concentration 
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over 18 h. Generally, both -NH3Cl and -NH2 hydrogels pre-incubated in Amp 
B and cultured under both normal growth conditions and when the PD was 
supplemented with 10% horse serum had a similar efficacy to C. albicans.  
When the hydrogels themselves were evaluated it was clear that there were 
no viable fungi on the -NH2 hydrogels or removed by the washing step 
whereas, viable fungi could be recovered from -NH3Cl hydrogels. This 
suggests, as anticipated more AmpB attaches to -NH2 hydrogels than the -
NH3Cl hydrogels confirming that the removal of hydrochloride via 
neutralisation allows more AmpB to interact electrostatically with the free 
amine groups of the hydrogel. Once the hydrogels had been removed from 
the wells it was important to evaluate if any fungi remaining could proliferate 
even if growth was low when the hydrogels were present. This could model 
the situation where the medicated lens was removed from the eye without 
knowing if all the infection had been removed. Over the subsequent 24 h very 
little fungal growth was observed in the well that had contained the -NH2 
hydrogels whereas the few fungi remaining after removal of the -NH3Cl 
hydrogels could proliferate. These data show that the concentration of AmpB 
attached to, and released from, the -NH2 hydrogels is fungicidal, whereas the 
amount of AmpB delivered from the -NH3Cl hydrogels is fungistatic.   
 
4.4.2 Elution and stability of AmpB: 
It is important to evaluate how much AmpB diffuses out of the hydrogels over 
time to help optimize the drug loading regime. It was determined that after 
storage for all time-points the -NH2 hydrogel released a clinically relevant 
dose of AmpB for 72 h, only falling below the MIC after 96 h. The -NH3Cl 
hydrogel released a clinically relevant dose for the first 24 h but reduced to 
the MIC threshold after 48 h. The -NH2 hydrogel released a significantly 
greater dose than the -NH3Cl hydrogel at each time-point analysed. These 
data demonstrate that the -NH2 hydrogels are more effective at delivering a 
clinically relevant dose of AmpB than the -NH3Cl hydrogels. Furthermore, it 
was demonstrated that the dose of AmpB delivered by the -NH2 hydrogel 
was stable enough after 48 h storage to kill C. albicans with a similar efficacy 
as a hydrogel used immediately after pre-incubation in AmpB. Effective 
treatment of fungal keratitis will require the bandage contact lens to maintain 
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the level of AmpB against the cornea at a therapeutic level to promote 
penetration of the drug into the corneal stroma. These data suggest that the -
NH2 hydrogel may be more effective at this than the -NH3Cl hydrogel. 
 
 
4.5 Early Detection of Pathogens Implicated in Microbial Keratitis 
 
Development of a bandage contact lens that can distinguish between Gram-
positive and Gram-negative bacteria by fluorescent labelling could provide a 
vital rapid detection tool for keratitis and improve early diagnosis. It would 
allow for a more accurate determination of which class of antibiotic may be 
required for treatment without having to wait several days for the culture 
analysis from corneal scrapes to become available. Hydrogel Su 60 14 was 
modified to change the amine functionality of the polymer backbone to a 
carboxyl moiety (Su 60 14 COOH) enabling attachment of amine functional 
AMPs. The AMPs (BAC ONE and BAC TWO) have an NBD fluorophore 
attached that is environmentally sensitive and fluoresces in hydrophobic 
environments such as cell membranes (Figure 4.5). The carboxyl 
modification of the hydrogel was confirmed both qualitatively by ninhydrin 
staining for primary amine groups followed by a quantitative analysis of 
amine functional groups via a methyl orange assay. It was determined that 
there were 60% more amine groups on the unmodified Su 60 14 hydrogel 
compared to the modified Su 60 14 COOH hydrogel. The reduction in amine 
groups is a direct consequence of the reaction of glutaric anhydride with the 
amine functional group in the polymer backbone resulting in a carboxyl 
moiety. 
 
4.5.1 Hydrogel/BAC peptide evaluation: 
The BAC ONE peptide is based on a fragment (residues 29 - 41) of the 59-
residue cytoplasmic peptide ubiquicidin and has an affinity for both Gram-
positive and Gram-negative organisms due to its cationic nature. Ubiquicidin 
binds non-specifically to both anionic lipids (Gram-negative) and teichoic 
acids (Gram-positive) allowing the NBD fluorophore to label both types of 
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bacteria (Akhtar et al., 2005; Wiesner and Vilcinskas, 2010; Akram et al., 
2015).  
 
The modified hydrogel was incubated with a range of concentrations (0 - 40 
μM) of BAC ONE peptide to test its efficacy when associated with the 
hydrogel. The result of the fluorescence intensity assay suggests that at the 
greatest incubation concentration (40 μM) a statistically greater signal was 
obtained from the hydrogel and BAC ONE when cultured with either E. coli or 
S. aureus compared to the hydrogel and BAC ONE alone. A similar result 
was observed with the BAC ONE peptide alone present. These data suggest 
that the fluorescence obtained is directly related to the bacteria in the assay 
that have been labelled with BAC ONE. The fluorescent intensity obtained for 
E. coli was much greater than that obtained for S. aureus when incubated 
with the hydrogel and BAC ONE or BAC ONE alone. This is in direct 
contradiction to the FITC images where E. coli was much harder to detect 
than S. aureus. One possibility for this is in the difference in planktonic 
growth characteristics of both organisms. S. aureus are cocci and tend to 
form grape-like clusters of 5 - 20 cells whereas E. coli are generally non-
cluster forming bacteria unless under conditions of stress (Koyama, Yamada 
and Matsuhashi, 1977; Novo et al., 1995; Mittal et al., 2003; Haaber et al., 
2012). The larger clusters of S. aureus may make fluorescence more obvious 
from micrographs and singular but more ubiquitous E. coli harder to 
distinguish from background fluorescence. The fluorescence intensity data 
confirmed that BAC ONE associated with the hydrogel labels both Gram-
positive and Gram-negative organisms used in this study. However, this was 
not confirmed by the FITC fluorescent images. The use of a confocal 
microscope to observe fluorescence may help to minimise any background 
fluorescence and allow E. coli to be more easily observed. 
 
The BAC TWO peptide used in this study is a derivative of polymyxin B. 
Polymyxin B is a pentacationic cyclic lipopeptide AMP that has been found to 
be nephrotoxic. Several derivatives of polymyxin B have been designed, 
such as BAC TWO, which replace some of the cationic groups on the linear 
part of the peptide with neutral compounds. These derivatives have been 
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found to be less nephrotoxic and more suitable candidates as antimicrobial 
agents (Mingeot-Leclercq et al., 2012; Vaara, 2013). Polymyxin B binds 
specifically to lipid A of LPS found in the outer membrane of Gram-negative 
bacteria forming a stable complex that is stoichiometric with one molecule of 
polymyxin B binding to one molecule of lipid A (Morrison and Jacobs, 1976).  
 
The modified hydrogel was incubated with a range of concentrations (0 - 40 
μM) of BAC TWO peptide to test its efficacy when associated with the 
hydrogel. The fluorescence quantification results showed that at the greater 
incubation concentration (40 μM) a statistically greater fluorescent signal was 
obtained from labelled E. coli when compared to the S. aureus and no 
peptide controls. This was confirmed with the FITC fluorescent images as 
more labelled E. coli were observed at the greater incubation concentration 
(40 μM) as well as some labelling at 20 and 10 μM when incubated with the 
hydrogel and BAC TWO. No fluorescence was observed when the hydrogel 
and BAC TWO was incubated with S. aureus or with no organism present 
across all the incubation concentrations tested. This result highlights the 
specific affinity of BAC TWO for Gram-negative organisms with both the 
fluorescence intensity data and FITC images confirming it. 
 
A direct comparison between the BAC peptides associated with the hydrogel 
and BAC peptides alone when incubated with bacteria is, however, not a like 
for like comparison. The BAC peptide concentration used in this study was 
the actual concentration of the peptide solution whereas the concentration of 
BAC peptide associated with the hydrogel was not determined and only the 
concentration of the incubation solution to which the hydrogel was immersed 
was used. The actual concentration of BAC peptides associated with the 
hydrogels may be lower and this appears to be reflected in the fluorescent 
intensity results. The BAC peptide alone gives a greater fluorescent result 
over any of the hydrogels with BAC peptide associated. However, other 
factors such as peptide hindrance within the hydrogel matrix may prevent 
optimal fluorescent signals being obtained. 
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The stability of the fluorescence from the NBD fluorophore was investigated 
as it may become a limiting factor in the length of time the hydrogel and BAC 
peptide system can be applied to the cornea for appropriate detection of 
microbial pathogens. The BAC ONE peptide associated with the hydrogel 
was stable for at least 21 h of incubation with S. aureus at 37 °C across all 
incubation concentrations investigated. Therefore, the stability of the BAC 
ONE peptide in situ for 21 h should be more than sufficient to allow for 
maximum labelling of bacterial pathogens in ocular disease. The BAC TWO 
peptide associated with the hydrogel was less stable than BAC ONE. It was 
stable for up to 4 h incubation with E. coli at 37 °C but at 21 h the 
fluorescence was significantly reduced at 20 and 40 μM incubation 
concentrations. The stability of the BAC TWO peptide in situ for 4 h and the 
fact a signal was observed < 30 min from incubation should still be sufficient 
to allow for maximum labelling of bacterial pathogens in ocular disease as 
part of a rapid detection system. 
 
 
 
 
 
 
 
 
Figure 4.5: Bacteria outer membrane composition with targets for BAC peptides 
highlighted. 
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4.5.2 Investigation of mammalian cell staining from BAC peptides: 
The labelling of non-specific cell types may not be optimal as a tool in the 
identification of specific pathogens involved in microbial keratitis. An 
emphasis was placed on the non-specific labelling of HCE-T cells in a co-
culture with bacteria. There was evidence of some non-specific staining of 
HCE-T cells when the hydrogel and BAC ONE were incubated in the co-
culture system. However, the fluorescence observed from S. aureus was 
prominent enough to be able to identify the pathogen in the co-culture. When 
the BAC TWO peptide modified hydrogels were incubated with a confluent 
culture of human corneal epithelial cells there was no evidence of fluorescent 
labelling of mammalian cells. A fluorescent signal was observed immediately 
upon addition of E. coli to the cell culture. The signal was directly associated 
with the microbes and gave confidence of the specificity of BAC TWO 
peptides towards E. coli when in contact corneal epithelial cells. Cationic 
AMPs such as BAC ONE and BAC TWO are initially attracted to the acidic 
phospholipids and teichoic acids on the bacterial cell wall. They then 
penetrate the wall with a hydrophobic tail resulting in the activation of the 
NBD fluorescence due to the hydrophobicity of the surrounding environment. 
The membrane surrounding mammalian cells have zwitterionic phospholipids 
present with no net negative charge that help to repel cationic molecules and 
as a result prevent toxicity (LaRock and Nizet, 2015). However, the presence 
of some anionic groups such as sialic acid, acidic amino acids and 
phosphate or sulphate groups present on the mammalian cell membrane 
may still promote non-specific binding as may have been the case for the 
less specific binding arrangement of BAC ONE against HCE-T cells 
(Crawford, 1987). 
 
4.5.3 Efficacy of hydrogel/BAC peptide system against an ex vivo model of 
bacterial keratitis:  
The ex vivo model was setup to try and replicate the in vitro results in a more 
appropriate model of bacterial keratitis. No unexpected results were 
observed from both BAC ONE and BAC TWO when associated with the 
hydrogel compared to the in vitro testing of the same materials. The hydrogel 
and BAC ONE and BAC ONE alone labelled S. aureus whilst the hydrogel 
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and BAC TWO and BAC TWO alone labelled E. coli. The only major 
difference observed from the in vitro testing was the conformation of bacteria 
on the hydrogel after removal from the ex vivo model. More clumped material 
was retrieved, possibly due to biofilm formation on the ex vivo model 
compared to the culture of planktonic bacteria in vitro. Staining was still 
evident but less was observed from clumps of bacteria in the ex vivo model 
compared to the more unicellular and ubiquitous bacteria in vitro. This 
provides further evidence of the efficacy of the peptides in identifying Gram-
positive and Gram-negative bacteria when associated with Su 60 14 COOH 
and may lead to testing the BAC peptide/hydrogel systems in an in vivo 
animal model. 
 
The BAC peptide/hydrogel system described here can be used to identify 
Gram-positive and Gram-negative organisms both microscopically and 
spectrophotometrically almost immediately after incubation with minimal 
toxicity observed in in vitro studies. This could provide a rapid, cost effective 
and less invasive technique to current methods that require corneal scrapes 
to retrieve culture specimens and long culture times to confirm pathogen 
identity. This technology may be of most use in developing countries where 
proximity to treatment centres and patient compliance are barriers to 
delivering the correct treatment regimen (Yoltan, 2001). 
 
A possible application of this system could involve a combination of both 
peptides associated with the hydrogel with different fluorophores and placed 
on an infected cornea. If isolates only stain for BAC TWO it would indicate 
only Gram-negative organisms are present. If both BAC ONE and BAC TWO 
fluorophores are excited, it would suggest a mixed colony of Gram-negative 
and Gram-positive organisms or only Gram-positive organisms are present. If 
no fluorescence is detected from either BAC peptide, then the indications 
could suggest that the keratitis is not of bacterial origin. This may be followed 
by a quick microscopic evaluation of the optically transparent hydrogel or 
periodic acid Schiff or Gomori methenamine silver staining techniques to 
identify evidence of fungal keratitis (Thomas, 2003). As is the case with most 
infections a mix of isolates are often present and can account for up to a third 
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of total cases of keratitis, in which case a measure of the fluorescence may 
determine the most prominent organism and treatment could be directed per 
the results (Tuft, 2006; Al-Mujaini et al., 2009). This may be followed with 
soaking the hydrogel in the most appropriate or in some cases of 
misdiagnosis, the correct antibiotic and applying it to the cornea thereby 
allowing patients to return to their communities and continue treatment at 
home with good compliance. All of this may be possible in the field, with 
specific reference to primary eye care centres in India, as only minimal 
equipment such as a microscope with fluorescent filters for direct observation 
of BAC peptides or a spectrophotometer for fluorescence quantification 
would be required. 
 
 
4.6 Adherence to the Principles of Green Chemistry: 
 
Some of the fundamental principles that underlie research and development 
of the hydrogel include the need for the process to be economical, the 
materials are non-animal derived and the principles of green chemistry are 
adhered to as much as possible. These principles are to ensure any product 
is commercially viable for SpheriTech Ltd. 
 
The relatively new field of green chemistry was developed in the 1990s with 
focus on designing chemical processes that minimise the production of 
harmful by-products and reduce the carbon footprint whilst maintaining an 
economical process. The primary motivation for the development of green 
chemistry was the increasing inefficiency of large scale industrial processes. 
The amount of chemical waste from these processes can be 5 - 100 times 
greater than the chemical or pharmaceutical end-products (Li and Trost, 
2008). Green chemistry is based on 12 principles and 11 of which have been 
addressed by the hydrogel polymerisation process in this report with number 
11 deemed unnecessary due to the lack of hazardous substance formation 
(Table 4.1). The design of the polymer reaction ensures all reactants are 
completely used and minimal waste is generated apart from non-toxic by-
products such as urea which is regarded as GRAS by the FDA and 
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reconstituted NHS (Anastas and Kirchhoff, 2002; Andersen, 2005; 
Hermanson, 2013b; Klykov and Weller, 2015). 
 
 
1. Prevention: It is better to prevent waste than to treat or clean up waste after it is 
formed 
2. Atom economy: Synthetic methods should be designed to maximize the 
incorporation of all materials used in the process into the final product 
3. Less hazardous chemical synthesis: Wherever practicable, synthetic methods 
should be designed to use and generate substances that possess little or no toxicity 
to human health and the environment 
4. Designing safer chemicals: Chemical products should be designed to affect their 
desired function while minimising their toxicity 
5. Safer solvents and auxiliaries: The use of auxiliary substances (e.g., solvents, 
separation agents, etc.) should be made unnecessary wherever possible and 
innocuous when used 
6. Design for energy efficiency: Energy requirements of chemical processes should 
be recognised for their environmental and economic impacts and should be 
minimised. If possible, synthetic methods should be conducted at ambient 
temperature and pressure 
7. Use of renewable feedstocks: A raw material or feedstock should be renewable 
rather than depleting whenever technically and economically practicable 
8. Reduce derivatives: Unnecessary derivatization (use of blocking groups, 
protection/deprotection, temporary modification of physical/chemical processes) 
should be minimised or avoided if possible, because such steps require additional 
reagents and can generate waste 
9. Catalysis: Catalytic reagents (as selective as possible) are superior to stoichiometric 
reagents 
10. Design for degradation: Chemical products should be designed so that at the end 
of their function they break down into innocuous degradation products and do not 
persist in the environment 
11. Real-time analysis for pollution prevention: Analytical methodologies need to be 
further developed to allow for real-time, in-process monitoring and control prior to the 
formation of hazardous substances 
12. Inherently safer chemistry for accident prevention: Substances and the form of 
a substance used in a chemical process should be chosen to minimise the potential 
for chemical accidents, including releases, explosions, and fires 
 
 
 
 
Short reaction times at room temperature combined with the use of a 
renewable feedstock such as pεK from microbial fermentation and bis-
carboxylic acids from plants help to reduce the energy impacts of the 
process. Currently, heat or UV sources are required to create free radicals for 
Table 4.1: The 12 principles of green chemistry. Adapted from Anastas and Eghbali, 
2010. 
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addition polymerisation used in the contact lens industry which have an 
environmental and economic impact (Maldonado-Codina, 2018). The 
polymerisation of pεK is carried out in water at room temperature. Water is 
the solvent used in the subsequent washing process for the hydrogels 
investigated in this study and is optimal due to the reduced environmental 
impact. Currently, hydrogel lens manufacture requires an extraction step with 
organic solvents to remove unreacted monomers which increases production 
costs and decreases efficiency (Ashton Acton, 2013). The use of NHS as the 
activation agent instead of explosive reagents such as HOBt also help to 
reduce risk (Anastas and Kirchhoff, 2002; Anastas and Eghbali, 2010). These 
hydrogels can be manufactured reproducibly and in an environmentally 
friendly way since they gel from aqueous solutions at room temperature 
requiring no harsh solvents such as those used in the production of silicone 
hydrogel contact lenses.  
 
Another aspect of green chemistry focusses on the degradation products and 
their potential environmental impact. Degradation has already been 
described as an important aspect of contact lens wear as long term 
degradation can lead to discomfort, reduced vision and signs of adverse 
ocular reactions (Tanner and Efron, 2018). The results of the degradation 
study in this report suggest that the hydrogel when stored under optimal 
conditions in storage media remains stable for at least 12 months with 
minimal physical signs of degradation. However, once degradation occurs it 
would result in the breakup of the polymer into lysine, pεK, bis-carboxylic 
acids or a mixture of both depending upon the affinity of proteolytic enzymes 
to cleaving the amide within pεK itself or the amide between pεK and bis-
carboxylic acids. Trypsin, secreted from the pancreas is one proteolytic 
enzyme known to have a specific affinity for cleaving the C-terminal of both 
lysine and arginine (Inagami and Mitsuda, 1964; Olsen, Ong and Mann, 
2004). However, to date the only known protease to cleave pεK is found in 
microbes that produce pεK as a defence mechanism with no studies on the 
degradation of pεK in vivo recorded. Hypothetically and based upon the 
mechanism of the pεK degrading enzyme, further proteolytic degradation of 
pεK would result in cleavage of individual molecules of the essential amino 
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acid L-lysine resulting in its absorption or excretion from the body (Yoshida 
and Nagasawa, 2003; Yamanaka et al., 2010; Yoshida, 2010). Bis-carboxylic 
acids are β-oxidised by the mitochondria and peroxisomes or pass through 
the body and are excreted in urine (Kølvraa and Gregersen, 1986; Jin and 
Tserng, 1990; Grego and Mingrone, 1995; Houten et al., 2012). The final 
degradation products (pεK/L-lysine and bis-carboxylic acids) are non-toxic, 
however, whether the process of degradation of the hydrogel in this study 
invokes an inflammatory response, foreign body reaction or injury as 
observed for other biomaterials is unknown (Anderson, 2001). 
 
Control of the rate of degradation could occur by the addition of other 
molecules that change the nature of the hydrogel cross-linking. This may be 
used to increase or decrease the rate of degradation. An example of this may 
be the addition of L-cysteine to the polymerisation which may result in the 
formation of the dimer molecule cystine and the introduction of weak 
disulphide bridges within the polymer backbone. These disulphide bridges 
readily reduce to cysteine and may result in an increase in the rate of 
degradation that’s controllable via the ratio of disulphide bridges to covalent 
bonds. This mechanism has been described for albumin where disulphide 
bridges and ionic bonds make it a readily degradable biopolymer for medical 
applications (Nair and Laurencin, 2007). The solubility of keratins is also 
facilitated by the oxidation and reduction of the main stabilising bonds, 
disulphide bridges. The cystine content can be as high as 18% in keratins 
(Kasperova, Kunert and Raska, 2013). 
 
All the aspects identified above ensure the polymerisation process for the 
hydrogel described in this study adheres to all the principles required for a 
green chemistry process and should allow for an industrially viable process. 
 
 
4.7 Further Hydrogel Optimisation 
 
Further optimisation of the hydrogel was undertaken to optimise the 
polymerisation process with particular reference to creating a reproducible 
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lens material. Previously, a reproducible hydrogel was polymerised as 1 mm 
thick sheets in trays, however, when the same polymer was cast in 
male/female contact lens moulds a build-up of CO2 gas from the reaction 
resulted in the break-up of the polymer. An investigation of methods to 
overcome this problem was undertaken and focussed on the polymerisation 
method and composition of the polymer. 
 
An initial emphasis focussed on using other polymerisation methods or 
vessels. Numerous attempts were made at creating a viable lens from the 
traditional mould methods with NHS as the activation agent but the formation 
of CO2 led to bubbles getting trapped within the polymer resulting in the 
deterioration of the hydrogel. The immiscible solvent technique was also tried 
and resulted in an uneven and non-reproducible polymer. A spin cast 
technique resulted in small hydrogel blobs that did not resemble contact lens 
materials. Spin casting may still provide a potential route with further 
development of the reaction parameters as an open vessel polymerisation 
would allow for the escape of any CO2 produced negating the need to 
replace NHS as the activation agent.   
 
NHS upon reaction with EDCI to form an activated ester intermediate and the 
subsequent stable bis-carboxylic acid ester can also result in the formation of 
β-alanine (Wilchek and Miron, 1987; Hermanson, 2013a). The β-alanine side 
product can be incorporated into the polymer backbone and influence the 
polymer mechanical properties. To overcome this and create a lens via this 
method NHS was replaced with other activating agents and the reactions 
monitored to identify suitable alternatives (Appendix 8.2, 8.3.2 and 8.4.2). 
HOBt was identified as the most suitable alternative to NHS as no gas was 
formed during the polymerisation and a viable lens was retrieved, however, 
the mechanical properties were negatively affected. 
 
A recent amino acid analysis (Alta Bioscience Ltd., Birmingham, England) of 
a polymer with 0.1, 0.25, 0.5, 0.75 and 1 equivalents of NHS to the total 
amino groups of pεK found an incremental increase in the incorporation of 
the β-alanine side-product as the level of NHS increased (4.2, 9.8, 21.9, 34.7 
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and 58.9% of the total amino acid content of the hydrogel). It is unknown at 
this point how much the mechanical properties are reliant on β-alanine 
incorporation or the efficiency of NHS as the optimal activation reagent or a 
mixture of both. These data follow the literature where it is stated that three 
molecules of NHS are required to create and incorporate one β-alanine 
residue into the polymer, so when increasing amounts of NHS are available 
in the reaction it results in an increase in β-alanine incorporation into the 
polymer. 
 
The addition of different levels of decanedioic and tridecanedioic acid with 
octanedioic acid was investigated to improve mechanical properties with a 
reduction in the amount of NHS used in the polymerisation. This was to try 
and get similar mechanical properties to Su 60 14 but with 0.2 equivalents of 
NHS as opposed to 0.5 equivalents and thereby reduce β-alanine and CO2 
production. A subsequent investigation of the mechanical properties, water 
content, contact angle and light transmittance was undertaken (Appendix 
8.3.3 and 8.4.3). An array of hydrogels with differing mechanical and physical 
properties were obtained but none were comparable to Su 60 14 with 0.5 
equivalents of NHS used in the polymerisation. 
 
The protein sorption capacity of the hydrogel variants was also investigated 
to determine the potential for biofouling. The depletion of IgG, BSA and 
trypsin in the supernatant was used to determine the amount of protein 
absorbed onto the hydrogel variants (Appendix 8.3.4 and 8.4.4). Almost all 
the BSA had adsorbed onto all the hydrogel variants after 18 h with no 
significance between them. Interestingly minimal BSA had adsorbed on any 
of the control materials. This may be explained by BSA’s greater affinity for 
hydrophilic surfaces compared to hydrophobic surfaces, although some 
adsorption onto hydrophobic surfaces would still be expected (Jeyachandran 
et al., 2009). Less than 10% of the total IgG had adsorbed onto any of the 
materials tested after 120 h possibly due to the denaturation and aggregation 
of the antibody molecule observed when it is incubated at elevated 
temperatures (Vermeer and Norde, 2000). Significantly more trypsin had 
adsorbed onto all the polymer variants after 120 h than the hydrophobic 
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material controls which is an unexpected result. However, this may be due 
again to the nature of the polymer backbone and as already suggested 
(section 4.1.2) the affinity of trypsin to cleave at the carboxyl end of lysine 
which is the major constituent of the hydrogel variants (Koutsopoulos et al., 
2007). 
 
 
4.8 Other Applications 
 
The polymer investigated in this report has already shown a diverse range of 
mechanical and physical properties which have been optimised for the 
development of a bandage contact lens. These modifiable properties could 
allow the hydrogel to be tailored for a range of other applications. So far, we 
have investigated Su 60 14 for its antibacterial, antifungal and ability to carry 
biomolecules for bacterial cell labelling. Additional procedures to complement 
the work already undertaken as well as some other possible applications are 
described below.  
 
As a substrate for tissue engineering in the cornea, current researchers 
within our group are seeking to use a thin layer of the gel to support corneal 
endothelial cell growth and proliferation. It is envisaged that a monolayer of 
corneal endothelial cells attached to the hydrogel could be placed on a 
damaged endothelium and left in situ to allow regeneration of the 
endothelium and a return of the pumping mechanism required to maintain a 
healthy functioning cornea. Part of this work will look to alter the hydrophilicity 
of the hydrogel to allow cell adherence. This may be achieved with the 
addition of long chain fatty acids such as hexanoic acid, octanoic acid or 
decanoic acid to increase hydrophobicity that may promote cell adherence. 
The covalent attachment of cell adhesion peptides such as RGD may also be 
an option to aid cell adhesion.  
 
As a side note, the above monoacids are also antimicrobial and may be 
incorporated into the hydrogel in the same way as extra pεK was added to Su 
PεK. Many other antimicrobial compounds could be incorporated in the same 
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way such as the vast array of AMPs. The functionality of the polymer could 
be changed to introduce new functional groups similar to the conversion of 
amine to a carboxyl functionality with the addition of glutaric anhydride. One 
possibility could be to incorporate molecules via ester linkages or the 
formation of disulphide bridges between a cysteine in the hydrogel network 
and a cysteine within an AMP as a means of controlling drug elution. As well 
as being able to change the release profile of attached drugs ester linkages 
and disulphide bridges within the hydrogel network could also provide a 
means of changing the degradation rate where necessary. 
 
Microparticles are another promising tool in the area of drug release and the 
incorporation of drug loaded microparticles into the hydrogel network during 
polymerisation may provide a dual release mechanism. First, the drug within 
the hydrogel network would have a burst release profile followed by slower 
elution of the drug within the microparticles into the hydrogel network and 
subsequent elution from the polymer. This may provide a method to change 
a drug release profile from the undesirable burst release profile. SpheriTech 
have developed microparticles (SpheriSomes®) that have shown promise in 
the incorporation and release of an array of compounds and may be a 
possible candidate for this mechanism.     
 
A suggestion for increasing the oxygen permeability of the hydrogel without 
introducing silicone was to introduce other oxygen absorbing molecules during 
polymerisation. Haem and pyrogallol were two of the compounds mentioned, 
however, it is unclear whether these compounds would release any absorbed 
oxygen and allow it to pass through the lens or just capture it in situ. A more 
simplistic approach may be the formation of a microporous hydrogel via the 
incorporation of water extractable porosigens that can be completely removed 
post polymerisation to leave voids that would allow oxygen to permeate 
through the hydrogel more freely (Tighe and Mann, 2016).  
 
Other compounds such as smart probes could also be introduced, for 
example, to monitor the pH of wounds and relay information to monitor the 
wound for infection. This could allow for less disturbance to the wound bed 
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area when looking for visible signs of infection and allow for a quicker 
response if infection has been detected. Wound healing compounds such as 
perlecan and decorin could potentially be incorporated to increase the rate of 
wound healing for chronic wounds.   
 
The range of different applications for this hydrogel are vast and leaves a lot 
of scope for study of this material within many different areas. 
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5. CONCLUSIONS 
 
This study identified the potential of pεK/bis-caboxylic acid hydrogels as 
suitable materials for drug delivery bandage contact lenses with potential use 
in a range of ocular applications. This work clearly identified hydrogels with 
mechanical and physical properties comparable to commercial contact lens 
materials. Furthermore, the hydrogels could be loaded with clinically relevant 
doses of biomolecules and used to identify microbial pathogens and reduce 
the microbial burden of known ocular pathogens. These hydrogel bandage 
lenses may lead to successful identification and treatment of ocular infections 
with particular emphasis on microbial keratitis. 
 
Mechanical and physical characterisation of the hydrogels: 
• A range of hydrogels with tailorable mechanical properties can be 
polymerised with pεK and a range of saturated bis-carboxylic acids. 
• A variety of pεK/octanedioic acid hydrogels were synthesised with a 
range of elastic moduli whilst maintaining a relatively high water 
content (70%). 
• A hydrogel (Su 60 14) was synthesised that has comparable 
mechanical and physical properties to commercial contact lens 
materials.   
 
Hydrogel cytotoxicity: 
• The hydrogel (Su 60 14) was non-cytotoxic to the HCE-T cell line and 
did not impede re-epithelialisation from the subsequent scratch assay. 
• The reformed monolayer had good tight junction formation identified 
via ZO-1 and occludin staining with expression of epithelial cell 
specific keratins also evident. 
• The addition of biomolecules did not substantially increase cytotoxicity 
although some was observed after 24 h for hydrogels Su PεK and Su 
Pen G. 
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Antibacterial activity: 
• The unmodified hydrogel (Su 60 14) had a minimal antibacterial 
activity and this did not change with differences in the cross-link 
percentage of the hydrogels tested. 
• The surface attachment of pεK to the hydrogel post-polymerisation (Su 
PεK) resulted in a 12-fold increase in amine functional groups and was 
most effective against S. aureus attached to the hydrogel. 
• The penicillin G loaded hydrogel (Su Pen G) was most effective 
against planktonic S. aureus. Penicillin G elution was detected for 5 h 
after initial incubation of the hydrogel. 
 
Antifungal activity: 
• The hydrogel (Su 60 15) was successfully modified to increase AmpB 
loading as determined via RP-HPLC. 
• Both AmpB loaded hydrogels can kill C. albicans, however, the -NH2 
hydrogel had the greatest killing affect. 
• A therapeutic dose of AmpB eluted from both hydrogels for at least 48 
h and up to 72 h for the -NH2 hydrogel. The AmpB eluted from the 
hydrogels remained stable for at least 48 h. 
 
Microbe detection peptide: 
• Both BAC peptides were successfully associated with a modified Su 
60 14 hydrogel (Su 60 14 COOH). 
• Gram-positive and Gram-negative bacteria were identified by a BAC 
ONE loaded hydrogel (40 μM optimal incubation concentration). 
• A Gram-negative organism was identified by a BAC TWO loaded 
hydrogel (40 μM optimal incubation concentration). The peptide had 
no affinity for Gram-positive organisms.  
• Some non-specific staining of HCE-T cells was evident from the 
hydrogel with BAC ONE associated whilst only microbial cells were 
labelled from the hydrogels with BAC TWO associated in a co-culture 
of S. aureus or E. coli and HCE-T cells. 
• In vitro results were replicated in an ex vivo bacterial keratitis model. 
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6. FUTURE DIRECTION 
 
The work completed as part of this thesis has formed the basis of a 
successful MRC grant application (MR/R006334/1) to continue the work and 
bring a bandage contact lens to market. Some of the work necessary to bring 
a viable lens to market as well as additional complementary work is detailed 
below. 
 
In this thesis, a reproducible hydrogel was described and well characterised 
physically and mechanically. However, it was later identified that the most 
appropriate casting method (male/female mould) was unsuitable due to the 
chemistry involved in polymerisation. During NHS/EDCI mediated cross-
linking several side reactions occur with β-alanine and CO2 produced. This 
has a detrimental effect on the polymer when it is cast in a closed vessel as 
CO2 becomes trapped within the matrix. An initial fix was to replace NHS with 
HOBt which minimises β-alanine and CO2 production. This allowed a lens 
material to be cast from the hydrogel; however, the mechanical properties 
were reduced. Several changes were made to get around the problem such 
as the addition of mono acids or a mix of bis-carboxylic acids, a change in 
the activating agent and alterations to the levels of NHS used with a mix of 
results. However, significantly more work must be done to overcome this 
issue with some notable hurdles such as a lack of water soluble alternatives 
to NHS as the activating agent. An alternative open vessel polymerisation 
method may negate the need to replace NHS completely; however, this may 
need to be designed specifically for this polymer. Also, it appears β-alanine 
incorporation may be necessary to obtain optimal mechanical properties so 
addition of β-alanine, or other amino acids combined with HOBt activation 
may provide a way forward. 
 
The ex vivo cornea model described in this thesis could be adapted to 
investigate the antimicrobial activity of the hydrogels and complement the 
findings of the in vitro bacterial and fungal keratitis studies. Clinical isolates of 
S. aureus and C. albicans could be used with the more clinically relevant P. 
aeruginosa replacing E. coli as the model Gram-negative organism. More 
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clinically relevant antibiotics could also be used with meropenem replacing 
penicillin G as the model broad spectrum β-lactam antibiotic. Natamycin is 
the model antifungal drug for filamentous fungal infections so an investigation 
of Fusarium clinical isolates with natamycin associated with the hydrogel via 
its carboxyl moiety may also be of interest (Müller, Kara-José and De Castro, 
2013).    
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8. APPENDIX 
 
8.1 Hydrogel Composition 
 
An Excel spreadsheet used to work out the polymer composition of each of 
the hydrogel variants is described below (Figure 8.1). The spreadsheet was 
developed by Dean Simpkin and further optimised by Andrew Gallagher of 
SpheriTech Ltd. 
 
 
 
 
The shaded boxes are parameters that can be changed and once they are 
filled in a goal seek analysis is run. The total volume of polymer solution 
required is inputted and cell C3 changed. This gives the polymer composition 
for the required final volume. 
 
Figure 8.1: Excel spreadsheet for determining hydrogel composition.  
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8.2 Activation Agent 
 
 
Reagent 
PεK / octanedioic acid hydrogels 
 (Su 60 14) 
NHS 
(Su 60 14) 
HOBt 
(Su 60 14) 
Oxyma 
(Su 60 14) 
Oxyma B 
(Su 60 14) 
4-nitrophenol 
PεK 1.48 g       
(8.62 mmol) 
1.48 g       
(8.62 mmol) 
1.48 g       
(8.62 mmol) 
1.48 g       
(8.62 mmol) 
1.48 g       
(8.62 mmol) 
Octanedioic 
acid 
0.45 g       
(2.59 mmol) 
0.45 g       
(2.59 mmol) 
0.45 g       
(2.59 mmol) 
0.45 g       
(2.59 mmol) 
0.45 g       
(2.59 mmol) 
NMM 0.95 cm3 0.95 cm3 0.95 cm3 0.95 cm3 0.95 cm3 
EDCI 2.48 g 
(12.94 
mmol) 
2.48 g 
(12.94 
mmol) 
2.48 g 
(12.94 
mmol) 
2.48 g 
(12.94 
mmol) 
2.48 g 
(12.94  
mmol) 
Activation 
agent 
0.50 g     
(4.34 mmol) 
0.66 g 
(4.34 mmol) 
0.62 g 
(4.34 mmol) 
0.80 g 
(4.34 mmol) 
0.60 g 
(4.34 mmol) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 8.1: Su 60 14 with various activation reagents. 
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8.3 Further Hydrogel Optimisation - Methods 
 
Hydrogel reagents were supplied from the same sources as in section 2.1. 
The following raw materials were used in this part of the study; 
hexadecanoic acid B20322 and trypsin J60402 (Alfa Aesar, Haverhill, MA, 
USA), oxyma FE04090 (CMS Chemicals Ltd., Berkshire, England), 1,3-
dimethylbarbituric acid 8.42116.0100 (Merck Millipore Ltd., Watford, 
England), sodium nitrite, hexanoic acid 153745, BSA A7906 and IgG 
18640 (Sigma-Aldrich, St Louis, MO, USA), octanoic acid O0027 (TCI 
Europe, Zwijndrecht, Belgium), acetic acid 20104.334, NaOH  28244.364, 
toluene 28675.465 and MeOH (VWR International Ltd., Lutterworth, 
England), tridecanedioic acid (Shanghai Worldyang Chemical Co., Ltd., 
Shanghai, China). All other equipment and reagents were supplied by 
SpheriTech Ltd. unless otherwise stated. 
 
8.3.1 Optimisation of hydrogel washing protocol: 
Reaction by-products such as the isourea and NHS as well as unreacted pεK 
and bis-carboxylic acid can remain associated with the hydrogel post-
polymerisation. The pεK is also supplied as the hydrochloride salt and this 
can remain associated with the amine functional groups of the hydrogel post-
polymerisation, potentially hindering biomolecule association. It is therefore 
vital that an optimal wash protocol is implemented post-polymerisation.  
 
In the first instance a comparison was made between Su 60 15, Su 60 14, Su 
60 13 and Su 65 15 either washed in 13 x H2O (50 cm3) or with a previously 
established washing system which consists of 1 x H2O, 3 x NaOH (0.25 mol 
dm-3), 3 x H2O, 3 x HCl (0.25 mol dm-3) and 3 x H2O. Each wash protocol 
was followed up with another H2O wash after 4 days. Samples of specified 
washes were monitored with a Cecil CE292 UV spectrophotometer (Cecil 
Instruments Ltd., Cambridge, England) at 230 nm to determine any 
leachables eluted from the hydrogels and compared to the initial wash. 
 
A continuation of this study investigated the mechanical properties of Su 60 
14 washed in three different ways. The wash system was either 10 x H2O or 
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1 x H2O, 2 x NaOH (0.25 mol dm-3), 2 x H2O, 2 x HCl (0.25 mol dm-3) and 4 x 
H2O or 5 x 10 v/v% aqueous NMM and 5 x H2O. All washes were 50 cm3 and 
the samples were again monitored with a Cecil CE292 UV 
spectrophotometer (Cecil Instruments Ltd., Cambridge, England) at 230 nm. 
The mechanical properties of the samples were monitored as in section 2.1.3 
over a period of one month.      
 
8.3.2 Activation agent: 
The cross-linking activation agents were altered for hydrogel Su 60 14 by 
reducing their amounts or changing the compound completely. This was to 
try and minimise the effects of the CO2 gas that forms during cross-linking 
and negate its effect on the hydrogel in closed vessels (i.e. contact lens 
moulds). The hydrogel was then renamed depending on the amount or 
activation compound used. 
 
The hydrogel was polymerised following the protocol in section 2.1.2 with the 
following adjustments; the amount of NHS was reduced to 50, 25, 20, 15 and 
12.5% of the original amount or NHS was replaced with either HOBt, oxyma, 
oxyma B or 4-nitrophenol (Table 8.1). The hydrogels (2 x 10 cm3 aliquots) 
were poured separately into 10 cm2 square Petri dishes (Thermo Scientific, 
Waltham, WA, USA). The remaining solution (30 cm3) was left in the 50 cm3 
Falcon tube with the lid sealed and left to polymerise. 
 
The shrinkage and colour of the polymer, gas formation and polymerisation 
time were all recorded. 
  
8.3.2.1 Oxyma B synthesis: 
The following protocol was adapted from the original protocol (Jad et al., 
2014). 1,3-dimethylbarbituric acid (2.5 mmol, 3.9 g) was dissolved in NaOH 
(2.5 M, 15 cm3). MeOH (2.5 cm3) was added to the transparent solution. 
Sodium nitrite (0.0275 mol, 1.9 g) was dissolved in water (7.5 cm3) and 
added to the 1,3-dimethylbarbituric acid solution and stirred at 45 °C for 2 - 3 
min to keep the solute in solution. The mixture was cooled to 10 °C to form a 
precipitate before adding acetic acid (7.5 mmol, 4.5 g) dropwise. The mixture 
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was kept at 25 °C for 1 h. The reaction was acidified with the addition of 
concentrated HCl (6.25 cm3) followed by stirring for 10 min. The precipitate 
was filtered using a water vacuum and washed with 50 v/v% aqueous MeOH 
followed by a water wash. The product was recrystallised from aqueous 
MeOH (2:1) to obtain white crystals of oxyma B. 
 
8.3.3 Additional molecules – bis-carboxylic acids: 
The composition of hydrogel Su 60 14 was altered with the addition of 
differing ratios of decanedioic and tridecanedioic bis-carboxylic acids to 
change the mechanical properties without changing the cross-linking and the 
density of the polymer. The hydrogel was then renamed depending bis-
carboxylic acids used.   
 
PεK (3.71 g) was added to a 50 cm3 Falcon tube with water (15 cm3) and 
placed on a roller to dissolve. Filtered 5 v/v% aqueous Tween 80 (250 mm3) 
was added. The bis-carboxylic acids supplied as solids were dissolved in 
water (5 cm3) with NMM (2.37 cm3) and sonicated until dissolved. The 
remaining bis-carboxylic acids supplied as liquids were mixed with the other 
bis-carboxylic acid solution as soon as a clear solution was obtained. The 
bis-carboxylic acid solution was added to the pεK solution and made up to 25 
cm3 with water. NHS (1.24 g) and EDCI (6.2 g) were measured into a 50 cm3 
Falcon tube and dissolved in water (15 cm3) before making up to 25 cm3. All 
solutions were filtered to 0.45 µm using a syringe filter. EDCI and NHS were 
mixed and immediately added to the pεK/octanedioic acid solution. This was 
inverted five times. An aliquot of the polymer solution (10 cm3) was poured 
into each 10 cm2 square Petri dish (Thermo Scientific, Waltham, WA, USA).  
These were incubated for at least 5 h at room temperature until the hydrogel 
had polymerised. The hydrogel was then covered with water to prevent 
dehydration. The hydrogels were washed 5 x H2O before the resulting 
analysis. 
 
Mechanical properties (section 2.1.3), refractive index (section 2.1.5), 
gravimetric water content (section 2.1.7) and contact angle (section 2.1.9) 
were all measured as in the relevant previous sections. 
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8.3.4 Protein sorption study: 
An investigation of biofouling was undertaken to determine the rate at which 
different proteins become absorbed onto the hydrogel variants. Hydrogels Su 
60 15, Su 60 14, Su 60 13 and Su 65 15 were polymerised as already 
described in section 2.1.2. 
 
A 1 mg cm-3 aqueous solution (10 cm3) of each protein (trypsin, BSA and 
IgG) was prepared. Hydrogel discs were cut (0.785 cm2) and incubated at 5 
discs in a 7 cm3 vial with each protein solution (5 cm3) at 37 °C for set time-
points over 18 h. At each time-point supernatant was removed (3 cm3) and 
the absorbance read at 280 nm with a Cecil CE292 UV spectrophotometer 
(Cecil Instruments Ltd., Cambridge, England) against the starting 
concentration of the corresponding protein solution. A standard curve of each 
protein concentration against absorbance was composed using 1, 0.5, 0.25, 
0.125 and 0.0625 mg cm-3 protein solutions against a water blank at 280 nm.  
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8.4 Further Hydrogel Optimisation - Results 
 
8.4.1 Hydrogel wash optimisation:  
An investigation of the hydrogel wash procedure post-polymerisation was 
undertaken to determine the most efficient method.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The wash supernatant from four hydrogel variants (Su 60 15, Su 60 14, Su 
60 13 and Su 65 15) was monitored via a spectrophotometer and the 
absorbance obtained was converted to a percentage of the absorbance from 
the first wash (Table 8.2). At the end of each wash procedure < 2% of 
leachables were still present for most the hydrogels except for Su 60 14 after 
the HCl/NaOH wash (15.9% ± 12.7%). However, there was a large margin of 
error associated with this value.  
Su 60 15 Su 60 14 Su 60 13 Su 65 15 Su 60 15 Su 60 14 Su 60 13 Su 65 15
H2O 100.0 100.0 100.0 100.0 H2O 100.0 100.0 100.0 100.0
H2O 13.0 +/- 1.3 69.2 +/- 1.6 17.6 +/- 0.4 15.2 +/- 3.0 NaOH 118.4 +/- 6.4 120.9 +/- 2.8 120.5 +/- 5.9 177.7 +/- 23.8
H2O NaOH
H2O 25.9 +/- 0.9 5.4 +/- 0.6 29.7 +/- 0.7 0.9 +/- 0.3 NaOH 23.0 +/- 3.1 25.1 +/- 0.7 35.0 +/- 2.1 49.6 +/- 5.4
H2O H2O
H2O 4.6 +/- 0.3 5.5 +/- 0.2 4.0 +/- 0.3 0.5 +/- 0.3 H2O 0.1 +/- 0.1 0.0 +/- 0.1 0.3 +/- 0.2 0.5 +/- 0.3
H2O H2O
H2O 2.8 +/- 0.3 6.0 +/- 0.8 2.3 +/- 1.3 0.5 +/- 0.4 HCl -0.6 +/- 0.2 -0.6 +/- 0.2 -0.7 +/- 0.3 -1.0 +/- 0.2
H2O HCl
H2O 0.9 +/- 0.2 4.2 +/- 0.3 3.7 +/- 0.4 1.5 +/- 0.1 HCl -0.3 +/- 0.1 -0.2 +/- 0.2 -0.3 +/- 0.2 -0.7 +/- 0.0
H2O H2O
H2O H2O
H2O 0.5 +/- 0.2 1.7 +/- 0.2 1.5 +/- 0.1 0.3 +/- 0.2 H2O 0.4 +/- 0.3 15.9 +/- 12.7 -0.4 +/- 0.1 -0.8 +/- 0.2
4d H2O 76.2 +/- 1.8 80.1 +/- 3.0 82.0 +/- 5.0 113.6 +/- 3.4 4d H2O -0.1 +/- 0.1 -0.1 +/- 0.1 0.0 +/- 0.0 -0.2 +/- 0.1
Mean % of first wash Mean % of first wash
Wash 
protocol
Wash 
protocol
Table 8.2: Absorbance of wash components against original wash. 
Figure 8.2: Freeze dried hydrogel after water washes (left) or NMM washes (right). 
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and c) NMM washes. Error bars ±SD, * p < 0.05 ** p < 0.01 *** p < 0.005 N = 4. 
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Table 8.3: Characteristics of hydrogel Su 60 14 when polymerised using different 
activation agents. N = 3.c) 
a) 
 
Figure 8.3: Mechanical properties of Su 60 14 after a) H2O washes, b) acid/base washes 
and c) NMM washes.a) 
b) 
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The NMM wash was more efficient at removing the hydrochloride salt 
associated with the hydrogel than the H2O wash (Figure 8.2). Mechanical 
property analysis over 32 days showed a statistically significant (p < 0.005) 
decrease in strain and increase in elastic modulus was obtained when 
hydrogel Su 60 14 was washed in H2O or HCl/NaOH (Figure 8.3). In contrast, 
there was no significant change in strain when the hydrogel was washed in 
NMM.  
 
8.4.2 Activation agent: 
An investigation of different activation agents with view to replacing NHS was 
undertaken. This was to potentially reduce gas formation during 
polymerisation. Four out of five of the hydrogels polymerised, with 
nitrophenol excluded as a potential activation agent due to the lack of 
hydrogel formation (Figure 8.4). Of the remaining hydrogels, NHS resulted in 
the fastest polymerisation time (7 min) and a clear polymer, however, gas 
was formed (Table 8.3). The addition of HOBt resulted in a clear hydrogel 
with no gas formation. The hydrogel also swelled upon washing and had a 
relatively long polymerisation time (29 min). Oxyma and oxyma B resulted in 
coloured hydrogels and gas was formed with oxyma B.  
 
 
Su 60 14 Polymerised 
Size (cm2) 
Washed 
Size (cm2) 
Polymerisation 
Time (min) 
Colour Gas 
NHS 7.37 +/- 0.1 7.17 +/- 
0.1 
7.00 +/- 0.0 Clear Y 
HOBt 8.83 +/- 0.2 9.97 +/- 
0.1 
29 +/- 1.0 Clear N 
Oxyma B 8.23 +/- 0.1 8.2 +/- 0.0 10 +/- 0.0 Light 
Orange 
Y 
Oxyma 7.7 +/- 0.1 8.1 +/- 0.1 21 +/- 1.0 Orange N 
Nitrophenol _ _ _ _ _ 
 
 
 
Table 8.3: Characteristics of hydrogel Su 60 14 when polymerised using different 
activation agents. N = 3. 
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8.4.2.1 Oxyma B synthesis: 
A white crystalline solid was obtained (3.5 g) with a yield of 76%. Once 
dissolved the solid turns to a purple/red colour. 
 
As 0.025 mol of 1,3-dimethylbarbituric acid was used and an equivalent of 
oxyma B can be expected as the end-product if a 100% yield is achieved. 
Therefore, an equivalent (0.025 mol) of oxyma B (MW: 185 g mol-1) is 4.625 
g. 
 
3.5 / 4.625 x 100 = 76% 
 
 
8.4.3 Additional molecules: 
The physical and mechanical properties of the hydrogel were monitored with 
the addition of decanedioic and tridecanedioic as a combination of bis-
carboxylic acid cross-linker with octanedioic acid. The same properties were 
monitored with varying levels of NHS added as the activating agent. 
 
8.4.3.1 Mechanical properties: 
The mechanical properties were measured as in section 2.1.3 and used to 
compare the effect of different levels of octanedioic/decanedioic acid, 
octanedioic/tridecanedioic acid and NHS have on the polymerised hydrogel. 
 
Figure 8.4: Hydrogel Su 60 14 with different activation agents. 
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Figure 8.5: Elastic modulus (a) and strain (b) of hydrogel variants with altered bis-
carboxylic acid and NHS compositions. Error bars ±SD, * p < 0.05 ** p < 0.01 *** p < 
0.005 N = 4. 
a) 
 
a) 
b) 
 
Figure 8.5: Elastic modulus (a) and strain (b) of hydrogel variants with altered bis-
carboxylic acid and NHS compositions. Error bars ±SD, * p < 0.05 ** p < 0.01 *** p < 
0.005 N = 4.b) 
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8.4.3.2 Water content: 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
8.4.3.3 Contact angle: 
 
 
 
 
 
 
 
 
 
 
Figure 8.6: Water content of hydrogel variants with altered bis-carboxylic acid and NHS 
compositions. Error bars ±SD, ** p < 0.01 N = 4. 
Figure 8.7: Contact angle of hydrogel variants with altered bis-carboxylic acid and NHS 
compositions. Error bars ±SD, * p < 0.05 ** p < 0.01 *** p < 0.005 N = 4. 
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8.4.3.4 Light transmittance: 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 8.8: Light transmittance of hydrogel variants with altered bis-carboxylic acid and 
NHS compositions. Error bars ±SD, * p < 0.05 ** p < 0.01 *** p < 0.005 N = 4. 
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8.4.4 Protein sorption: 
 
 
 
 
a) 
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b) 
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Figure 8.9: Sorption of BSA (a), IgG (b) and trypsin (c) onto the hydrogel variants. Error 
bars ±SD, * p < 0.05 ** p < 0.01 *** p < 0.005 N = 4. 
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